UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal Year ended December 31, ~~2023~~2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________.

Commission file number: 001-41309

iCoreConnect Inc.

(Exact name of registrant as specified in its charter)

Delaware

86-2462502

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

529 E Crown Point Road, Suite 250 Ocoee, FL 34761

(Address of principal executive offices) (Zip Code)

(888) 810-7706

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbols(s)		Name of each exchange on which registered
Common stock, par value $0.0001 per share		ICCT		The NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging Growth Company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The aggregate market value of voting and non-voting stock held by non-affiliates of FG Merger Corp. (“FG”), our predecessor, on June 30, 2023, based on the closing price of $10210.5360 for shares of FG’s common stock, was approximately $85.2 million. Shares of common stock beneficially owned by each executive officer, director, and holder of more than 10% of our common stock have been excluded in that such persons may be deemed to be affiliates.

The number of shares outstanding of the Registrant’s Common Stock as of ~~April~~May 1829, ~~2024~~2025: 104,~~150~~877,~~753~~080

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive proxy statement for its 2024 Annual Meeting of Stockholders (Proxy Statement) to be filed within 120 days of the registrant’s fiscal year ended December 31, 2023, are incorporated by reference in Part III of this Report on Form 10-K. Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K.None

Table of Contents

Item			Page	~~Page~~
Part I
	Forward-Looking Statements	~~Forward-Looking Statements~~	3	3
1.	Business	~~Business~~	4	4
1A.	Risk Factors	~~Risk Factors~~	9	9
1B.	Unresolved Staff Comments	~~Unresolved Staff Comments~~	20	18
1C.	Cybersecurity	~~Cybersecurity~~	20	18
2.	Properties	~~Properties~~	21	18
3.	Legal Proceedings	~~Legal Proceedings~~	21	18
4.	Mine Safety Disclosures	~~Mine Safety Disclosures~~	21	18
Part II
5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	~~Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities~~	22	19
6.	Reserved	~~Reserved~~	23	20
7.	Management’s Discussion and Analysis of Financial Condition and Results of Operation	~~Management’s Discussion and Analysis of Financial Condition and Results of Operation~~	23	20
7A.	Quantitative and Qualitative Disclosures About Market Risk	~~Quantitative and Qualitative Disclosures About Market Risk~~	31	27
8.	Financial Statements and Supplementary Data	~~Financial Statements and Supplementary Data~~	32	28
9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	~~Changes in and Disagreements with Accountants on Accounting and Financial Disclosure~~	33	29
9A.	Controls and Procedures	~~Controls and Procedures~~	33	29
9B.	Other Information	~~Other Information~~	34	30
9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.	~~Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.~~	34	30
Part III
10.	Directors, Executive Officers and Corporate Governance	~~Directors, Executive Officers and Corporate Governance~~	35	31
11.	Executive Compensation	~~Executive Compensation~~	40
12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	~~Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters~~	44	31
13.	Certain Relationships and Related Transactions, and Director Independence	~~Certain Relationships and Related Transactions, and Director Independence~~	46	31
14.	Principal Accounting Fees and Services	~~Principal Accounting Fees and Services~~	47	31
Part IV
15.	Exhibits, Financial Statement Schedules	~~Exhibits, Financial Statement Schedules~~	48	32
16.	Form 10-K Summary	~~Form 10-K Summary~~	49	33
Signatures			50	34

Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Report and the documents we have filed with the Securities and Exchange Commission (the “SEC”) that are incorporated by reference herein contain forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that involve significant risks and uncertainties. Any statements contained, or incorporated by reference, in this Report that are not statements of historical fact may be forward-looking statements. When we use the words “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will” and other similar terms and phrases, including references to assumptions, we are identifying forward-looking statements. Forward-looking statements involve risks and uncertainties which may cause our actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements.

Important factors that could cause actual results to differ materially from our expectations include, but are not limited to, the factors discussed in the sections entitled “Item 1A. Risk Factors” and under the heading “Critical Accounting Policies and Estimates” within “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” All forward-looking statements attributable to us are expressly qualified in their entirety by the factors that may cause actual results to differ materially from anticipated results. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s opinion only as of the date hereof. We undertake no duty or obligation to revise or publicly release the results of any revision to these forward-looking statements. Readers should carefully review the risk factors described in Item 1A of this document as well as in other documents we file from time to time with the SEC for an understanding of the variables that can affect our business and results of operations.

Note Regarding Reverse Stock Split

The Company effected a reverse stock split of its outstanding common stock at a ratio of 1-for-20, effective as of December 23, 2024, for the purpose of complying with Nasdaq Listing Rule 5550(a)(2) and satisfying the bid price requirements. We have reflected the reverse stock splits herein, unless otherwise indicated.

Table of Contents

PART I

Item 1. Business.

Overview

Company History

iCoreConnect Inc., (the “Company”), a Delaware Corporation, is a cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise platform of applications and services.

Business Combination

On January 5, 2023, the Company entered into a Merger Agreement and Plan of Reorganization (the “Merger Agreement”), by and among the Company, iCoreConnect, Inc.., a Nevada corporation (“Old iCore”), and FG Merger Sub Inc., a Nevada corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”). The Merger Agreement provided that, among other things, at the closing (the “Closing”) of the transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Old iCore (the “Merger”), with Old iCore surviving as a wholly-owned subsidiary of the Company. In connection with the Merger, the Company changed its name from FG Merger Corp. to “iCoreConnect Inc.” The Merger and the other transactions contemplated by the Merger Agreement are hereinafter referred to as the “Business Combination.” On August 25, 2023, Old iCore and FGMC consummated the Business Combination, with Old iCore surviving as a wholly owned subsidiary of FGMC.

On October 1, 2024, the Company sold the assets of its Managed IT Services (MSP and MSaaS).

Table of Contents

Software as a Service (SaaS) Offerings

The Company currently markets secure Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) offerings under the names of iCoreRx, iCorePDMP, iCoreEPCS, iCoreVerify, iCoreVerify+, iCoreHuddle~~, iCoreHuddle~~+, iCoreCodeGenius, iCoreExchange, iCoreCloud, iCorePay, iCoreSecure, iCoreClaims and iCoreIT. The Company’s software is sold under annual recurring revenue subscriptions.

iCoreRx - iCoreRx is a HIPAA compliant electronic prescription SaaS solution that integrates with popular practice management and electronic health record systems. It saves time by selecting exact medications at available doses with built-in support from a drug directory and provides full support for Electronic Prescriptions for Controlled Substances (iCoreEPCS). Additional functionality to iCoreRx to extend your electronic prescribing capabilities to include controlled substances as defined by the DEA schedule. iCorePDMP is an add-on for iCoreRx that seamlessly integrates with state databases to automate prescription drug monitoring. Providers in many states are required to check the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances. This service provides one-click real-time access to the state databases without the need to manually enter data. This tool also generates patient risk scores and an interactive visualization of usage patterns to help the prescriber identify potential risk factors. The prescriber can then use this report to make decisions on objective insight into potential drug misuse or abuse which will ultimately lead to improved patient safety and better patient outcomes.

iCoreVerify and iCoreVerify+ - iCoreVerify is a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits seven (7) days in advance of their appointment and on-demand using iCoreConnect’s real time technology. Automation runs daily to verify insurance for every patient on the schedule a full week in advance of their appointment date. The system returns results typically in less than one second for most responses. This substantially reduces the phone calls and labor hours for the practice. This tool integrates with most popular practice management systems. iCoreVerify+ adds a unique add-on service that augments iCoreConnect’s automation with a concierge service that turns around requests traditionally in less than 24 hours. It includes all carriers including non-digital ones and is customized to the client's specialty.

iCoreClaims - iCoreClaims is responsible for processing and managing claims submitted by policyholders or dental care providers and typically involves: (a) Claim Submission: Dental care providers (such as dentists or orthodontists) submit claims to the insurance company on behalf of patients after providing dental services. The claim includes details such as the type of treatment provided, codes for procedures performed, patient information, and provider details; (b) Verification and Eligibility: iCoreClaims service verifies the patient's eligibility for coverage based on the terms of their insurance policy. This involves checking if the patient's policy covers the specific dental treatment or procedure being claimed; (c) Adjudication: Once the claim is submitted and eligibility is confirmed, iCoreClaims processes the claim by reviewing it against the terms of the policy. This includes checking for any exclusions or limitations on coverage, ensuring the services rendered are medically necessary, and determining the applicable co-pays, deductibles, and coverage limits; (d) Communication: Throughout the claims process, iCoreClaims communicates with both the dental care provider and the policyholder to resolve any issues, provide explanations of benefits (EOBs), and answer any questions related to the claim; (e) Record Keeping: iCoreClaims maintains records of all claims processed, payments made, and communications related to each claim for auditing, reporting, and customer service purposes; (f) iCoreClaims service plays a crucial role in facilitating the reimbursement process for dental care services covered under insurance policies, ensuring that policyholders receive the benefits they are entitled to and that dental care providers are appropriately compensated for their services; (g) From a technology standpoint, the use of cloud software for documentation and U.S.-based billing specialists highlights iCoreConnect's strategy to combine advanced software with expert human intervention. This hybrid approach can be particularly appealing to healthcare providers who are seeking technological solutions without completely forgoing the human touch that is often necessary for complex billing and coding scenarios.

Table of Contents

iCoreHuddle and iCoreHuddle+ - iCoreHuddle is a powerful HIPAA compliant SaaS solution to instantly reveal the revenue potential of each patient. This product is currently limited to dental practices. The service connects to most popular practice management and electronic health record systems to optimize revenue realization. It provides the practice with a dashboard containing various metrics, analytics, and key performance indicators (“KPIs”). iCoreHuddle provides a daily view of patient schedules, including their outstanding balances, unscheduled treatment plans, recall information, procedure information and the amount of remaining insurance benefits. The software also provides one-click access to each patient’s insurance eligibility, including a detailed benefits and deductibles report. This tool aims to increase the workflow efficiency of the dentist’s practice by reducing the number of required lookups and clicks for each patient. iCoreHuddle+ offers enhanced analytical tools for practices to optimize their revenue generation process and workflows.

iCoreCodeGenius - iCoreCodeGenius is a medical coding reference SaaS solution that provides the coding standards for the 10th revision of the International Classification of Diseases and Related Health Problems (ICD-10), a medical classification list published by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury and diseases. This year the company added CPT codes to the software. CPT Codes (Current Procedural Terminology Codes) are a set of medical codes used by healthcare providers to describe medical, surgical, and diagnostic services and procedures. They are maintained by the American Medical Association (AMA) and are essential for billing and documentation in the healthcare system, iCoreCodeGenius includes a full ICD-10 code lookup and guidance, automatic prompting of comorbidities and Hierarchical Condition Category’s (HCC) to aid in obtaining the appropriate reimbursement with a high degree of accuracy, and the ability to reduce or eliminate queries and denials.

~~iCoreCodeGenius~~iCoreExchange ~~includes~~- iCoreExchange provides a ~~full~~secure, ~~ICD-10~~HIPAA ~~code~~compliant ~~lookup~~SaaS ~~and~~email ~~guidance,~~solution ~~automatic~~using ~~prompting~~the ofdirect ~~comorbidities~~protocol that allows doctors to send and ~~Hierarchical~~receive ~~Condition~~secure ~~Category’s~~email ~~(HCC)~~with attachments to ~~aid~~and infrom ~~obtaining~~other healthcare professionals in the ~~appropriate~~network. ~~reimbursement~~iCoreExchange also provides a secure email mechanism to communicate with users outside the exchange e.g., patients and referrals. Users can build a ~~high~~community, ~~degree~~access ofother ~~accuracy~~communities and increase referrals and collaboration. Users can email standard office documents, JPEG, PDF as well as patient files with discrete data, which can then be imported and ~~the~~accessed ~~ability~~on tomost ~~reduce~~Electronic orHealth ~~eliminate~~Record ~~queries~~(EHR) and ~~denials~~Practice Management (PM) systems in a HIPAA compliant manner.

~~iCoreExchange~~iCoreCloud - ~~iCoreExchange~~iCoreCloud ~~provides~~offers acustomers ~~secure,~~the ~~HIPAA~~ability ~~compliant~~to ~~SaaS~~back ~~email~~up ~~solution~~their ~~using~~on-premise servers and computers to the ~~direct~~cloud. ~~protocol~~iCoreCloud ~~that~~is ~~allows~~a ~~doctors~~fully toHIPAA ~~send~~compliant and ~~receive~~automated ~~secure~~backup ~~email~~solution. ~~with~~The ~~attachments~~data tobacked ~~and~~up ~~from~~is ~~other~~encrypted ~~healthcare~~both ~~professionals~~ in ~~the~~transit ~~network.~~and ~~iCoreExchange~~while ~~also~~at ~~provides~~rest. aIn ~~secure~~case ~~email~~of ~~mechanism~~full todata ~~communicate~~loss, ~~with~~the ~~users~~mirrored ~~outside~~data in the ~~exchange~~cloud ~~e.g.,~~can ~~patients~~be ~~and~~seamlessly ~~referrals.~~restored ~~Users~~back ~~have~~to the ~~ability~~practice toon ~~build~~ a ~~community,~~new ~~access~~computer ~~other~~or ~~communities~~a ~~and~~server. ~~increase~~The ~~referrals~~data ~~and~~is ~~collaboration.~~stored ~~Users~~encrypted ~~can~~in ~~email~~HIPAA ~~standard~~compliant ~~office~~data ~~documents,~~centers ~~JPEG,~~with ~~PDF~~multiple aslayers ~~well~~of asredundancy. ~~patient~~The ~~files~~data ~~with~~centers ~~discrete~~are ~~data,~~physically ~~which~~secure ~~can~~with ~~then~~restricted bepersonnel ~~imported~~ and ~~accessed~~biometric onaccess. ~~most~~The ~~Electronic~~locations ~~Health~~are ~~Record~~also ~~(EHR)~~guarded ~~and~~by ~~Practice~~security ~~Management~~24 ~~(PM)~~hours ~~systems~~a inday, a365 ~~HIPAA~~days ~~compliant~~a ~~manner~~year.

~~iCoreCloud~~iCorePay - ~~iCoreCloud~~iCorePay ~~offers~~is ~~customers~~a ~~the~~cloud-based ~~ability~~financial totechnology ~~backup~~(FinTech) ~~their~~solution ~~on-premise~~designed ~~servers~~to streamline the billing and ~~computers~~payment toprocesses ~~the~~for ~~cloud.~~healthcare ~~iCoreCloud~~providers, isoffering a ~~fully~~modern ~~HIPAA~~and ~~compliant~~efficient ~~and~~way ~~automated~~to ~~backup~~manage ~~solution~~patient payments. The ~~data~~platform ~~backed~~integrates upwith isexisting ~~encrypted~~healthcare ~~both~~management insystems, ~~transit~~allowing ~~and~~for ~~while~~easy atcreation ~~rest.~~and Insending ~~case~~ of ~~full~~HIPAA-compliant ~~data~~billing ~~loss~~statements, ~~the~~as ~~mirrored~~well ~~data~~as inaccepting ~~the~~various ~~cloud~~digital ~~can~~payment bemethods ~~seamlessly~~like ~~restored~~Apple ~~back~~Pay, toGoogle ~~the~~Pay, ~~practice~~and onPayPal. aThis ~~new~~system ~~computer~~aims orto aimprove ~~server.~~patient ~~The~~experience ~~data~~by ismaking ~~stored~~payments ~~encrypted~~easier inand ~~HIPAA~~more ~~compliant~~convenient, ~~data~~while ~~centers~~also ~~with~~boosting ~~multiple~~revenue ~~layers~~collection offor ~~redundancy~~healthcare providers. ~~The~~Additionally, ~~data~~iCorePay ~~centers~~helps ~~are~~reduce ~~physically~~costs ~~secure with restricted personnel~~ and ~~biometric~~administrative ~~access.~~burdens ~~The locations are also guarded~~ by ~~security~~automating 24much ~~hours~~of athe ~~day,~~billing ~~365 days a year~~process.

~~iCorePay~~iCoreSecure -We ~~iCorePay~~used ~~offers~~our aexpertise ~~seamless patient payment processing~~ and ~~billing~~development ~~solution~~capabilities ~~for~~from ~~customers.~~our ~~iCorePay~~HIPAA ~~integrates~~compliant ~~into~~iCoreExchange ~~the practice workflow for payment~~ and ~~revenue~~developed ~~cycle tracking. Unlike traditional healthcare billing methods~~iCoreSecure, ~~iCorePay~~an ~~speeds~~encrypted upemail ~~the~~solution ~~payment~~for ~~process~~anyone bythat ~~connecting~~needs ~~with~~encrypted ~~your~~email ~~patients~~to onprotect ~~the~~personal ~~platforms~~ and ~~with~~financial ~~the~~data. ~~digital~~iCoreSecure ~~payment~~is ~~methods~~a ~~they’re~~secure ~~already~~SaaS ~~using.~~solution ~~Create~~that ~~custom~~solves ~~messaging~~privacy ~~for~~concerns ~~valuable~~in ~~patient~~insurance, ~~touchpoints.~~real ~~Deliver~~estate, ~~flexible~~financial ~~payment plans~~ and ~~payment~~many ~~reminders~~other onindustry ~~your~~sectors ~~own~~that ~~schedule,~~have ~~with~~a ~~your~~need ~~own branding, with patient savings~~ for ~~same~~secure ~~day~~encrypted ~~or pre-appointment payments~~email.

iCoreSecure -We used our expertise and development capabilities from our HIPAA compliant iCoreExchange and developed iCoreSecure, an encrypted email solution for anyone that needs encrypted email to protect personal and financial data. iCoreSecure is a secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors that have a need for secure encrypted email.

iCoreIT - The trend in IT Services companies for over a decade has been to move away from a “Break/Fix '' model to a “Managed Service Provider (MSP)” and “Managed Software as a Service (MSaaS)” model with recurring revenue.

Managed IT Services (MSP and MSaaS)

The MSP/MSaaS approach, by using preventative measures, keeps computers and networks up and running while data is accessible and safeguarded. Installation of critical patches and updates to virus protection are automated. Systems are monitored and backed up in real-time. They are fixed or upgraded before they cause a service disruption. A Unified Threat Management solution is deployed to protect against viruses, malware, SPAM, phishing and ransomware attacks. Remote technical support is a click away. All support is delivered at a predictable monthly cost.

By leveraging managed services with our expertise in cloud computing, our customers can scale their business without extensive capital investment or disruption in services.

Table of Contents

The Company believes it is well positioned to address the growing need for managed services:

· Our current and future customers need managed IT services, along with cloud computing, storage and HIPAA compliant backup and encryption; · Managed service providers that can support the migration to cloud computing are in high demand; · The decision makers for our current technology and those for managed services are, in many cases, the same person or group of people; · Our management team has decades of experience operating successful IT companies; and the MSP revenue model matches our SaaS and MSaaS MRR (monthly recurring revenue) models.

Competition - The Company experiences competition from a variety of sources with respect to virtually all of its products and services. The Company knows of no single entity that competes with it across the full range of its products and services; however, each of the lines of business in which the Company is engaged is highly competitive. Competition in the markets served is based on several considerations, which may include price, technology, applications, experience, know-how, reputation, service, and distribution. While we believe we offer a unique combination of products and services, a few competitors offer one or more similar products and services in one or more of our niche markets.

Competitive Strengths

The key advantages of our products and services include:

1. Secure, private, scalable, and reliable.

Our services have been designed to provide our customers with privacy and high levels of performance, reliability, and security. We have built, and continue to invest in, a comprehensive security infrastructure, including firewalls, intrusion detection systems, and encryption for transmission over the Internet, which we monitor and test on a regular basis. We have designed, built, and continue to maintain a multi-tenant application architecture that has been designed to enable our service to scale securely, reliably and cost effectively. Our multi-tenant application architecture maintains the integrity and separation of customer data while still permitting all customers to use the same application functionality simultaneously.

2. Rapid deployment and lower total cost of ownership.

Our services can be deployed rapidly since our customers do not have to spend time procuring, installing, or maintaining the servers, storage, networking equipment, security products or other hardware and software. We enable customers to achieve up-front savings relative to the traditional enterprise software model. Customers benefit from the predictability of their future costs since they generally pay for the service on a per subscriber basis for the term of the subscription contract.

3. High levels of user adoption.

We have designed our products and services to be intuitive and easy to use. Our products and services contain many tools and features recognizable to users of popular consumer web services, so users have a more familiar user experience than typical EHR applications. As a result, our users can often use and gain benefit from our solutions with minimal training. We have also designed our products and services to be used on popular mobile devices, making it possible for people to conduct business from their smartphones or tablets.

Table of Contents

Competitive Strategy

Key elements of our strategy include:

1. Extending existing service offerings. We continue to innovate based on customer feedback and have designed our solutions to easily accommodate new features and functionality, especially in underserved areas of compliance and improved workflow/profitability for dental and physician practices. We continually look to improve our products and services by adding new features, functions and increased security through our own development, acquisitions, and partnerships.

2. Expanding existing customer relationships. We see significant opportunities to deepen our relationships with our existing customers. As our customers realize the benefits of our products and services, we aim to provide additional value-added products and services.

3. Expanding into new horizontal markets. As part of our growth strategy, we are delivering innovative solutions in new categories, including analytics, claims , coding, billing processing, and electronic prescribing. We drive innovation both organically and through acquisitions.

4. Extending go to market capabilities. We believe that our offerings provide significant value for businesses of any size. We continue to pursue businesses of all sizes and industries through our direct sales force and partnerships. In the past several years we have competed and won over 100 major healthcare association endorsements in 33 states. We plan to increase the number of direct sales professionals we employ and intend to develop additional distribution channels for our products and services.

In addition to the key elements of our business strategy described above, from time to time, we evaluate opportunities to acquire or invest in complementary businesses, services and technologies, and intellectual property rights.

Table of Contents

Customers

We had no significant customers (greater than 10% of total revenue) for the years ended December 31, ~~2023~~2024 and ~~2022~~2023, respectively. Customer concentration is not significant as the Company has a large number of individual customers. In addition, concentration is reduced by the number of new customers generated through the acquisitions we completed during 2024 and 2023 respectively, as well as through organic growth in both the number of customers and number of services being purchased by new and existing customers. We had accounts receivable concentration with one customer representing 2526% of total accounts receivables outstanding as of December 31, ~~2023~~2024 and one customer that represented 3125% of accounts receivable outstanding as of December 31, ~~2022~~2023.

Intellectual Property

Our success depends, at least in part, on our ability to protect our core technology and intellectual property. To accomplish this, we currently rely on a combination of trade secrets, including know-how, employee and third-party nondisclosure agreements, and other contractual rights to establish and protect our proprietary rights in our technology. We do not currently own any patents or trademarks.

Government Regulations

We are not currently subject to direct regulation by any government agency, other than regulations applicable to businesses generally, and there are currently few laws or regulations directly applicable to the access of or commerce on the Internet. However, it is possible that a number of laws and regulations will be adopted with respect to the Internet, covering issues such as user privacy, pricing, characteristics, e-mail marketing and quality of products and services. Such laws and regulations could dampen the growth and use of the Internet generally and decrease the acceptance of the Internet as a communication and commercial medium and could thereby have a material adverse effect on our business, results of operations and financial condition.

EMPLOYEES

As of December 31, ~~2023~~2024 the Company had 7072 employees of which 6768 were full-time employees.

AVAILABLE INFORMATION

Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports are filed with the SEC pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are filed with the SEC. Such reports and other information that we file with the SEC are available free of charge on our website at https://www.icoreconnect.com/sec-filings when such reports are available on the SEC website. The SEC maintains an Internet site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC at http://www.sec.gov. The contents of these websites are not incorporated into this filing. Further, the foregoing references to the URLs for these websites are intended to be textual references only.

Item 1A. Risk Factors.

Investing in our common stock involves a high degree of risk. Before purchasing our common stock, you should carefully consider the following risk factors as well as all other information contained in this Report, including our financial statements and the related notes. The risks and uncertainties described below are not the only ones facing us. Additional risks and uncertainties that we are unaware of, or that we currently deem immaterial, also may become important factors that affect us. If any of the following risks occur, our business, financial condition or results of operations could be materially and adversely affected. In that case, the trading price of our common stock could decline, and you may lose some or all of your investment.

Table of Contents

Risks Related to Our Business

Our business is difficult to evaluate because we have a limited operating history.

Because we have a limited operating and revenue generating history, we do not have significant historical financial information on which to base planned revenues and operating expenses. Revenues for the years ended December 31, ~~2023~~2024 and December 31, ~~2022~~2023, were $810,~~151~~746,~~587~~466 and $78,~~987~~151,~~902~~587, respectively. We expect to experience fluctuations in future quarterly and annual operating results that may be caused by many factors, including: merger and acquisition activity; our ability to achieve significant sales for our products and services; the cost of technology, software and other costs associated with the production and distribution of our products and services; the size and rate of growth of the market for Internet products and online content and services; the potential introduction by others of products that are competitive with our products; the unpredictable nature of online businesses and e-commerce in general; and the general economic conditions in the United States and worldwide.

Investors should evaluate us considering the delays, expenses, problems and uncertainties frequently encountered by companies developing markets for new products, services and technologies. We may never overcome these obstacles.

Our board of directors recently concluded that we needed to restate previously issued financial statements as a result of a change in accounting for debt with embedded derivatives.

Our audit committee concluded, after consultation with management, that our previously issued unaudited financial statements for the periods ended September 30, 2024, included in the Company’s Quarterly Reports of Form 10-Q for the period ended September 30, 2024, should no longer be relied upon as a result of the change in accounting for debt with embedded derivatives. The Company valued the warrant and conversion features using a Black Scholes model and recognized the value of the warrants as equity and expense over the term of the loan and had expensed the value of the conversion feature and increased the value of its debt over the term of the loan. The Company concluded that conversion features and warrants should have been recognized as embedded derivatives, bifurcated from the host instruments and presented and valued at fair value. The adjustments resulting therein, change to current liabilities, paid-in-capital, other expenses – finance fee, other expenses – change in fair value of warrants, other expenses – change in fair value of embedded derivatives, net loss, and net loss attributable to common stockholders that we previously reported, but has no impact on previously reported cash.

One of our secured creditors has commenced an auction of substantially all of our assets in order to satisfy a debt obligation and we if are unable to satisfy the obligations subject to the auction and prevent the auction for being completed, our business will be irreparably harmed.

On March 10, 2025, we received notice from PIGI Solutions, LLC (“PIGI”) that PIGI was exercising its purported right as a secured creditor under the Uniform Commercial Code (Del. UCC § 9-613) to conduct a public auction of substantially all of our personal property. PIGI has indicated that the closing of the auction is to occur on or after May 9, 2025. PIGI claims the Company owes $2,434,243 in principal and interest, which we dispute. The disputed amounts arise out of a finder’s fee agreement discussed below.

On April 4, 2025, we and our wholly-owned subsidiary, iCore Midco Inc., a Nevada corporation (“Midco”) filed a complaint in the United States District Court Middle District of Florida initiating a civil action against PIGI and John Schneller (the “Defendants”). In the complaint, we and Midco assert, among other claims, that the Defendants fraudulently induced Midco into a finder’s fee agreement, under which PIGI allegedly acted as an unregistered broker-dealer, and that the finder’s fee agreement is voidable under Section 29(b) of the Securities Exchange Act of 1934. The relief requested includes, among other things, rescission of the finder’s fee agreement and related loan documents, injunctive relief against PIGI taking any further action to enforce the finder’s fee agreement, and monetary damages.

On May 6, 2025, the Company, Midco, the Defendants, and the bidder of the assets entered into a Settlement and Mutual Release Agreement (the “Settlement Agreement”) pursuant to which the parties agreed that the Company will have the right until May 30, 2025, to effectively terminate the auction and retain control of the Company’s assets by making a payment of $3,099,747, which includes the satisfaction of amounts owed to PIGI and the payment of certain expenses related to the auction, and a payment of $50,000 to the bidder of the assets. Upon the payment of the foregoing amounts, the Company and Midco have agreed to dismiss the above lawsuit with prejudice and the parties have agreed to mutual releases. The Company expects to satisfy the payment obligations pursuant to the Settlement Agreement prior to May 30, 2025. However, if we are unsuccessful in preventing the sale of our assets, our business will be irreparably harmed.

Under the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), we could face potential liability related to the privacy of health information we obtain.

Most health care providers, from which we may obtain patient information, are subject to privacy regulations promulgated under the Health Insurance Portability and Accountability Act of 1996, or HIPAA. Although we are not directly regulated by HIPAA, we could face substantial criminal penalties if we knowingly receive individually identifiable health information from a health care provider that has not satisfied HIPAA’s disclosure standards. Further, we may face civil liability if our HIPAA compliant system fails to satisfy its disclosure standards. Claims that we have violated individuals’ privacy rights or breached our contractual obligations, even if we are not found liable, could be expensive and time consuming to defend and could result in adverse publicity that could harm our business.

Table of Contents

We believe that we meet the HIPAA requirements currently in effect that are applicable to our internal operations and our clients. However, if we are unable to deliver application solutions that achieve or maintain compliance with the applicable HIPAA rules in effect, or as they may be modified or implemented in the future, then customers may move their businesses to application solution providers whose systems are, or will be, HIPAA compliant. As a result, our business could suffer.

If our security measures or those of our third-party data center hosting facilities, cloud computing platform providers, or third-party service partners, are breached, and unauthorized access is obtained to a customer’s data, our data or our IT systems, our services may be perceived as not being secure, customers may curtail or stop using our services, and we may incur significant legal and financial exposure and liabilities.

Our services involve the storage and transmission of our customers’ patient’s health and other sensitive data, including personally identifiable information. Security breaches could expose us to a risk of loss of this information, litigation and possible liability. While we have security measures in place, they may be breached as a result of third-party action, including intentional misconduct by computer hackers, employee error, malfeasance or otherwise and result in someone obtaining unauthorized access to our IT systems, our customers’ data or our data, including our intellectual property and other confidential business information. Additionally, third parties may attempt to fraudulently induce employees or customers into disclosing sensitive information such as usernames, passwords or other information in order to gain access to our customers’ data, our data or our IT systems. Because the techniques used to obtain unauthorized access, or to sabotage systems, change frequently and generally are not recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. In addition, our customers may authorize third-party technology providers to access their customer data, and some of our customers may not have adequate security measures in place to protect their data that is stored on our services. Because we do not control our customers or third-party technology providers, or the processing of such data by third-party technology providers, we cannot ensure the integrity or security of such transmissions or processing. Malicious third parties may also conduct attacks designed to temporarily deny customers access to our systems and supporting services. Any security breach could result in a loss of confidence in the security of our software, damage our reputation, negatively impact our future sales, disrupt our business and lead to legal liability.

Our ability to deliver our software is dependent on the development and maintenance of the infrastructure of the Internet by third parties.

The Internet’s infrastructure is comprised of many different networks and services that are highly fragmented and distributed by design. This infrastructure is run by a series of independent third-party organizations that work together to provide the infrastructure and supporting services of the Internet under the governance of the Internet Corporation for Assigned Numbers and Names (ICANN) and the Internet Assigned Numbers Authority (IANA), now under the stewardship of ICANN.

Even though the Internet has never experienced an outage, some providers to portions of its infrastructure have experienced outages and other delays as a result of damages, denial of service attacks or related cyber incidents, and it could face outages and delays in the future. These outages and delays could reduce the level of Internet usage or result in fragmentation of the Internet, resulting in multiple separate Internets. These scenarios are not under our control and could reduce the availability of the Internet to us or our customers for delivery of our Internet-based services. Any resulting interruptions in our services or the ability of our customers to access our services could result in a loss of potential or existing customers and harm our business.

1011 Table of Contents

Our business may not succeed if we are unable to keep pace with rapid technological changes.

Our services and products are impacted by rapidly changing technology, evolving industry standards, emerging competition and frequent new use, software and other product introductions. There can be no assurance that we can successfully identify new business opportunities or develop and bring new services or products to market in a timely and cost-effective manner, or those services, products or technologies developed by others will not render our services or products non-competitive or obsolete. In addition, there can be no assurance that our services, products or enhancements will achieve or sustain market acceptance or be able to address compatibility, interoperability or other issues raised by technological changes or new industry standards.

If we suffer system failures or overloading of computer systems, our business and prospects could be harmed. The success of our online offerings is highly dependent on the efficient and uninterrupted operation of our computer and communications hardware systems. Fire, floods, earthquakes, power fluctuations, telecommunications failures, hardware “crashes,” software failures caused by “bugs” or other causes, and similar events could damage or cause interruptions in our systems. Computer viruses, electronic break-ins or other similar disruptive problems could also adversely affect our websites. If our systems, or the systems of any of the websites on which we advertise or with which we have material marketing agreements, are affected by any of these occurrences, our business, results of operations and financial condition could be materially and adversely affected.

The establishment of our brand is important to our future success.

Establishing and maintaining a brand name and recognition is critical for attracting and expanding our client base. The promotion and enhancement of our name depends on the effectiveness of our marketing and advertising efforts and on our success in continuing to provide high-quality services, neither of which can be assured. If our brand marketing efforts are unsuccessful, our business could fail.

Our business could suffer if we are unable to protect our intellectual property rights or are liable for infringing the intellectual property rights of others.

We have certain trade secrets and other similar intellectual property which are significant to our success, and we rely upon related law, trade secret protection, and other confidentiality and license agreements with our employees, strategic partners, and others to protect our proprietary rights to the extent such protection is available and enforceable. Such protection has only limited effectiveness. The development of the Internet has also increased the ease with which third parties can distribute our copyrighted material without our authorization.

We may seek to pursue the registration of trademarks, trade dress and trade secrets in the United States and, based upon anticipated use, in certain other countries. We may not be entitled to the benefits of any such registration for an extended period due to the cost and delay in effecting such registration. In addition, effective trademark and trade secret protection may not be available in every country in which our products are available. We expect that we may license, in the future, elements of our trademarks, trade dress and other similar proprietary rights to third parties. Further, we may be subject to claims in the ordinary course of our business, including claims of alleged infringement of the trademarks and intellectual property rights of third parties by us and our licensees.

Other parties may assert claims of infringement of intellectual property or other proprietary rights against us. These claims, even if without merit, could require us to expend significant financial and managerial resources. Furthermore, if claims like this were successful, we might be required to change our trademarks, alter our content or pay financial damages, any of which could substantially increase our operating expenses. We also may be required to obtain licenses from others to refine, develop, market and deliver new services. We may be unable to obtain any needed license on commercially reasonable terms or at all, and rights granted under any licenses may not be valid and enforceable.

Our success will be limited if we are unable to attract, retain and motivate highly skilled personnel.

Our future success will depend on our ability to attract, retain and motivate highly skilled programming, management, sales and other key personnel. Competition for such personnel is intense in the Internet industry, and we may be unable to successfully attract, integrate or retain sufficiently qualified personnel. In addition, our ability to generate revenues relates directly to our personnel in terms of both the numbers and expertise of the personnel we have available to work on our projects. Moreover, competition for qualified employees may require us to increase our cash or equity compensation, which may have an adverse effect on earnings.

Table of Contents

We are also dependent on the services of our executive officers and key consultants and independent agents. There can be no assurance, however, that we can obtain executives of comparable expertise and commitment in the event of death, or that our business would not suffer material adverse effects as the result of a death, disability or voluntary departure of any such executive officer. Further, the loss of the services of any one or more of our key employees or consultants could have a materially adverse effect on our business and our financial condition. In addition, we will also need to attract and retain other highly skilled technical and managerial personnel for whom competition is intense. If we are unable to do so, our business, results of operations and financial condition could be materially adversely affected.

11 Table of Contents

Any system failure or slowdown could significantly harm our reputation and damage our business.

System failures would harm our reputation and reduce our attractiveness to customers. In addition, the users of the services we maintain for our customers depend on Internet service providers, online service providers and other web site operators for access to our web sites. Some of these providers and operators have experienced significant outages in the past, and they could experience outages, delays and other difficulties due to system failures unrelated to our systems.

We compete in a highly competitive market and many of our competitors have greater financial resources and established relationships with major corporate customers.

Our future profitability depends on our ability to compete successfully by continuing to differentiate our products and services from the products and services of our competitors. If one or more of our competitors begins to offer integrated, Internet Based, HIPAA Compliant healthcare information collaboration solutions, there may be a material adverse effect on our business, financial condition or operating results. We believe that our ability to compete successfully depends on a number of factors, including: our ability to produce products that are superior in quality to that of our competitors and get those products and services to market quickly; our ability to deliver our products and services at a price that remains competitive with that of our competitors; our ability to respond promptly and effectively to the challenges of technological change, evolving standards, and our competitors’ innovations; the scope of our products and services and the rate at which we and our competitors introduce them; customer service and satisfaction; and industry and general economic trends.

Regulatory developments in the future related to the Internet could create a legal uncertainty; such developments could materially harm our business.

We are vulnerable to changes in general economic conditions.

We are affected by certain economic factors that are beyond our control, including changes in the overall economic environment and systemic events such as the Covid-19 Pandemic which impact our operations as well as our customers.

Legal proceedings could lead to unexpected losses.

From time to time during the normal course of carrying on our business, we may be a party to various legal proceedings through private actions, class actions, administrative proceedings, regulatory actions or other litigations or proceedings. The outcome of litigation, particularly class action lawsuits and regulatory actions, is difficult to assess or quantify. In the event that management determines that the likelihood of an adverse judgment in a pending litigation is probable and that the exposure can be reasonably estimated, appropriate reserves are recorded at that time pursuant to the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 450, “Contingencies.” The final outcome of any litigation could adversely affect operating results if the actual settlement amount exceeds established reserves and insurance coverage.

Table of Contents

Our results of operations could vary as a result of the methods, estimates, and judgments that we use in applying accounting policies.

The methods, estimates, and judgments that we use in applying accounting policies have a large impact on our results of operations. For further information, see “Critical Accounting Estimates” in Part II, Item 7 of this Form 10-K. These methods, estimates, and judgments are subject to large risks, uncertainties, and assumptions, and changes could affect our results of operations

We have identified material weaknesses in internal control over financial reporting. If we fail to maintain effective internal controls over financial reporting, the price of our common stock may be adversely affected.

We are required to establish and maintain appropriate internal controls over financial reporting. Failure to establish those controls, or any failure of those controls once established, could adversely impact our public disclosures regarding our business, financial condition or results of operations. Any failure of these controls could also prevent us from maintaining accurate accounting records and discovering accounting errors and financial fraud.

As of December 31, ~~2023~~2024, our principal executive officer and principal financial and accounting officer concluded that our disclosure controls and procedures were not effective due to a material weakness related to our accounting for complex financial instruments and related to our inability to adequately segregate responsibilities over the financial reporting process. Management has further identified deficiencies within its corporate governance practices, as ~~the Company did not have the necessary controls in place to understand the impact on equity holders and monitor the issuance~~ of ~~instruments~~December ~~with down round features. In addition~~31, in2024 ~~the~~due ~~future management’s assessment of internal controls over financial reporting and corporate governance may identify additional weaknesses and conditions that need~~ to bea ~~addressed~~material ~~or other potential matters that may raise concerns for investors. Any actual or perceived~~ weaknesses ~~and~~as conditions that need to be addressed in our internal control over corporate governance, financial reporting or disclosure of management’s assessment of our internal controls over financial reporting may have an adverse impact on the price of our common stock.follows:

12· ~~Table~~The Company lacks formal review and approval procedures, including lack of ~~Contents~~review of Service Organization Control (SOC) reports, and lack of controls over proper IT related change management, backup of data and privileged user assess. · Ineffective internal controls with respect to the valuation of intangible assets. Specifically, the Company's controls failed to demonstrate appropriate review over valuation methodologies, documentation, and other processes for intangible assets. · A lack of controls in place to correctly identify derivative liabilities as part of convertible notes, accounting implications for convertible notes with no floor, or ability to distinguish between equity or liability treatment for warrant and understand the accounting impact of instruments with down round features. · Lack of adequate segregation of duties over financial transaction processing and reporting due to a lack of a sufficient number of accounting personnel. · The Company lacks the ability to timely maintain accurate books and records, which impacts the Company's ability to file accurate financial reports in a timely manner.

To address these material weaknesses, management has devoted, and plans to continue to devote, significant effort and resources to the remediation and improvement of its internal control over financial reporting. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance these processes to better evaluate its research and understanding of the nuances of the complex accounting standards that apply to its financial statements. We plan to include providing enhanced access to accounting literature, research materials and documents and increased communication among its personnel and third-party professionals with whom it consults regarding complex accounting applications and we also plan to hire additional personnel to help provide adequate segregation of duties in the financial reporting process.

Table of Contents

We may engage in merger and acquisition activity from time to time and may not achieve the contemplated benefits from such activity.

We have engaged in recent merger and acquisition activity. Achieving the contemplated benefits from such activity may be subject to a number of significant challenges and uncertainties, including integration issues, coordination between geographically separate organizations, and competitive factors in the marketplace. We could also encounter unforeseen transaction and integration-related costs or other circumstances such as unforeseen liabilities or other issues. Any of these circumstances could result in increased costs, decreased revenue, decreased synergies and the diversion of management time and attention. If we are unable to achieve our objectives within the anticipated time frame, or at all, the expected benefits may not be realized fully or at all, or may take longer to realize than expected, which could have an adverse effect on our business, financial condition and results of operations, or cash flows. Any of these risks could harm our business. In addition, to facilitate these acquisitions or investments, we may seek additional equity or debt financing, which may not be available on terms favorable to us or at all, which may affect our ability to complete subsequent acquisitions or investments, and which may affect the risks of owning our common stock.

A system failure or breach of system or network security could delay or interrupt services to our customers or subject us to significant liability.

We have implemented security measures such as firewalls, virus protection, intrusion detection and access controls to address the risk of computer viruses and unauthorized access. However, there can be no assurances that any of these efforts will be adequate to prevent a system failure, accident or security breach, any of which could result in a material disruption to our business. In addition, substantial costs may be incurred to remedy the damages caused by any such disruptions.

Our software may not operate properly, which could damage our reputation, give rise to claims against us, or divert application of our resources from other purposes, any of which could harm our business and operating results.

Software development is time-consuming, expensive, and complex. Unforeseen difficulties can arise. We may encounter technical obstacles, and it is possible that we discover additional problems that prevent our applications from operating properly. If our systems do not function reliably or fail to achieve client expectations in terms of performance, clients could assert liability claims against us or attempt to cancel their contracts with us. This could damage our reputation and impair its ability to attract or retain clients.

Information services as complex as those we offer have in the past contained, and may in the future develop or contain, undetected defects, vulnerabilities, or errors. We cannot assure that material performance problems or defects in our services will not arise in the future. Errors may result from sources beyond our control, including the receipt, entry, or interpretation of patient information; interface of our services with legacy systems that we did not develop; or errors in data provided by third parties. It is challenging for us to test our software for all potential problems because it is difficult to simulate the wide variety of computing environments or treatment methodologies that its clients may deploy or rely upon. Therefore, despite testing, defects or errors may arise in our existing or new software or service processes following introduction to the market.

In light of this, defects, vulnerabilities, and errors and any failure by us to identify and address them could result in loss of revenue or market share; liability to clients, their patients, or others; failure to achieve market acceptance or expansion; diversion of development and management resources; delays in the introduction of new services; injury to our reputation; and increased service and maintenance costs. Defects, vulnerabilities, or errors in our software and service processes might discourage existing or potential clients from purchasing services from us. Correction of defects, vulnerabilities, or errors could prove to be impossible or impracticable. The costs incurred in correcting any defects, vulnerabilities, or errors or in responding to resulting claims or liability may be substantial and could adversely affect our operating results.

1315 Table of Contents

If our services fail to provide accurate and timely information, or if its content or any other element of any of its services is associated with faulty clinical decisions or treatment, we could have liability to clients, clinicians, or patients, which could adversely affect its results of operations.

Some of our software, content, and services are used to support clinical decision-making by providers and deliver information about patient medical histories, treatment plans, medical conditions, and the use of particular medications. If our software, content, or services fail to provide accurate and timely information or it is associated with faulty clinical decisions or treatment, then clients, clinicians, or their patients could assert claims against it that could result in substantial costs to us, harm our reputation in the industry, and cause demand for our services to decline.

Our iCoreRX service provide healthcare professionals with access to clinical information, including information regarding particular medical conditions and the use of particular medications. If our content, or content we obtain from third parties, contains inaccuracies, or we introduce inaccuracies in the process of implementing third-party content, it is possible that patients, physicians, consumers, the providers of the third-party content, or others may sue us if they are harmed as a result of such inaccuracies. We cannot assure that our quality control procedures will be sufficient to ensure that there are no errors or omissions in particular content.

The assertion of such claims and ensuing litigation, regardless of its outcome, could result in substantial cost to us, divert management’s attention from operations, damage our reputation, and decrease market acceptance of our services. We attempt to limit by contract our liability for damages and requires that our clients assume responsibility for medical care. Despite these precautions, the allocations of responsibility and limitations of liability set forth in our contracts may not be enforceable, be binding upon patients, or otherwise protect us from liability for damages. Furthermore, general liability and errors and omissions insurance coverage may not continue to be available on acceptable terms or may not be available in sufficient amounts to cover one or more large claims against us. In addition, the insurer might disclaim coverage as to any future claim. One or more large claims could exceed our available insurance coverage. If any of these risks occur, they could materially adversely affect our business, financial condition, or results of operations.

Because we generally recognize revenues from our subscription service over the subscription term, a decrease in new subscriptions or renewals during a reporting period may not be immediately reflected in our operating results for that period.

We generally recognize revenues from customers ratably over the terms of their subscriptions. Net new annual contract value from new subscriptions, expanded contracts and contract renewals entered into during a period can generally be expected to generate revenues for the duration of the subscription term. As a result, a small portion of the revenues we report in each period are derived from the recognition of deferred revenues relating to subscriptions entered into during previous periods. Consequently, a decrease in new or renewed subscriptions in any single reporting period will have a limited impact on our revenues for that period. In addition, our ability to adjust our cost structure in the event of a decrease in new or renewed subscriptions may be limited.

Further, a decline in new subscriptions, expanded contracts or renewals in a given period may not be fully reflected in our revenues for that period, but they will negatively affect our revenues in future periods. Accordingly, the effect of significant downturns in sales and market acceptance of our services, and changes in our rate of renewals, may not be fully reflected in our results of operations until future periods. Our subscription model also makes it difficult for us to rapidly increase our revenues through additional sales in any period, as revenues from new customers are generally recognized over the applicable subscription term. Additionally, due to the complexity of certain customer contracts, the actual revenue recognition treatment required under Accounting Standard Codification Topic 606, “Revenue from Contracts with Customers (“Topic 606”)” depends on contract-specific terms and may result in greater variability in revenues from period to period. In addition, a decrease in new subscriptions, expansion contracts or renewals in a reporting period may not have an immediate impact on billings for that period due to factors that may offset the decrease, such as an increase in billings duration, the dollar value of contracts with future start dates, or the dollar value of collections in the current period related to contracts with future start dates.

1416 Table of Contents

Risks Related to Our Common Stock

The price of our common stock may be volatile.

The price of our common stock has been and is likely to continue to be volatile. Since our common stock began trading as iCoreConnect on August 28, 2023, our common stock has traded from a low price of $0.9124 to a high price of $20414.7000. The market price for our common stock may be influenced by many factors, including the other risks described in this section of the prospectus. In addition, the stock markets in general, and the markets for former special purpose acquisition companies post-business combination businesses in particular, have experienced extreme volatility. This volatility can often be unrelated to the operating performance of the underlying business. These broad market and industry factors may seriously harm the market price of our common stock, regardless of our operating performance.

We may incur significant costs from class action litigation due to the expected stock volatility.

The price of our common stock may fluctuate for many reasons, including as a result of public announcements regarding the progress of our business. When the market price of a stock has been volatile as our common stock, holders of that stock have occasionally brought securities class action litigation against the company that issued the stock. Additionally, there has recently been a general increase in litigation against companies that have recently completed a business combination with a special purpose acquisition company alleging fraud and other claims based on inaccurate or misleading disclosures. If any of our stockholders were to bring a lawsuit of this type against us, even if the lawsuit is without merit, we could incur substantial costs defending the lawsuit. Any such lawsuit could also divert the time and attention of management.

~~Any~~On ~~failure~~May to20, ~~meet~~2025, ~~the~~we ~~continued~~received ~~listing~~a ~~requirements~~determination ofletter from the Nasdaq ~~Capital~~Hearings ~~Market~~Panel ~~could~~that ~~result~~the inPanel ahas ~~delisting~~determined ofto delist our common stock from Nasdaq. Suspension of trading of the common stock occurred at the opening of business on May 22, 2025.

IfAs wepreviously ~~fail to satisfy the continued listing requirements of the Nasdaq Capital Market~~disclosed, such as failing to satisfy any applicable corporate governance requirements or the minimum closing bid price requirement, the Nasdaq Capital Market may take steps to delist our securities. Such a delisting would likely have a negative effect on the price of our securities and would impair your ability to sell or purchase the securities when you wish to do so. In the event of a delisting, we ~~can~~were ~~provide~~notified ~~no assurance that any action taken~~ by ~~us to restore compliance with listing requirements would allow our securities to become listed again, stabilize~~ the ~~market~~Listing ~~price~~Qualifications orDepartment ~~improve the liquidity~~ of ~~our securities, prevent our securities from dropping below the~~ Nasdaq ~~Capital~~that ~~Market~~we ~~minimum~~were ~~bid~~not ~~price~~in ~~requirement or prevent future non-~~compliance with ~~the~~certain ~~Nasdaq Capital Market’s~~ listing requirements~~. Additionally~~, ifincluding ~~our~~Listing ~~securities~~Rule ~~are~~5250(c)(1) ~~not~~since ~~listed~~we ~~on,~~had ornot ~~become~~yet ~~delisted~~filed ~~from,~~our ~~the~~Form ~~Nasdaq~~10-K ~~Capital Market~~ for ~~any reason, and are quoted on~~ the ~~OTC~~period ~~Bulletin~~ended ~~Board,~~December ~~an inter-dealer automated quotation system for equity securities that is not a national securities exchange~~31, ~~the liquidity and price of our securities may be more limited than if our securities were quoted or listed on the Nasdaq Capital Market or another national securities exchange~~2024. ~~You may be unable to sell your securities unless a market can be established or sustained.~~

We requested a hearing with a Nasdaq Hearings Panel (“Panel”), which had the effect of staying any suspension or delisting action pending the conclusion of the hearings process. On April 24, 2025, we received notification from the Panel that it had granted an extension until May 15, 2025 to file our Form 10-K for the period ended December 31, 2024, and until June 30, 2025, to demonstrate compliance with all continued listing requirements for the Nasdaq Capital Market.

On May 20, 2025, we received a determination letter from the Panel informing us that the Panel has determined to delist our common stock from Nasdaq for failure by the Company to timely file its Form 10-K for the year ended December 31, 2024 and Form 10-Q for the quarter ended March 31, 2025. Suspension of trading of the common stock occurred at the opening of business on May 22, 2025.

The notification indicates that Nasdaq will effect the delisting by filing a Form 25 Notification of Delisting with the Securities and Exchange Commission after the applicable Nasdaq appeal and review periods have expired. We may appeal the delisting determination to the Nasdaq Listing and Hearing Review Council within the required 15 days from the date of the Panel’s decision. However, an appeal would not stay the suspension of the trading of our securities on Nasdaq.

Delisting from Nasdaq will adversely affect our ability to raise additional financing through the public or private sale of equity securities, may significantly affect the ability of investors to trade our securities and may negatively affect the value and liquidity of our common stock. Delisting can have other negative results, including the potential loss of employee confidence, the loss of institutional investors and general investors that will consider investing in our common stock, a reduction in the number of market makers in our common stock, a reduction in the availability of information concerning the trading prices and volume of our common stock, a reduction in the number of broker-dealers willing to execute trades in shares of our common stock or interest in business development opportunities. Further, we may become a “penny stock” in the future, which would make trading of our common stock more difficult.

We are an “emerging growth company” and it cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors, which may make it more difficult to compare our performance with other public companies.

We are an emerging growth company as defined in the JOBS Act, and we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. To the extent we continue to take advantage of any of these exemptions, the information that we provide stockholders may be different than what is available with respect to other public companies. Investors may find our common stock less attractive because we will continue to rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for the common stock, and the stock price may be more volatile.

1517 Table of Contents

An emerging growth company may elect to delay the adoption of new or revised accounting standards. Because we have made this election, Section 102(b)(2) of the JOBS Act allows us to delay adoption of new or revised accounting standards until those standards apply to non-public business entities. As a result, the financial statements contained in this prospectus and those that we will file in the future may not be comparable to companies that comply with public business entities revised accounting standards effective dates.

We are also a “smaller reporting company” as such term is defined in the Rule 12b-2 of the Exchange Act, meaning that the market value of our common stock held by non-affiliates plus any proposed aggregate amount of gross proceeds to us as a result of an offering is less than $700 million and our annual revenue is less than $100 million during the most recently completed fiscal year. Even after we no longer qualify as an emerging growth company, we may still qualify as a “smaller reporting company” which would allow us to take advantage of many of the same exemptions from disclosure requirements, including exemption from compliance with the auditor attestation requirements of Section 404 and reduced disclosure obligations regarding executive compensation in periodic reports and proxy statements. Investors could find our common stock less attractive because it may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and the trading price may be more volatile.

Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our common stock.

We currently expect that securities research analysts will establish and publish their own periodic financial projections for our business. These projections may vary widely and may not accurately predict our results. Our stock price may decline if our actual results do not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrade our stock or publishes inaccurate or unfavorable research about our business, our stock price could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, our stock price or trading volume could decline. While we expect research analyst coverage, if no analysts commence coverage of us, the trading price and volume for our common stock could be adversely affected.

Delaware law and provisions in our certificate of incorporation and bylaws could make a takeover proposal more difficult.

Our organizational documents are governed by Delaware law. Certain provisions of Delaware law and of our certificate of incorporation and bylaws could discourage, delay, defer or prevent a merger, tender offer, proxy contest or other change of control transaction that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares of the common stock held by our stockholders. These provisions include the ability of the Board to designate the terms of and issue new series of preference shares, supermajority voting requirements to amend certain provisions of our certificate of incorporation, and a prohibition on stockholder actions by written consent, which may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.

These anti-takeover provisions as well as certain provisions of Delaware law could make it more difficult for a third party to acquire us, even if the third party’s offer may be considered beneficial by many of our stockholders. As a result, our stockholders may be limited in their ability to obtain a premium for their shares. If prospective takeovers are not consummated for any reason, we may experience negative reactions from the financial markets, including negative impacts on the price of the common stock. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and to cause us to take other corporate actions that our stockholders desire.

1618 Table of Contents

Our certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings and the federal district courts as the sole and exclusive forum for other types of actions and proceedings, in each case, that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain what such stockholders believe to be a favorable judicial forum for disputes with us or our directors, officers or other employees or increase our stockholders’ costs in bringing such a claim.

Our certificate of incorporation provides that, unless we consents to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company; (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or employee of the Company to the Company or its stockholders; (iii) any action asserting a claim against the Company or any director, officer or employee arising pursuant to any provision of the DGCL or our certificate of incorporation or bylaws; or (iv) any action asserting a claim against the Company or any director, officer or employee of the Company governed by the internal affairs doctrine, and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to (A) the personal jurisdiction of the state and federal courts within Delaware and (B) service of process on such stockholder’s counsel. The provision described in the immediately preceding sentence will not apply to (i) suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction and (ii) any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder, for which the federal courts will be the exclusive forum. Any person or entity purchasing or otherwise acquiring an interest in any shares of our capital stock will be deemed to have notice of and to have consented to the forum provisions in our certificate of incorporation. These choice-of-forum provisions may limit a stockholder’s ability to bring a claim in a judicial forum that he, she or it believes to be favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers, or other employees and may result in increased litigation costs for our stockholders. We note that there is uncertainty as to whether a court would enforce these provisions and that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

Alternatively, if a court were to find these provisions of our certificate of incorporation inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and the Board.

WeThe ~~have~~terms ~~registered the resale~~ of ~~a significant number of our shares of common stock, and~~ the ~~holders~~convertible ofnotes ~~the~~we ~~shares~~have ofissued ~~common stock registered~~ may beimpose ~~willing~~additional tochallenges ~~sell~~on ~~their~~our ~~shares~~ability atto araise ~~price lower than the public market price~~capital.

InAs ~~October~~of ~~2023~~December 31, 2024, we ~~registered~~have ~~the~~outstanding ~~resale~~convertible ofnotes ain ~~significant~~aggregate ~~number~~principal ofand ~~shares~~interest amounts of ~~our common stock for certain selling stockholders~~$5,797,850 ~~most~~that ofare ~~which~~convertible ~~consisted~~into ofcommon ~~shares~~stock ~~underlying~~at ~~our~~an ~~Series~~average Aconversion ~~preferred~~price ~~stock~~of ~~and warrants~~$13.56. ~~Because~~The ~~certain~~additional ~~selling stockholders purchased~~ shares ~~privately~~of atcommon astock ~~price~~issued ~~below~~upon the ~~current~~conversion ~~market price, they may have an incentive to sell shares~~ of ~~their~~the ~~common~~convertible ~~stock~~notes ~~because~~will ~~they~~result ~~could~~in ~~profit~~dilution ~~despite~~to the ~~current~~then ~~market~~existing ~~price~~holders of our common stock. ~~While~~and ~~these~~increase ~~selling~~the ~~stockholders~~number ~~may,~~of onshares ~~average,~~eligible ~~experience~~for aresale ~~positive~~in ~~rate of return based on~~ the ~~current~~public market. ~~price,~~Sales ~~public~~of ~~securityholders may not experience~~ a ~~similar~~substantial ~~rate~~number of ~~return~~such onshares in the ~~securities~~public ~~they~~market ~~purchased~~could ~~due~~adversely toaffect ~~differences in~~ the ~~purchase~~market ~~prices~~price ~~and~~of ~~the~~our ~~current~~common ~~market price~~stock.

~~Sales~~19 ofTable ~~shares~~ of ~~the common stock pursuant to the registration statement we filed in October 2023 may have negative pressure on the public trading price of the common stock.~~Contents

The selling stockholders in the registration statement we filed in October 2023 will determine the timing, pricing and rate at which they sell the shares of common stock registered for resale into the public market. Significant sales of shares of common stock pursuant to the registration statement may have negative pressure on the public trading price of the common stock. Assuming all of our warrants were exercised and the Series A preferred stock was converted, the selling stockholders would own 11,122,810 shares of common stock, representing over 50% of the total outstanding common stock. Based on the current closing price of our common stock, certain private investors may have an incentive to sell their shares, because they will still profit on sales due to the lower prices at which they purchased their shares as compared to the public investors.

17 Table of Contents

Item 1B. Unresolved Staff Comments.

None.

Item 1C. Cybersecurity.

Risk Management and Strategy

We utilize a Cloud-only architecture which enables us to reduce risk by leveraging the scalability, high availability, and advanced security features of cloud platforms, thereby minimizing the potential for system downtime and data breaches while ensuring seamless disaster recovery options.

All 3rd party vendors' security policies are reviewed and updated as part of our annual Security Risk Assessment. Access to sensitive data is strictly regulated and provided on a need to know basis. Access is granted for the express purpose of assisting our customers with technical and training issues related to the use of our SaaS products; or for the purpose of research, design and development of product related features and bugfixes.

Risk management in software development involves identifying, assessing, and mitigating risks that could impact the project's success. This strategy begins with a thorough risk identification process, where potential issues such as technical challenges, project scope changes, and resource constraints are recognized early. Each risk is then assessed for its probability of occurrence and potential impact on the project. Based on this assessment, risk mitigation strategies are developed and implemented. These strategies might include adopting flexible project management methodologies like Agile, investing in training for team members, implementing robust testing and quality assurance processes, and maintaining open communication channels with all stakeholders. Additionally, regular risk reviews are conducted throughout the project lifecycle to ensure that new risks are identified and managed promptly.

The Company’s’ Cybersecurity Policies are updated annually and reviewed by Independent 3rd Party Vendors to certify compliance. The Company requires Cybersecurity Awareness training for all new hires and a minimum of an annual review of such policies for all employees. The Company created and deployed an extensive Learning Management System that tracks employee adherence to Cyber Security Awareness, HIPAA and other related content. The Company’s’ Cybersecurity Incident Response Policy provides specific steps for any employee that detects an attack to take to help stop the propagation of the threat and report the incident to their Superiors, the IT Team and the Security Manager.

While there are significant threats of all types in the modern connected world, studies show that phishing attacks and social engineering through email and other electronic means are of high concern. With the vast majority (some say as high as 95%) of such attacks originating via email, employee education on how to identify and handle suspicious email and other forms of communication is critical in protecting the data and infrastructure.

To date, we have not experienced any cybersecurity incidents that have materially affected our business strategy, results of operations or financial condition.

Governance

The Board is responsible for general risk oversight. The Board reviews and evaluates management's evaluation and mitigation of cyber risks as part of its oversight of the Company's Risk Management program. Management periodically reviews cyber risks, incidents, and risk mitigation plans and activities with the Board.

We engaged an outside consulting firm to conduct a review of our information systems environment and make recommendations to improve security where appropriate. Management shared the report's findings with the Board and periodically updates the Board regarding our progress on implementing the report's recommendations.

Table of Contents

Item 2. Properties.

The Company operates from a 7,650 square foot headquarters located in Ocoee, Florida which has been leased on a six year and one month lease beginning January 2022, with an optional five-year renewal term. In April 2023, the Company entered into a lease agreement with its existing landlord of its Florida location for a lease of an additional 2,295 square feet of space beginning at the earlier of June 1, 2023 or completion of build out for a five year term. ~~The~~This ~~Company~~additional ~~also~~lease ~~operates from a 2,100 square foot office~~ space inwas ~~Concord,~~terminated ~~NC which is leased~~ by ~~the~~mutual ~~Company~~agreement ~~through~~and ~~August~~returned ~~31,~~to ~~2024.~~the ~~The~~landlord ~~Company also operates from a 630 square foot office space~~ in ~~Scottsdale,~~April ~~AZ which is leased by the Company to May 12, 2024~~2025.

Item 3. Legal Proceedings

On February 21, 2023, the Company received a notice under section 21 of Indian Arbitration and Conciliation Act, 1996 related to a dispute pursuant to a contract between the Company and a service provider, pursuant to which the service provider has asserted the Company has violated the terms of the contract and has claimed damages of approximately $635,000. The Company is evaluating the claims asserted against it and intends to defend itself vigorously in these proceedings; however, there can be no assurances that it will be successful in its efforts.

On March 10, 2025, the Company received notice from PIGI Solutions, LLC (“PIGI”) that PIGI was exercising its purported right as a secured creditor under the Uniform Commercial Code (Del. UCC § 9-613) to conduct a public auction of substantially all of the Company’s personal property. PIGI has indicated that the closing of the auction is to occur on or after May 9, 2025. PIGI claims the Company owes $2,434,243 in principal and interest, which the Company disputes. The disputed amounts arise out of a finder’s fee agreement discussed below. On April 4, 2025, the Company and its wholly-owned subsidiary, iCore Midco Inc., a Nevada corporation (“Midco”) filed a complaint in the United States District Court Middle District of Florida initiating a civil action against PIGI and John Schneller (the “Defendants”). In the complaint, the Company and Midco assert, among other claims, that the Defendants fraudulently induced Midco into a finder’s fee agreement, under which PIGI allegedly acted as an unregistered broker-dealer, and that the finder’s fee agreement is voidable under Section 29(b) of the Securities Exchange Act of 1934. The relief requested includes, among other things, rescission of the finder’s fee agreement and related loan documents, injunctive relief against PIGI taking any further action to enforce the finder’s fee agreement, and monetary damages.

Item 4. Mine Safety Disclosures.

Not applicable.

1821 Table of Contents

PART II

Market Information

Our common stock iswas listed on the NASDAQ Capital Market under the symbol “ICCT” until May 22, 2205 and has been listed on the OTC market since May 22, 2025.

Holders

As of ~~April~~May 1529, ~~2024~~2025, there were ~~245~~266 holders of record of our common stock, with 104,~~150~~877,~~753~~080 shares of our common stock issued and outstanding.

Dividend Policy

~~The~~We ~~Company~~have ~~has~~ never declared or paid dividends on our Common Stock since our formation, and we do not anticipate paying dividends in the foreseeable future. ~~For~~The payment of dividends in the ~~year~~future ~~ended~~will ~~December~~be 31contingent upon our revenues and earnings, ~~2022~~if ~~the~~any, ~~Company~~capital ~~recorded~~requirements aand ~~charge~~general ~~related~~financial condition. We currently intend to retain earnings, if any, to finance the ~~revaluation~~growth and development of ~~certain~~our ~~warrants~~business. ~~which~~Payment isof ~~presented~~future asdividends, aif ~~Dividend~~any, towill ~~Common~~be ~~Stockholders~~at ~~however~~the nodiscretion ~~actual~~of ~~dividend~~our ~~was~~board ~~declared~~of ordirectors ~~paid~~and will depend on our financial condition, results of operations, capital requirements, restrictions contained in any financing instruments, provisions of applicable law and other factors the board deems relevant.

Securities Authorized for Issuance under Equity Compensation Plans

The information required by this item will be incorporated by reference from our definitive proxy statement to be filed with the SEC pursuant to Regulation 14A.

Sale of Unregistered Securities

InAll ~~September~~information ~~2023~~related ~~the~~to ~~Company~~equity ~~issued~~securities ~~40,000~~sold ~~shares~~by ofus ~~Common~~during ~~Stock~~the toperiod ~~the~~covered ~~seller~~by ofthis ~~the~~report ~~assets~~that ofwere ~~Preferred~~not ~~Dental~~registered ~~Development,~~under ~~LLC~~the ~~which~~Securities ~~were~~Act ~~acquired~~have bybeen ~~the~~included ~~Company~~in asour ~~per~~Form ~~the~~10-Q ~~Asset~~filings ~~Acquisition~~or ~~Agreement.~~in a Form 8-K filing.

In September 2023, the Company issued 46,500 shares of Preferred Stock in exchange for $465,000 in cash proceeds.

In October 2023, the Company issued 6,629 shares of Common Stock and 6,629 common stock warrants in conjunction with a Convertible Promissory Note to a related party which matures on May 26, 2024 which is convertible into 43,837 of common stock. The Company also issued 14,000 common stock warrants to the same related party in conjunction with a Promissory Note which matures on December 31, 2023. In October 2023, the Company also issued 24,500 common stock warrants to an investor in conjunction with a Convertible Promissory Note which matures in May 2024 which is convertible into 189,190 shares of common stock. The Company also issued a convertible note which matures in October 2024 which is convertible into 263,158 shares of common stock.

In December 2023 the Company issued five convertible notes convertible into: 180,506; 34,483; 34,483; 63,695 and 382,051, shares of Common Stock.

Issuer Purchases of Equity Securities

We did not repurchase any of our equity securities during the year ended December 31, ~~2023~~2024.

1922 Table of Contents

Item 6. Reserved

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our restated financial condition and results of operations should be read in conjunction with our financial statements and the notes to those financial statements included elsewhere in this annual report. This discussion contains forward-looking statements, which are based on our assumptions about the future of our business. Our actual results will likely differ materially from those contained in the forward-looking statements. Please read “Cautionary Note Regarding Forward-Looking Statements” included at the beginning of this annual report for additional information.

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is provided in addition to the accompanying consolidated financial statements and notes to assist readers in understanding our results of operations, financial condition, and cash flows. MD&A is organized as follows:

· Overview. Discussion of our business and overall analysis of financial and other highlights affecting the company in order to provide context for the remainder of MD&A. · Critical Accounting Estimates. Accounting estimates that we believe are most important to understanding the assumptions and judgments incorporated in our reported financial results and forecasts. · Results of Operations. An analysis of our financial results are presented to compare ~~2023~~2024 to ~~2022~~2023. We also provide a discussion of our Liquidity and Capital Resource position and usage.

Overview

We are a cloud-based software and technology company focused on increasing workflow productivity and customer profitability through our enterprise platform of applications and services.

During ~~2023~~2024 we developed our newest ~~product~~products iCoreClaims. iCoreClaims is responsible for processing and managing claims submitted by policyholders or dental care providers and typically involves: (a) Claim Submission: Dental care providers (such as dentists or orthodontists) submit claims to the insurance company on behalf of patients after providing dental services. The claim includes details such as the type of treatment providediCoreVerifyPro, ~~codes~~iCorePay ~~for procedures performed, patient information,~~ and ~~provider details; (b) Verification and Eligibility: iCoreClaims service verifies the patient's eligibility for coverage based on the terms of their insurance policy~~iCoreAcademy. This involves checking if the patient's policy covers the specific dental treatment or procedure being claimed; (c) Adjudication: Once the claim is submitted and eligibility is confirmed, iCoreClaims processes the claim by reviewing it against the terms of the policy. This includes checking for any exclusions or limitations on coverage, ensuring the services rendered are medically necessary, and determining the applicable co-pays, deductibles, and coverage limits; (d) Communication: Throughout the claims process, iCoreClaims communicates with both the dental care provider and the policyholder to resolve any issues, provide explanations of benefits (EOBs), and answer any questions related to the claim; (e) Record Keeping: iCoreClaims maintains records of all claims processed, payments made, and communications related to each claim for auditing, reporting, and customer service purposes. iCoreClaims service plays a crucial role in facilitating the reimbursement process for dental care services covered under insurance policies, ensuring that policyholders receive the benefits they are entitled to and that dental care providers are appropriately compensated for their services. From a technology standpoint, the use of cloud software for documentation and U.S.-based billing specialists highlights iCoreConnect's strategy to combine advanced software with expert human intervention. This hybrid approach can be particularly appealing to healthcare providers who are seeking technological solutions without completely forgoing the human touch that is often necessary for complex billing and coding scenarios.

20iCoreVerifyPro ~~Table~~is a comprehensive, full-service insurance verification solution. This service is designed to handle the entire insurance verification process on behalf of ~~Contents~~dental practices, ensuring that all insurance benefits are accurately entered directly into patient charts. This allows dental staff to focus on critical tasks, improve patient experience, and help patients maximize their insurance benefits. iCoreVerifyPro is part of a tiered offering that includes:

	·	iCoreVerify: Provides automated insurance verifications, handling approximately 80-90% of verifications through automation.
	·	iCoreVerify+: Combines automation with concierge assistance, where a U.S.-based team addresses any outlying manual verifications, achieving 100% verification coverage.
	·	iCoreVerifyPro: Offers a dedicated U.S.-based professional who manages all verifications, entering insurance benefits directly into patient charts, ensuring comprehensive and accurate insurance information.

By utilizing iCoreVerifyPro, dental practices can eliminate the need for staff to perform manual insurance verifications, thereby enhancing efficiency, reducing errors, and improving overall patient satisfaction.

Table of Contents

iCorePay is a state-of-the-art patient payment and billing platform designed to streamline the billing process for healthcare providers while enhancing the patient payment experience. The key features of iCorePay:

	·	Simplified Billing Procedures: Allows healthcare providers to securely create and send HIPAA-compliant billing statements, reducing administrative burdens and potential errors.
	·	Flexible Payment Options: Supports a wide variety of digital payment methods, including major digital wallets like Google Pay, Apple Pay, Venmo, and PayPal, enabling patients to pay using their preferred platforms.
	·	Enhanced Revenue Cycle Management: Accelerates payment processes, leading to quicker collections and improved cash flow for practices. Users have reported significant increases in collections and reductions in costs after implementing iCorePay.
	·	Improved Patient Experience: Offers an easy-to-use interface that allows patients to receive bills directly on their preferred devices and pay promptly, leading to higher satisfaction and engagement.

By integrating iCorePay, healthcare practices can modernize their billing systems, reduce operational costs, and provide a seamless payment experience for their patients.

iCoreAcademy is a patient education video library designed to enhance patient understanding and improve treatment plan acceptance. It offers over 100 high-quality 4K, 3D educational videos covering a wide range of dental topics, including oral surgery, implants, pediatrics, and more. These videos are available in both English and Spanish, ensuring accessibility for a diverse patient population. The key features of iCoreAcademy:

	·	Comprehensive Video Library: Provides detailed explanations of dental conditions and procedures, aiding patients in making informed decisions about their oral health.
	·	Enhanced Patient Understanding: Simplifies complex dental topics, reducing patient anxiety and improving satisfaction.
	·	Flexible Access: Allows patients to view educational content both in-office and at home via text or email links, facilitating continuous learning and support.
	·	Practice Branding: Offers customization options to include practice logos in videos, reinforcing brand identity and trust.

By integrating iCoreAcademy into their practice, dental professionals can effectively educate patients, leading to higher treatment plan acceptance rates and improved overall patient outcomes.

Table of Contents

SaaS Offerings

The Company currently markets secure Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) offerings under the names of iCoreRx, iCorePDMP, iCoreEPCS, iCoreVerify, iCoreHuddle, iCoreHuddle+, iCoreCodeGenius, iCoreExchange, iCoreCloud, iCorePay, iCoreSecure, iCoreClaims and iCoreIT. The Company’s software is sold under annual recurring revenue subscriptions.

Managed IT Services (MSP and MSaaS)

The trend in IT Services companies for over a decade has been to move away from a “Break/Fix '' model to a “Managed Service Provider (MSP)” model with recurring revenue. This group of assets were sold in October 2024.

The MSP/MSaaS approach, by using preventative measures, keeps computers and networks up and running while data is accessible and safeguarded. Installation of critical patches and updates to virus protection are automated. Systems are monitored and backed up in real-time. They are fixed or upgraded before they cause a service disruption. A Unified Threat Management solution is deployed to protect against virus, malware, SPAM, phishing and ransomware attacks. Remote technical support is a click away. All support is delivered at a predictable monthly cost. By leveraging managed services with our expertise in cloud computing, our customers can easily scale their business without extensive capital investment or disruption in services.

The decision makers for our current technology and those for managed services are, in many cases, the same person or group of people and the MSP revenue model matches our SaaS, MSaaS MRR (monthly recurring revenue) models.

Financing

We are currently funding our business capital requirements through revenues from product sales and services and sales of our common stock and debt arrangements. While we intend to seek additional funding, if revenue increases to a point where we are able to sustain ourselves and increase our budget to match our growth needs, we may significantly reduce the amount of investment capital we seek. The amount of funds raised, and revenue generated, if any, will determine how aggressively we can grow and what additional projects we will be able to undertake. No assurance can be given that we will be able to raise additional capital when needed or at all, or that such capital, if available, will be on terms acceptable to us. If we are unable to, or do not raise additional capital in the near future or if our revenue does not begin to grow as we expect, we will have to curtail our spending and downsize our operations.

2125 Table of Contents

Critical Accounting Estimates

Our significant accounting policies are disclosed in Note 3 to the consolidated financial statements. The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the U.S., or GAAP, requires our management to make judgments, assumptions and estimates that affect the amounts of revenue, expenses, income, assets and liabilities, reported in our consolidated financial statements and accompanying notes. Understanding our accounting policies and the extent to which our management uses judgment, assumptions and estimates in applying these policies is integral to understanding our financial statements.

We have identified the following accounting policies as those that require significant judgments, assumptions and estimates and that have a significant impact on our financial condition and results of operations. These policies are considered critical because they may result in fluctuations in our reported results from period to period due to the significant judgments, estimates and assumptions about highly complex and inherently uncertain matters and because the use of different judgments, assumptions or estimates could have a material impact on our financial condition or results of operations. We evaluate our critical accounting estimates and judgments required by our policies on an ongoing basis and update them as appropriate based on changing conditions.

Software Development Capitalization and Amortization

We account for software development costs, including costs to develop software products or the software component of products to be marketed to external users.

In accordance with ASC 350, Internal-Use-Software, research and planning phase costs are expensed as incurred and development phase costs including direct materials and services, payroll and benefits and interest costs are capitalized.

We have determined that technological feasibility for our products to be marketed to external users was reached before the development of those products and, as a result, the development costs and related acquisition costs after the establishment of technological feasibility were capitalized as incurred. Capitalized costs for software to be marketed to external users are amortized based on current and projected future revenue for each product with an annual minimum cost equal to the straight-line amortization of the costs over three years.

Stock-Based Compensation

The Company estimates the fair value of each option award on the date of grant using a Black-Scholes option pricing model that uses the following assumptions. The Company estimates the fair value of its shares of restricted Common Stock using the closing stock price of its common stock on the date of the award. The Company estimates the volatility of its Common Stock at the date of grant based on its historical stock prices. The Company determines the expected life based on historical experience with similar awards, giving consideration to the contractual terms, vesting schedules and post-vesting forfeitures. The Company uses the risk-free interest rate of the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid cash dividends on its Common Stock and does not anticipate paying any cash dividends in the foreseeable future.

Long-Lived Assets and Goodwill

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, Property, Plant and Equipment, Impairment or Disposal of Long-lived Assets. This accounting standard requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. As part of its impairment assessment in ~~2023~~2024 the Company determined that the carrying value of an intangible asset for customer list ~~exceed~~and its acquired softwares were less than their fair value and astherefore ~~such~~brought ~~recorded~~the ancarrying ~~impairment~~value ~~expense~~down into ~~2023 in~~ the ~~amount~~assets offair ~~$105,676~~value.

The Company accounts for goodwill and intangible assets in accordance with ASC 350, Intangibles - Goodwill and Other. Goodwill represents the excess of the purchase price of an entity over the estimated fair value of the assets acquired and liabilities assumed. ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. As of December 31, ~~2023~~2024 there is no impairment of the Company’s Goodwill.

2226 Table of Contents

Results of Operations

The following table sets forth our selected financial data for the periods indicated below:

	For Years Ended
	December 31,			December 31,
	2023			2022
	2024			2023
Revenue	$	810,~~151~~746,~~587~~466		$	78,~~987~~151,~~902~~587
Cost of sales		2,~~029~~496,~~145~~486			2,~~243~~029,~~253~~145
Gross profit		68,~~122~~249,~~442~~980			56,~~744~~122,~~649~~442
Expenses
Selling, general and administrative		1520,~~124~~754,~~081~~205			915,~~254~~124,~~670~~081
Depreciation and amortization		13,~~274~~002,~~963~~585			1,~~292~~274,~~085~~963
Total operating expenses		1623,~~399~~756,~~044~~790			1016,~~546~~399,~~755~~044
Loss from operations		(1015,~~276~~506,~~602~~810	)		(410,~~802~~276,~~106~~602	)
Other income (expense)
Interest expense		(1,~~109~~428,~~388~~459	)		(~~785~~1,~~406~~109,388	)
Financing costs		(1,~~287~~835,~~916~~077	)		(~~426~~1,~~419~~287,916	)
Other income (expense)		(459,965	)		(65,893	)
Change in fair value of embedded derivative instruments		(2,562,027	)		-
Impairment of intangible asset		(105,676	)		-
Change in fair value of warrants		1,616,972			-
Change in fair value of forward purchase agreement		(2,312,116	)		-
Other income (expense)		(439,622	)		(459,965	)
Total other income (expense)		(5,275,061	)		(1,277,718	)
Impairment of intangible asset		(6,631,862	)		(105,676	)
Net loss		(15,551,663	)		(6,079,824	)
Gain on sale of assets		980,197			-
Preferred dividends		(368,699	)		-
Change in fair value of forward purchase agreement		(5,350,129	)		(2,312,116
Dividends to Common Stockholders		-			(1,794,704	)
Total other income (expense)		(15,650,007	)		(5,275,061	)
Net loss attributable to Common Stockholders	$	(15,920,362	)	$	(7,874,528	)
Net loss		(31,156,817	)		(15,551,663	)
Preferred dividends		(2,044,866	)		(368,699	)
Dividends to Common Stockholders		-			-
Net loss attributable to Common Stockholders	$	(33,201,683	)	$	(15,920,362	)

Year ended December 31, ~~2023~~2024 compared to the year ended December 31, ~~2022~~2023

Revenues. Net revenues increased 232% or $~~163~~2,~~685~~594,879 to $810,~~151~~746,~~587~~466 in ~~2023~~2024 from $78,~~987~~151,~~902~~587 in ~~2022~~2023. Revenue growth was attributed to strong growth in the number of recurring revenue subscribers both in terms of new customers as well as with new and existing product uptake along with price increases on existing customer base subscription prices. Recurring revenues increased $~~194~~2,~~503~~793,302 year on year while non-recurring revenues ~~remained~~decreased $(198,423) flat year on year, reflecting the divesture of Managed IT Services assets in Q4 2024.

Cost of sales. Cost of sales ~~decreased~~increased 1023% or $~~(214~~467,~~108)~~341 to $2,~~029~~496,~~145~~486 in ~~2023~~2024 from $2,~~243~~029,~~253~~145 in ~~2022~~2023. The ~~decrease~~increase in cost of sales is due to ~~the~~higher ~~change~~one-time incosts ~~the~~associated ~~mix~~with ofbringing ~~revenues~~on inlarger ~~which~~scale recurring ~~revenues~~revenue ~~have~~enterprise alevel ~~lower~~customers ~~cost~~coupled ofwith ~~service~~higher ~~than~~costs ~~non-recurring~~associated ~~revenues.~~with ~~The~~delivering ~~increase in recurring and decrease in~~ non-recurring revenues ~~both~~during ~~contributed~~the ~~to lower costs of sales~~year.

Selling, general and administrative expenses. Selling, general and administrative (“SGA”) expenses increased 6337% or $5,~~869~~630,~~411~~124 to $1520,~~124~~754,~~081~~205 in ~~2023~~2024 from $915,~~254~~124,~~670~~081 in ~~2022~~2023. The increase in SGA is largely driven by ~~approximately~~a one-time non-recurring $34,~~200~~525,~~000~~811 ~~increase~~charge inrelated ~~spend~~to ~~associated~~stock ~~with~~based ~~professional~~compensation ~~fees~~which ~~primarily~~accounted ~~attributable~~for to80% of the ~~Company’s~~increase ~~merger~~year inon ~~August~~year ~~2023.~~coupled ~~Office~~with ~~expenses~~an ~~increased~~increase ~~approximately~~in ~~$700,000~~salaries ~~year~~and onwages ~~year~~of ~~driven~~approximately by$2,400,000 ~~costs~~ associated with ~~financing~~the ~~discounts and~~ additional ~~insurance~~head ~~costs~~count ~~not~~brought ~~incurred~~ in ~~prior~~with ~~years.~~the ~~Personnel~~acquisition ~~costs~~of ~~increased~~assets byin ~~approximately~~January ~~$1,800,000~~2024. ~~year~~These oncosts ~~year~~were ~~largely~~offset ~~driven~~by ona ~~the~~decrease ~~additional~~in ~~labor~~professional ~~costs~~fees ~~brought~~of onapproximately ~~with~~$2,200,000 ~~the asset acqusition along~~ with anall ~~increase~~other inline ~~stock-based~~expenses ~~compensation~~remaining ~~expense~~relatively flat.

2327 Table of Contents

Depreciation and amortization expenses. Depreciation and amortization expenses ~~decreased~~increased $~~(17~~1,~~122)~~727,622 or ~~(1)~~136% to $13,~~274~~002,~~963~~585 in ~~2023~~2024 from $1,~~292~~274,~~085~~963 in ~~2022~~2023. The ~~decrease~~increase in expenses is due to noseveral ~~new~~ additions being added to intangible assets ~~and~~related to the asset acquisitions completed in January 2024 along with a moderate increase in capitalized software in ~~2023~~2024 compared to ~~2022~~2023.

Interest expense. Interest expense increased $~~323~~319,~~982~~071 or 4129% to $1,~~109~~428,~~388~~459 in ~~2023~~2024 from $~~785~~1,~~406~~109,388 in ~~2022~~2023. The increase in interest expense is attributable to the increase in total debt ~~taken~~outstanding ~~out~~ in ~~2023~~2024 ~~versus~~compared ~~2022~~ to ~~help~~2023 ~~bridge~~which saw some of the Company’s todebt ~~the~~equitized as part of its Business Combination thereby reducing the overall interest costs in that year.

Other income (expense). Other expenses ~~increased~~decreased $~~394~~20,~~072~~343 or ~~598~~4% to $~~459~~439,~~965~~622 in ~~2023~~2024 from $65459,~~893~~965 in ~~2022~~2023. The ~~increase~~decrease is related to the charge for a make whole provision the Company entered into in 2023 with one of its lenders who converted their debt into common stock and provided the lender a make whole from the face value of $10.00 to the price they ultimately sold the common stock at.

Financing costs. Financing costs increased $~~861~~547,~~497~~161 or ~~202~~42% to $1,~~287~~835,~~916~~077 in ~~2023~~2024 from $~~426~~1,~~419~~287,916 in ~~2022~~2023. The increase in financing fees was a result of the Company issuing higher amounts of convertible debt with features including warrants and inducement shares in 2024 than in 2023.

Change in fair value of ~~forward~~embedded ~~purchase~~derivative ~~agreement~~instruments. Change in fair value of ~~forward~~embedded ~~purchase~~derivative ~~agreement~~instruments ~~expenses~~ increased to $2,~~312~~562,~~116~~027 or 100% ~~to $2,312,116 in 2023~~ from $nil in ~~2022~~2023. The expense relates to the ~~derived~~changes in fair value ~~change~~ of the ~~shares~~Company’s ~~underlying~~derivative ~~the~~liabilities ~~forward~~associated ~~purchase~~with ~~agreement~~its ~~market~~convertible ~~from~~debt ~~the~~which ~~balance~~is ~~sheet~~bifurcated ~~date~~and tovalued ~~estimated~~at ~~maturity~~each ~~date~~reporting period.

~~Impairment~~Change onin ~~intangible~~fair ~~asset.~~value ~~The~~of ~~Company~~warrants. ~~incurred~~Change ~~$105,676 expense~~ in ~~2023~~fair ~~related~~value toof ~~the~~warrants ~~carrying~~incurred ~~value~~a gain of a$1,616,972 ~~customer~~or ~~list~~100% ~~purchased~~from nil in ~~2022~~2023. ~~which~~The ~~was~~gain relates to the changes in ~~excess~~fair value of ~~its~~the Company’s fair value. ~~The~~of ~~Company~~its ~~adjusted~~warrants ~~the~~associated ~~carrying~~with ~~value~~its toconvertible ~~equal~~debt ~~the~~which ~~fair~~is ~~value.~~bifurcated Noand ~~impairment~~valued ~~was~~at ~~determined~~each inreporting ~~2022~~period.

~~Preferred~~Change ~~dividends~~in fair value of forward purchase agreement. ~~Preferred~~Change ~~dividends~~in fair value of forward purchase agreement expenses increased toby $~~368~~3,~~699~~038,012 or ~~100~~131% to $~~368~~5,~~699~~350,128 in ~~2023~~2024 from $~~nil~~2,312,116 in ~~2022~~2023. The ~~preferred~~expense ~~dividend~~ relates to ~~dividends accrued for~~ the ~~Company’s~~derived ~~issued~~fair ~~and~~value ~~outstanding~~change ~~Series~~of Athe ~~Preferred~~shares ~~Stock~~underlying ~~excluding~~the ~~Series~~forward Apurchase ~~Preferred~~agreement ~~Stock~~market ~~held~~from by the ~~sponsor~~balance ofsheet ~~the~~date ~~SPAC~~to ~~transaction~~estimated ~~and~~maturity ~~the~~date ~~shares~~in ~~underlying~~February ~~the Forward Purchase Agreement~~2025.

~~Dividends~~Gain toon ~~Common~~sale ~~Stockholders~~of assets. ~~The~~Gain ~~Company~~on ~~incurred~~sale ~~expenses related to the revaluation~~ of ~~certain~~assets ~~warrants~~increased ~~that~~to ~~contained~~$980,197 ~~anti-dilution~~in ~~provisions~~2024 ~~related~~from tonil ~~down~~in ~~round~~2023 ~~financing~~from ~~for~~the ~~total~~sale ~~expense~~ of ~~$nil~~company’s ~~for~~Managed ~~2023~~IT ~~and~~Services ~~$1,794,704~~(MSP ~~for~~and ~~2022,~~MSaaS) ~~respectively~~contracts.

24Impairment ~~Table~~on intangible asset. The Company incurred $6,631,862 in impairment expense in 2024 consisting of ~~Contents~~$5,723,862 in impairment on the carrying value of its acquired technology purchased in 2024 and $908,000 on the carrying value of its customer lists purchased in 2023 in comparison to $105,676 expense in 2023 related to the carrying value of a customer list purchased in 2022 which was in excess of its fair value. The impairment charges are largely related to the Company’s continued decline in financial stability and lack of capital resources to further develop and market its technology and products. The Company has experienced a significant decline in market capitalization during 2024, indicating a decline in the value of its assets. Based upon these factors, the Company determined that the carrying value of its asset required adjustment.

Preferred dividends. Preferred dividends increased by $1,676,167 or 455% to $2,044,866 in 2024 from $368,699 in 2023 reflecting the full year accrual of dividends in 2024 versus only four months in 2023. The preferred dividend relates to dividends accrued for the Company’s issued and outstanding Series A Preferred Stock excluding Series A Preferred Stock held by the sponsor of the SPAC transaction and the shares underlying the Forward Purchase Agreement.

Table of Contents

GOING CONCERN AND LIQUIDITY

The following table sets forth our selected financial data for the periods indicated below and the percentage dollar increase (decrease) of such items from period to period:

	December 31,			December 31,			% Incr/
Balance Sheet Data	~~2023~~2024			~~2022~~2023			(Decr)
Total Current Assets	$	31,~~508~~183,~~325~~238		$	13,~~091~~508,~~668~~325			~~221~~(66	)%
Total Current Liabilities		812,~~876~~434,~~310~~882			68,~~798~~876,~~969~~310			3140	%
Working capital (deficit)	$	(511,~~367~~251,~~985~~644	)	$	(5,~~707~~367,~~301~~985	)		(6110	)%
Deferred Revenue	$	~~119~~138,~~598~~053		$	13119,~~847~~598			~~764~~15	%

Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, debt service, acquisitions, contractual obligations and other commitments. We assess liquidity in terms of our cash flows from operations and their sufficiency to fund our operating and investing activities. As of December 31, ~~2023~~2024, we had cash totaling $1202,~~219,358~~177.

We expect our capital expenditures and working capital requirements to increase moderately in the near future, as we continue to innovate with new products, add enhancements and increase our sales force. Over the next two to three years, we expect to spend in excess of $42,000,000 on software development.

We will need to raise additional funds in the immediate short-term, including through the issuance of equity, equity-related or debt securities or by obtaining additional credit from financial institutions to fund, together with our principal sources of liquidity, ongoing costs, such as software development, expansion of our sales force, and new strategic investments. If such financings are not available, or if the terms of such financings are less desirable than we expect, we may be forced to take actions to reduce our capital or operating expenditures, including by not seeking potential acquisition opportunities, eliminating redundancies, or reducing or delaying our product development road map, which may adversely affect our business, operating results, financial condition and prospects. Further, any future debt or equity financings may be dilutive to our current stockholders.

The following table summarizes the impact of operating, investing and financing activities on our cash flows for the years ended December 31, ~~2023~~2024 and ~~2022~~2023.

	Year Ended
	December 31,			December 31,
	2023			2022
	2024			2023
Net cash used in operating activities	$	(83,~~824~~230,~~972~~688	)	$	(18,~~272~~824,~~995~~972	)
Net cash used in investing activities		(10539,~~214,715~~416	)		(~~293~~10,~~965~~214,715	)
Net cash provided by financing activities		202,~~062~~752,~~892~~923			120,~~691~~062,~~306~~892
Net Increase in cash		1,023,205			124,346
Net (decrease) increase in cash		(1,017,181	)		1,023,205
Cash at the beginning of the year		~~196~~1,~~153~~219,358			71196,~~807~~153
Cash at the end of the year	$	1202,~~219,358~~177		$	~~196~~1,~~153~~219,358

The primary factors that influence our liquidity include, but are not limited to, the amount and timing of our revenues, cash collections from our clients, investments in software development, and ongoing capital raise efforts.

2529 Table of Contents

Operating Activities: Net cash required by operating activities ~~increased~~decreased $75,~~551~~594,~~977~~284 or ~~593~~63% to $83,~~824~~230,~~972~~688 in ~~2023~~2024 from $18,~~272~~824,~~995~~972 in ~~2022~~2023. The increase in cash utilized by operating activities is primarily attributable to the larger net loss year on year of $933,~~840~~201,~~538~~683 offset with non-cash add backs of $312,~~211~~353,~~125~~828 and $14,~~014~~962,~~462~~009 in working capital changes year on year, respectively. Future spending on operating activities are expected to be funded by the revenues realized by the Company, the issuance of notes payable and the sale of additional shares of either common stock or Series A Preferred Stock.

Investing Activities: Net cash used by investing activities ~~increased~~decreased $9,~~920~~675,~~750~~299 or ~~3,375~~95% to $10539,~~214,715~~416 in ~~2023~~2024 from $~~293~~10,~~965~~214,715 in ~~2022~~2023. The ~~increase~~decrease in cash utilized by investing activities was primarily due to the Company entering into a Forward Purchase Agreement which accounted for $7,796,672 of the net change along with $1,559,144 used in the asset acquisition of Preferred Dental Services. Future spending on investing activities is expected to be funded by the issuance of notes payable and the sale of additional shares of either common stock or Series A Preferred Stock..

Financing Activities: Net cash provided by financing activities ~~increased~~decreased $1817,~~371~~309,~~586~~969 or ~~1,086~~86% to $202,~~062~~752,~~892~~923 in ~~2023~~2024 from $120,~~691~~062,~~306~~892 in ~~2022~~2023. The ~~issuances~~Company ofraised ~~Series A Preferred Stock for~~ $184,~~312~~134,~~897~~392 ~~along~~less ~~with the issuances of common stock~~ in ~~the~~debt, ~~amount~~raised of $286,~~881,024~~603 ~~coupled~~less ~~with the net proceeds of debt~~ in ~~the~~common ~~amount~~stock ofand raised $618,~~561~~312,~~354~~897 ~~accounted~~less ~~for~~in ~~the~~Series ~~majority~~A ofPreferred ~~the~~Stock ~~increase~~than in 2023 coupled with the offset by $7,692,383 in merger transaction costs in 2023.

U.S. GAAP requires management to assess a company’s ability to continue as a going concern within one year from the financial statement issuance and to provide related note disclosures in certain circumstances.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

For the fiscal year period ended December 31, ~~2023~~2024, the Company generated an operating loss of $1015,~~276~~506,~~602~~810. In addition, the Company has an accumulated deficit, and net working capital deficit of $~~115~~148,~~038~~240,~~758~~441 and $511,~~367~~251,~~985~~644. The Company’s activities were primarily financed through private placements of equity securities and issuance of debt. The Company ~~intends~~will be required to raise additional capital in the immediate short-term through the issuance of debt and/or equity securities to fund its operations. The Company is reliant on future fundraising to finance operations in the near future. The financing may not be available on terms satisfactory to the Company, if at all. Considering these matters, there is substantial doubt that the Company will be able to continue as a going concern.

2630 Table of Contents

Our material cash requirements from known contractual and other obligations primarily relate to our content, debt and lease obligations. As of December 31, ~~2023~~2024, the expected timing of those payments are as follows:

Total

Next 12

Beyond 12 Months

Debt (1)

67,~~691~~912,~~566~~802

5,~~271~~934,~~429~~416

1,~~420~~978,~~137~~386

Operating lease obligations (2)

1939,~~187,834~~053

~~241~~299,~~945~~284

~~945~~639,~~889~~769

Total

78,~~879~~851,~~400~~855

56,~~513~~233,~~374~~700

2,~~366~~618,~~026~~155

	(1)	Debt obligations include our Notes and Notes to Related Party consisting of principal and interest payments. See Note 8 Debt and Note 13 Related Party in the accompanying notes to our financial statements for further details.

	(2)	See Note 11 Commitments and Contingencies in the accompanying notes to our financial statements for further details regarding leases.

~~Item~~Restatement ~~7A.~~of ~~Quantitative~~Previously ~~and~~Issued ~~Qualitative~~Financial ~~Disclosures~~Statements ~~About Market Risk.~~(Unaudited)

WeOur ~~are~~audit committee concluded, after consultation with management, that our previously issued unaudited financial statements for the periods ended September 30, 2024, included in the Company’s Quarterly Reports of Form 10-Q for the period ended September 30, 2024, should no longer be relied upon as a ~~smaller~~result ~~reporting~~of ~~company~~the change in accounting for debt with embedded derivatives. The Company valued the warrant and conversion features using a Black Scholes model and recognized the value of the warrants as ~~defined~~equity byand ~~Rule~~expense ~~12b-2~~over the term of the ~~Exchange~~loan ~~Act~~and had expensed the value of the conversion feature and ~~are~~increased ~~not~~the ~~required~~value toof ~~provide~~its debt over the term of the loan. The Company concluded that conversion features and warrants should have been recognized as embedded derivatives, bifurcated from the host instruments and presented and valued at fair value starting in September 2024. The adjustments resulting therein, change to current liabilities, paid-in-capital, other expenses – finance fee, other expenses – change in fair value of warrants, other expenses – change in fair value of embedded derivatives, net loss, and net loss attributable to common stockholders that we previously reported, but has no impact on previously reported cash. For further information ~~required~~including ~~under~~the impact of this ~~item~~adjustment, please see Notes 16 to the audited consolidated financial statements included in this Annual Report on Form 10-K.

27Item ~~Table~~7A. ofQuantitative ~~Contents~~and Qualitative Disclosures About Market Risk.

~~Item~~We 8.are ~~Financial~~a ~~Statements~~smaller reporting company as defined by Rule 12b-2 of the Exchange Act and ~~Supplementary~~are ~~Data .~~not required to provide the information required under this item.

A31 ~~list~~Table of financial statements filed herewith is contained and is set forth on the financial statements that immediately follow this page of this Report and is incorporated by reference herein. The financial statement schedules have been omitted because they are not required, not applicable or the information has been included in the Exhibit Index beginning on Part IV of this Annual Report on Form 10-K and are incorporated herein by reference.Contents

			Page
FINANCIAL STATEMENTS - AS OF DECEMBER 31, 2023 AND 2022
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID 688;			F-1
CONSOLIDATEDBALANCE SHEETS AS OF DECEMBER 31, 2023 AND 2022			F-2
CONSOLIDATEDSTATEMENTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022			F-3
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022			F-4
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022			F-5
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS			F-6

Item 8. Financial Statements and Supplementary Data .

28A ~~Table~~list of ~~Contents~~financial statements filed herewith is contained and is set forth on the financial statements that immediately follow this page of this Report and is incorporated by reference herein. The financial statement schedules have been omitted because they are not required, not applicable or the information has been included in the Exhibit Index beginning on Part IV of this Annual Report on Form 10-K and are incorporated herein by reference.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

		Page

FINANCIAL STATEMENTS - AS OF DECEMBER 31, 2024 AND 2023

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID 688;		F-1
CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2024 AND 2023		F-2
CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023		F-3
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023		F-4
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023		F-5
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS		F-6

To32 ~~the~~Table ~~Shareholders and Board~~ of ~~Directors of~~ Contents

~~iCoreConnect,~~REPORT ~~Inc.~~OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

~~Opinion~~To on the ~~Financial~~Stockholders ~~Statements~~and Board of Directors of

~~We have audited the accompanying consolidated balance sheets of~~ iCoreConnect, Inc. (the “Company”) as of December 31, 2023 and 2022, the related consolidated statements of operations, changes in stockholders’ equity (deficit) and cash flows for each of the two years in the period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

~~Explanatory~~Opinion ~~Paragraph~~on –the ~~Going~~Financial ~~Concern~~ Statements

~~The~~We ~~accompanying~~have ~~financial~~audited ~~statements~~the ~~have~~accompanying ~~been~~consolidated ~~prepared~~balance ~~assuming~~sheets ~~that~~of iCoreConnect, Inc. (the “Company”) ~~will~~as ~~continue~~of asDecember a31, ~~going~~2024 ~~concern.~~and As2023, ~~more~~the ~~fully~~related ~~described~~consolidated instatements ~~Note~~of 3operations, stockholders’ equity (deficit) and cash flows for each of the ~~Company~~two ~~has~~years ain ~~significant~~the ~~working~~period ~~capital~~ended ~~deficiency~~December 31, ~~has~~2024, ~~incurred~~and ~~significant~~the ~~losses~~related ~~and~~notes ~~needs~~(collectively referred to ~~raise~~as ~~additional~~the ~~funds~~“financial tostatements”). In ~~meet~~our ~~its~~opinion, the ~~obligations~~financial ~~and~~statements ~~sustain~~present ~~its~~fairly, ~~operations.~~in ~~These~~all ~~conditions~~material ~~raise~~respects, ~~substantial~~the ~~doubt~~financial ~~about~~position of the Company's ~~ability~~as toof ~~continue~~December as31, a2024 ~~going~~and ~~concern.~~2023, ~~Management's~~and ~~plans~~the inresults ~~regard~~of toits ~~these~~operations ~~matters~~and ~~are~~its ~~also~~cash ~~described~~flows for each of the two years in ~~Note~~the 3.period ~~The~~ended ~~financial~~December ~~statements~~31, do2024, ~~not~~in ~~include~~conformity ~~any~~with ~~adjustments~~accounting ~~that~~principles ~~might~~generally ~~result~~accepted ~~from~~in the ~~outcome~~United States of ~~this uncertainty~~America.

~~Basis~~Explanatory ~~for~~Paragraph ~~Opinion~~– Going Concern

~~These~~The accompanying financial statements ~~are~~have ~~the~~been ~~responsibility~~prepared ofassuming that the Company's ~~management.~~will ~~Our~~continue ~~responsibility~~as isa togoing ~~express~~concern. anAs ~~opinion~~more onfully ~~the~~described ~~Company's~~in ~~financial~~Note ~~statements~~3, ~~based~~the onCompany ~~our~~has ~~audits.~~a Wesignificant ~~are~~working acapital ~~public~~deficiency, ~~accounting~~has ~~firm~~incurred ~~registered~~significant ~~with~~losses ~~the~~and ~~Public~~needs ~~Company~~to ~~Accounting~~raise ~~Oversight~~additional ~~Board~~funds ~~(United~~to ~~States)~~meet ~~("PCAOB")~~its obligations and ~~are~~sustain ~~required~~its tooperations. beThese ~~independent~~conditions ~~with~~raise ~~respect~~substantial todoubt about the Company's inability ~~accordance~~to ~~with~~continue ~~the~~as Ua going concern.S. ~~federal~~Management's ~~securities~~plans ~~laws~~in ~~and~~regard ~~the~~to ~~applicable~~these ~~rules~~matters ~~and~~are ~~regulations~~also ofdescribed ~~the~~in ~~Securities~~Note ~~and~~3. ~~Exchange~~The ~~Commission~~financial ~~and~~statements do not include any adjustments that might result from the ~~PCAOB~~outcome of this uncertainty.

WeBasis conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for ~~the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.~~ Opinion

~~Our~~These ~~audits~~financial ~~included~~statements ~~performing~~are ~~procedures to assess~~ the ~~risks~~responsibility of ~~material misstatement of~~ the ~~financial~~Company's ~~statements,~~management. ~~whether~~Our ~~due~~responsibility is to ~~error~~express oran ~~fraud,~~opinion ~~and~~on ~~performing~~the ~~procedures~~Company's ~~that~~financial ~~respond~~statements tobased ~~those~~on ~~risks~~our audits. ~~Such~~We ~~procedures~~are ~~included examining, on~~ a ~~test~~public ~~basis,~~accounting ~~evidence~~firm ~~regarding~~registered with the ~~amounts~~Public ~~and~~Company ~~disclosures~~Accounting inOversight ~~the~~Board ~~financial~~(United ~~statements.~~States) ~~Our~~("PCAOB") ~~audits~~and ~~also~~are ~~included~~required ~~evaluating~~to ~~the~~be ~~accounting~~independent ~~principles~~with ~~used~~respect ~~and~~to ~~significant~~the ~~estimates~~Company ~~made~~in byaccordance ~~management,~~with asthe ~~well~~U.S. asfederal ~~evaluating~~securities ~~the~~laws ~~overall~~and ~~presentation of~~ the ~~financial~~applicable ~~statements.~~rules Weand ~~believe~~regulations ~~that~~of ~~our~~the ~~audits~~Securities ~~provide~~and aExchange ~~reasonable~~Commission ~~basis~~and ~~for~~the ~~our opinion~~PCAOB.

~~Critical~~We ~~Audit~~conducted ~~Matters~~our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

~~Critical~~Our ~~audit~~audits ~~matters~~included ~~are~~performing ~~matters~~procedures ~~arising~~to ~~from~~assess the ~~current~~risks ~~period~~of ~~audit~~material misstatement of the financial statements, ~~that~~whether ~~were~~due ~~communicated~~to error or ~~required~~fraud, toand beperforming ~~communicated~~procedures that respond to ~~the~~those ~~audit~~risks. ~~committee~~Such ~~and~~procedures ~~that:~~included ~~(1)~~examining, ~~relate~~on toa ~~accounts~~test orbasis, ~~disclosures~~evidence ~~that~~regarding ~~are~~the ~~material~~amounts toand disclosures in the financial statements. Our audits also included evaluating the accounting principles used and ~~(2)~~significant ~~involved~~estimates ~~our~~made ~~especially~~by ~~challenging~~management, ~~subjective,~~as orwell ~~complex~~as ~~judgments~~evaluating the overall presentation of the financial statements. We ~~determined~~believe that ~~there~~our ~~are~~audits noprovide ~~critical~~a ~~audit~~reasonable ~~matters~~basis for our opinion.

/s/ Marcum LLP

Marcum LLP

We have served as the Company’s auditor since 2021.

New York, NY

~~April~~May 1829, ~~2024~~2025

F-1

Table of Contents

iCoreConnect Inc.

CONSOLIDATED BALANCE SHEETS

	As of
	December 31,			December 31,
	2023			2022
	2024			2023
ASSETS
Cash	$	1202,~~219,358~~177		$	~~196~~1,~~153~~219,358
Accounts receivable, net		~~563~~814,~~905~~061			~~414~~563,~~809~~905
Prepaid expenses and other current assets	~~1,725,062~~	167,000			~~480~~1,~~706~~725,062
Total current assets		31,~~508~~183,~~325~~238			13,~~091~~508,~~668~~325
Property and equipment, net		~~202~~173,~~421~~611			74202,~~194~~421
Right of use lease asset - operating		1871,~~122,412~~167			~~944~~1,~~487~~122,412
Software development costs, net		~~903~~1,~~412~~679,615			~~531~~903,~~061~~412
Acquired technology, net		-			~~79,428~~-
Customer relationships, net		2164,~~980,412~~015			2,~~350~~980,~~380~~412
Forward purchase agreement		5134,~~484,556~~429			-5,484,556
Goodwill		1,484,966			1,484,966
Total long-term assets		124,~~178~~507,~~179~~803			512,~~464~~178,~~516~~179
TOTAL ASSETS	$	155,~~686~~691,~~504~~041		$	615,~~556~~686,~~184~~504
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Accounts payable and accrued expenses	$	34,~~243~~769,~~338~~856		$	23,~~336~~243,~~174~~338
Operating lease liability, current portion		~~241~~299,~~945~~284			~~169~~241,~~417~~945
Notes payable, current portion		4,720,455			4,034,865
Warrant and embedded derivative liability		1,293,273			-
Related party notes payable		550,974			244,666
Notes payable, current portion		5,353,007			4,720,455
Deferred revenue		119,598			13,847
Related party notes payable		581,409			550,974
Total current liabilities		8,876,310			6,798,969
Deferred revenue		138,053			119,598
Long-term debt, net of current maturities		1,420,137			1,449,261
Total current liabilities		12,434,882			8,876,310
Operating lease liability, net of current portion		945,889			809,458
Warrant and embedded derivative liability, net current		432,978			-
Total long-term liabilities		2,366,026			2,258,719
Long-term debt, net of current maturities		1,823,474			1,420,137
TOTAL LIABILITIES	$	11,242,336		$	9,057,688
Related party notes payable, net of current maturities		154,912			-
Operating lease liability, net of current portion		639,769			945,889
Total long-term liabilities		3,051,133			2,366,026
TOTAL LIABILITIES	$	15,486,015		$	11,242,336
Commitments and Contingencies (Note 11)		-			-
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred Stock par value $0.0001; 40,000,000 shares authorized; Issued and Outstanding: 3,755,209 as of December 31, 2023 and 0 as of December 31, 2022		376			-
Convertible Preferred Stock par value $0.0001; 40,000,000 shares authorized; Issued and Outstanding: 821,929 as of December 31, 2024 and 3,755,209 as of December 31, 2023		82			376
Common Stock par value $0.0001; 100,000,000 shares authorized; Issued and Outstanding: 10,068,477 as of December 31, 2023 and 6,076,078 as of December 31, 2022		1,007			608
Common Stock par value $0.0001; 250,000,000 shares authorized; Issued and Outstanding: 2,066,016 as of December 31, 2024 and 503,424 as of December 31, 2023		207			50
Additional paid-in-capital		~~119~~138,~~481~~445,~~543~~178			80119,~~359~~482,~~848~~500
Accumulated deficit		(~~115~~148,~~038~~240,~~758~~441	)		(82115,~~861~~038,~~960~~758	)
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)		4(9,~~444~~794,~~168~~974	)		(24,~~501~~444,~~504~~168	)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUIITY(DEFICIT)	$	155,~~686~~691,~~504~~041		$	615,~~556~~686,~~184~~504

The accompanying notes are an integral part of these consolidated financial statements

F-2

Table of Contents

iCoreConnect Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Years Ended
	December 31,			December 31,
	2023			2022
	2024			2023
Revenue	$	810,~~151~~746,~~587~~466		$	78,~~987~~151,~~902~~587
Cost of sales		2,~~029~~496,~~145~~486			2,~~243~~029,~~253~~145
Gross profit		68,~~122~~249,~~442~~980			56,~~744~~122,~~649~~442
Expenses
Selling, general and administrative		1520,~~124~~754,~~081~~205			915,~~254~~124,~~670~~081
Depreciation and amortization		13,~~274~~002,~~963~~585			1,~~292~~274,~~085~~963
Total operating expenses		1623,~~399~~756,~~044~~790			1016,~~546~~399,~~755~~044
Loss from operations		(1015,~~276~~506,~~602~~810	)		(410,~~802~~276,~~106~~602	)
Other expense
Interest expense		(1,~~109~~428,~~388~~459	)		(~~785~~1,~~406~~109,388	)
Finance charges		(1,~~287~~835,~~916~~077	)		(~~426~~1,~~419~~287,916	)
Change in fair value of forward purchase agreement		(2,312,116	)		-
Change in fair value of embedded derivative instruments		(2,562,027	)		-
Impairment of intangible asset		(105,676	)		-
Change in fair value of warrants		1,616,972			-
Other expense		(459,965	)		(65,893
Change in fair value of forward purchase agreement		(5,350,129	)		(2,312,116	)
Total other expense		(5,275,061	)		(1,277,718	)
Gain on sale of assets		980,197			-
Net loss		(15,551,663	)		(6,079,824	)
Impairment of intangible asset		(6,631,862	)		(105,676	)
Dividends to common stockholders		-		(1,794,704		)
Other expense		(439,622	)		(459,965	)
Preferred dividends		(368,699	)		-
Total other expense		(15,650,007	)		(5,275,061	)
Net loss attributable to common stockholders	$	(15,920,362	)	$	(7,874,528	)
Net loss		(31,156,817	)		(15,551,663	)
Net loss per share, basic and diluted	$	(2.17	)	$	(1.37	)
Dividends to Common Stock shareholders		-			-
Weighted average number of shares, basic and diluted		7,349,541			5,768,249
Preferred dividends		(2,044,866	)		(368,699	)
Net loss attributable to common stockholders	$	(33,201,683	)	$	(15,920,362	)
Net loss per share, basic and diluted	$	(45.78	)	$	(43.32	)
Weighted average number of shares, basic and diluted		725,183			367,478

The accompanying notes are an integral part of these consolidated financial statements

F-3

Table of Contents

iCoreConnect Inc.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE YEARS ENDED DECEMBER 31, ~~2023~~2024 ~~AND~~and ~~2022~~2023

													Additional						TotalStockholders'
	Common stock						Convertible Preferred Stock						AdditionalPaid In			Accumulated			TotalStockholders'Equity
	Common stock						Preferred Stock						Paid In			Accumulated			Equity
	Shares			Amount			Shares			Amount			Capital			Deficit			(Deficit)
Balances at January 1, 2022		167,493,479		$	167,493			-		$	-		$	83,633,061		$	(82,795,263)		$	1,005,291
Balances at January 1, 2023		9,066,027			908			-			-			86,192,839			(88,875,087	)		(2,681,340	)
Retroactive application of reverse capitalization (Note 2)		(~~161~~8,~~880~~762,~~406)~~227	)		(~~166,932)~~877	)								~~166~~180,~~932~~713			(10,243,~~017)~~309	)		(10,~~243~~063,~~017)~~473	)
Balances at January 1, 2022		5,613,073			561			-			-			83,799,993			(93,038,280)			(9,237,726)
Balances at January 1, 2023		303,800			31			-			-			86,373,552			(99,118,396	)		(12,744,813	)
Stock issued for cash		~~191~~74,~~785~~486			197									~~449~~2,~~981~~880,978						~~450~~2,~~000~~880,985
Origination fee in convertible debt agreement		322			-									~~426~~1,~~419~~040,165						~~426~~1,~~419~~040,165
Stock issued for conversion of debt		769,~~620~~647			17									225,~~386~~747,490						225,~~387~~747,497
Stock repurchased and cancelled as part of settlement		(41,890)			(3)									(99,997)						(100,000)
Stock compensation expense		12,168			1									1,942,035						1,942,036
Exercise of Common Stock Options		23,459			2									2,098						2,100
Issuance of Series A Convertible Preferred Stock on merger								3,782,191			378			17,846,920						17,847,298
Repurchase of Common Stock Warrants														(45,000)						(45,000)
Common stock issued on exercise of options		9,919			1									(5,941	)					(5,940	)
Stock compensation expense		282,031			28									1,817,095						1,817,123
Conversion of Series A Convertible Preferred Stock to Common Stock		10,643			1			(212,842	)		(21	)		20						-
Net loss																	(6,079,824)			(6,079,824)
Balances at December 31, 2022		6,076,078			608			-			-			86,372,975			(99,118,104)			(12,744,521)
Balances at January 1, 2023		181,320,528			181,321			-			-			86,192,262			(88,875,087)			(2,501,504)
Retroactive application of reverse capitalization (Note 2)		(175,244,450)			(180,713)									180,713			(10,243,309)			(10,243,309)
Balances at January 1, 2023		6,076,078			608			-			-			86,372,975			(99,118,396)			(12,744,813)
Stock issued for cash		1,489,707			149									2,880,836						2,880,985
Origination fee in convertible debt agreement		6,629			1									1,040,164						1,040,165
Stock issued for conversion of debt		1,392,936			139									5,747,358						5,747,497
Stock compensation expense		243,347			24									1,942,012						1,942,036
Issuance of Series A Preferred Stock on merger								3,782,191			378			17,846,920						(17,847,298	)
Common stock issued on exercise of options		198,378			20									(5,940)						(5,920)
Conversion of Series A Preferred Stock to Common Stock		212,842			21			(212,842)			(21)									-
Series A Preferred Stock issued for cash								46,500			5			464,995						465,000
Stock issued for purchase of assets of Preferred Dental		402,000			4-									~~399~~400,~~996~~000						400,000
Modification of warrant agreement														1,987,460						1,987,460
Origination fee on equity line of credit		~~291~~14,~~259~~563			291									599,~~971~~999						600,000
Stock issued for the conversion of warrants		~~117~~5,~~301~~866			121									(3,~~512)~~501	)					(3,500)	)
Preferred stock issued on exercise of warrants								139,360			14			(14)	)					-
Merger transaction costs														208,322						208,322
Net loss																	(15,920,362)	)		(15,920,362)	)
Balance at December 31, 2023		10503,~~068,477~~424		$	~~1,007~~50			3,755,209		$	376		$	119,~~481~~482,~~543~~500		$	(115,038,758	)	$	4,444,168

The accompanying notes are an integral part of these consolidated financial statements

Balances at January 1, 2024	503,424		50	3,755,209			376			119,482,500			(115,038,758	)		4,444,168
Stock issued for cash	185,000		19							303,581						303,600
Stock issued for inducement of STRATA	15,000		2							156,028						156,030
Origination fee in convertible debt agreement	31,252		2							1,010,233						1,010,235
Stock issued for conversion of debt	468,650		46							2,096,357						2,096,403
Stock issued for purchase of FeatherPay				480,000			48			4,799,952						4,800,000
Stock issued for the purchase of Verifi Dental				84,000			8			839,992						840,000
Stock issued for the purchase of Teamworx				57,500			6			574,994						575,000
Stock issued for the purchase of Healthcare Circle of Excellence	1,616		-							30,000						30,000
Stock issued for dividend in kind				201,711			19			2,017,090						2,017,109
Common stock issued on exercise of warrants				156,369			16			(16	)					-
Conversion of Series A Convertible Preferred Stock to Common Stock	763,161		77	(3,912,860	)		(391	)		314						-
Stock compensation expense	69,877		7							7,134,156						7,134,163
Stock issued for rounding on reverse stock split	28,036		4							(4	)					-

Net loss													(33,201,683	)		(33,201,683	)
Balance at December 31, 2024	2,066,016	$	207	821,929		$	82		$	138,445,178		$	(148,240,441	)	$	(9,794,974	)

~~F-4~~The ~~Table~~accompanying notes are an integral part of ~~Contents~~these consolidated financial statements

~~iCoreConnect~~F-4 ~~Inc.~~ Table of Contents

~~CONSOLIDATED~~iCoreConnect ~~STATEMENTS OF CASH FLOWS~~Inc.

	For the years ended
	December 31,			December 31,
	2023			2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(15,920,362	)	$	(6,079,824	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		17,429			22,521
Amortization expense		1,257,534			1,269,564
Finance charges		1,287,916			426,419
Bad debt expense		158,620			261,717
Change in value of forward purchase agreement		2,312,116			-
Stock compensation expense		1,942,036			1,717,123
Gain on sale of assets		(13,778	)		-
Dividend expense		368,699			-
Non-cash interest expense		167,265			603,146
Impairment of intangible assets		105,676			-
Changes in assets and liabilities:
Accounts receivable		(307,716	)		(47,479	)
Prepaid expenses and other current assets		(1,244,356	)		(26,420	)
Right of use asset, net of lease liability		31,034			34,386
Accounts payable and accrued expenses		907,164			552,424
Deferred revenue		105,751			(6,572	)
NET CASH USED IN OPERATING ACTIVITIES		(8,824,972	)		(1,272,995	)
INVESTING ACTIVITIES
Cash portion of consideration paid to acquire Preferred Dental		(1,559,144	)		-
Investment in forward purchase agreement		(7,796,672	)		-
Proceeds from sale of assets		28,000			-
Purchases of capital assets		(159,878	)		(4,153	)
Additions to capitalized software		(727,021	)		(289,812	)
NET CASH USED IN INVESTING ACTIVITIES		(10,214,715	)		(293,965	)
FINANCING ACTIVITES
Net proceeds from debt		7,796,753			3,585,000
Payments on debt		(1,235,399	)		(2,323,181	)
Proceeds from issuance of common stock		2,881,024			450,000
Conversion of convertible debt into common stock		-			22,387
Proceeds from issuance of series A preferred stock		18,312,897			-
Proceeds from exercise of employee stock options		-			2,100
Effect of merger, net of transactions		(7,692,383	)		-
Repurchase of warrants for common stock		-			(45,000	)
NET CASH PROVIDED BY FINANCING ACTIVITIES		20,062,892			1,691,306
NET CHANGE IN CASH		1,023,205			124,346
CASH AT BEGINNING OF THE YEAR		196,153			71,807
CASH AT END OF THE YEAR	$	1,219,358		$	196,153
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	$	18,750		$	696,355
Stock issued for acquisition of Preferred Dental	$	400,000		$	-
Stock issued for conversion of notes payable	$	5,765,656		$	22,387
Dividends to Common Stockholders		-		$	1,794,704

CONSOLIDATED STATEMENTS OF CASH FLOWS

The accompanying notes are an integral part of these consolidated financial statements

	For the years ended
	December 31,			December 31,
	2024			2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(33,201,683	)	$	(15,920,362	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		26,957			17,429
Amortization expense		2,975,628			1,257,534
Finance charges		1,835,080			1,287,916
Change in fair value of embedded derivative instruments		(2,562,027	)		-
Change in fair value of warrants		1,616,972			-
Bad debt expense		241,396			158,620
Change in value of forward purchase agreement		5,350,127			2,312,116
Stock compensation expense		7,134,163			1,942,036
Loss (gain) on sale of assets		(980,197	)		(13,778	)
Dividend expense		2,044,866			368,699
Non-cash interest expense		1,202,281			167,265
Impairment of intangible assets		6,631,862			105,676
Changes in assets and liabilities:
Accounts receivable		(436,334	)		(307,716	)
Prepaid expenses and other current assets		1,539,567			(1,244,356	)
Right of use asset, net of lease liability		2,676			31,034
Accounts payable and accrued expenses		1,558,077			907,164
Warrant and embedded derivative liability		1,726,251			-
Deferred revenue		63,649			105,751
NET CASH USED IN OPERATING ACTIVITIES		(3,230,688	)		(8,824,972	)

INVESTING ACTIVITIES
Cash portion of consideration paid to acquire Preferred Dental					(1,559,144	)
Cash portion of consideration paid to acquire FeatherPay, LLC		(500,000	)		-
Cash portion of consideration paid to acquire Verifi Dental LLC		(370,000	)		-
Cash portion of consideration paid to acquire Teamworx, LLC					-
Investment in forward purchase agreement		-			(7,796,672	)
Proceeds from sale of assets		1,733,612			28,000
Purchases of capital assets		-			(159,878	)
Additions to capitalized software		(1,403,028	)		(727,021	)
NET CASH USED IN INVESTING ACTIVITIES		(539,416	)		(10,214,715	)

FINANCING ACTIVITES
Net proceeds from debt		3,662,361			7,796,753
Payments on debt		(1,322,002	)		(1,235,399	)
Proceeds from issuance of common stock		303,619			2,881,024
Conversion of convertible debt into common stock		108,945			-
Proceeds from issuance of series A convertible preferred stock		-			18,312,897
Effect of merger, net of transactions		-			(7,692,383
NET CASH PROVIDED BY FINANCING ACTIVITIES		2,752,923			20,062,892

NET CHANGE IN CASH		(1,017,181	)		1,023,205
CASH AT BEGINNING OF THE YEAR		1,219,358			196,153
CASH AT END OF THE YEAR	$	202,177		$	1,219,358

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	$	224,237		$	18,750
Stock issued for acquisitions	$	6,245,000		$	400,000
Stock issued for conversion of notes payable	$	2,039,479		$	5,765,656

~~F-5~~The ~~Table~~accompanying notes are an integral part of ~~Contents~~these consolidated financial statements

~~Notes~~F-5 toTable ~~Consolidated~~of ~~Financial Statements~~Contents

1.Notes ~~NATURE~~to OFConsolidated ~~OPERATIONS~~Financial Statements

~~iCoreConnect Inc~~1., ~~(the~~NATURE ~~“Company”),~~OF a Delaware Corporation, is a cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise platform of applications and services.OPERATIONS

2iCoreConnect Inc., ~~MERGER~~(the ~~AND~~“Company”), ~~RECAPITALIZATION~~a Delaware Corporation, is a cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise platform of applications and services.

~~On August 25, 2023, Old iCore and FGMC consummated the Business Combination, with Old iCore surviving as a wholly owned subsidiary of FGMC~~2. AsMERGER ~~part~~AND of the Business Combination, FGMC changed its name to iCoreConnect Inc. Upon the closing of the Business Combination (the “Closing”), the Company’s certificate of incorporation provided for, among other things, a total number of authorized shares of capital stock of 140,000,000 shares, of which 40,000,000 shares were designated Series A preferred stock, $0.0001 par value per share and 100,000,000 were designated common stock, $0.0001 par value per share.RECAPITALIZATION

~~The~~On ~~Business~~August ~~Combination~~25, is2023, ~~accounted~~Old ~~for~~iCore asand aFGMC ~~reverse~~consummated ~~recapitalization~~the inBusiness ~~accordance~~Combination, with ~~U.S.~~Old ~~GAAP.~~iCore ~~Under~~surviving ~~this~~as ~~method~~a ofwholly ~~accounting,~~owned subsidiary of FGMC. isAs ~~treated~~part asof the ~~“acquired”~~Business ~~company~~Combination, ~~and~~FGMC ~~Old~~changed ~~iCore~~its isname ~~treated~~to asiCoreConnect ~~the~~Inc. ~~acquirer~~Upon ~~for~~the ~~financial~~closing ~~reporting~~of ~~purposes.~~the ~~Accordingly,~~Business ~~for~~Combination ~~accounting~~(the ~~purposes~~“Closing”), the ~~Business~~Company’s ~~Combination~~certificate ~~was~~of ~~treated~~incorporation asprovided ~~the~~for, ~~equivalent~~among other things, a total number of ~~Old~~authorized ~~iCore~~shares ~~issuing~~of capital stock ~~for~~of ~~the~~140,000,000 ~~net~~shares, ~~assets~~ of ~~FGMC~~which 40,000,000 ~~accompanied~~shares bywere adesignated ~~recapitalization.~~Series ~~The~~A ~~net~~preferred ~~assets~~stock, of$0.0001 ~~FGMC~~par ~~are~~value ~~stated~~per atshare ~~historical~~and ~~cost~~100,000,000 ~~with~~were nodesignated ~~goodwill~~common orstock, ~~intangible~~$0.0001 ~~assets~~par ~~recorded~~value per share.

~~Upon~~The ~~the consummation of the~~ Business Combination, ~~each~~is ~~issued~~accounted ~~and~~for ~~outstanding~~as ~~share~~a ofreverse ~~Old~~recapitalization ~~iCore~~in ~~Common~~accordance ~~Stock~~with ~~was~~U.S. ~~canceled~~GAAP. ~~and~~Under ~~converted~~this ~~into~~method ~~Company~~of ~~Common~~accounting, ~~Stock~~FGMC ~~based~~is ~~upon~~treated ~~the Exchange Ratio (~~as ~~defined in~~ the ~~Merger~~“acquired” ~~Agreement).~~company ~~The shares~~ and ~~corresponding~~Old ~~capital~~iCore ~~amounts~~is ~~and~~treated ~~loss~~as ~~per~~the ~~share~~acquirer ~~related~~for tofinancial ~~Old~~reporting ~~iCore~~purposes. ~~Common~~Accordingly, ~~Stock~~for ~~prior~~accounting topurposes, the Business Combination ~~have~~was ~~been~~treated ~~retroactively~~as ~~restated~~the toequivalent ~~reflect~~of ~~the~~Old ~~Exchange~~iCore ~~Ratio.~~issuing ~~All~~stock ~~non-redeemed~~for ~~shares~~the net assets of FGMC, ~~common~~accompanied ~~stock~~by ~~were~~a ~~converted~~recapitalization. ~~into~~The ~~new~~net ~~iCoreConnect~~assets ~~Inc.~~of ~~Series~~FGMC Aare ~~preferred~~stated ~~stock~~at ~~(the~~historical ~~“Preferred~~cost, ~~Stock”)~~with onno agoodwill ~~one~~or ~~for~~intangible ~~one~~assets ~~basis~~recorded.

~~Unvested~~Upon ~~outstanding~~the ~~stock~~consummation ~~options~~of tothe ~~purchase~~Business ~~shares~~Combination, each issued and outstanding share of Old iCore Common Stock ~~(“Old~~was ~~iCore~~canceled ~~Options”)~~and ~~granted~~converted ~~under~~into ~~the~~Company ~~iCoreConnect~~Common ~~Inc~~Stock ~~2016~~based ~~Stock~~upon ~~Incentive~~the ~~Plan~~Exchange Ratio (~~“2016~~as ~~Plan”)~~defined ~~converted~~in ~~into~~the ~~stock~~Merger ~~options~~Agreement). ~~for~~The shares ofand ~~Company~~corresponding ~~Common~~capital ~~Stock~~amounts ~~upon the same terms~~ and ~~conditions~~loss ~~that~~per ~~were~~share inrelated ~~effect with respect~~ to ~~such~~Old ~~stock~~iCore ~~options~~Common ~~immediately~~Stock prior to the Business Combination, ~~after~~have ~~giving~~been ~~effect~~retroactively restated to reflect the Exchange Ratio ~~(the “Exchanged Options”)~~. ~~Old~~All ~~iCore~~non-redeemed ~~Options that were vested at the time of the merger converted into~~ shares of ~~Company~~FGMC ~~Common~~common ~~Stock~~stock ~~upon the same terms and conditions that~~ were inconverted ~~effect~~into ~~with~~new ~~respect~~iCoreConnect toInc. ~~such~~Series ~~options~~A ~~immediately~~preferred ~~prior~~stock to (the ~~Business~~“Preferred ~~Combination,~~Stock”) ~~after~~on ~~giving~~a ~~effect~~one tofor ~~the~~one ~~Exchange Ratio~~basis.

~~Outstanding~~Unvested ~~warrants~~outstanding stock options to purchase shares of Old iCore Common Stock (“Old iCore ~~warrants~~Options”) ~~issued~~granted under the iCoreConnect Inc 2016 Stock Incentive Plan (“2016 Plan”) converted into stock options for shares of Company Common Stock upon the same terms and ~~outstanding~~conditions that were in effect with respect to such stock options immediately prior to the Business Combination, after giving effect to the Exchange Ratio (the “Exchanged Options”). Old iCore Options that were vested at the time of the merger converted into shares of Company Common Stock upon the same terms and conditions that were in effect with respect to such ~~warrants~~options immediately prior to the Business Combination, after giving effect to the Exchange Ratio.

~~F-6~~Outstanding ~~Table~~warrants to purchase shares of ~~Contents~~Old iCore Common Stock (“Old iCore warrants”) issued and outstanding converted into shares of Company Common Stock upon the same terms and conditions that were in effect with respect to such warrants immediately prior to the Business Combination, after giving effect to the Exchange Ratio.

~~The~~F-6 ~~following~~Table ~~table details the number~~ of ~~shares of Company Common Stock issued immediately following the consummation of the Business Combination:~~Contents

	Common Stock			Preferred Stock
Common stock of FGMC outstanding prior to business combination		8,050,000			-
Less: Redemptions of FGMC common stock		(6,460,059	)		-
Common stock held by former FGMC shareholders		1,589,941			-
FGMC sponsor shares		1,692,374			-
Underwriter shares		40,250			-
Sponsor shares transferred for services		2,000			-
Sponsor shares transferred for non-redemption		373,126			-
Shares issued related to extension note		84,500			-
Total FGMC common shares outstanding prior to conversion to preferred stock		3,782,191			-
Conversion of existing FGMC common stockholders to new preferred stock		(3,782,191	)		3,782,191
Shares issued to Old iCore stockholders for purchase consideration		8,095,706			-
Total		8,095,706			3,782,191

The following table details the number of shares of Company Common Stock issued immediately following the consummation of the Business Combination:

The following table reconciles the elements of the Business Combination to the Company’s consolidated statement of changes in stockholders’ equity (deficit):

	Common Stock			Preferred Stock

Common stock of FGMC outstanding prior to business combination		402,500			-
Less: Redemptions of FGMC common stock		(323,003	)		-
Common stock held by former FGMC shareholders		79,497			-
FGMC sponsor shares		84,619			-
Underwriter shares		2,013			-
Sponsor shares transferred for services		100			-
Sponsor shares transferred for non-redemption		18,657			-
Shares issued related to extension note		4,225			-
Total FGMC common shares outstanding prior to conversion to preferred stock		189,111			-
Conversion of existing FGMC common stockholders to new convertible preferred stock		(189,111	)		3,782,191
Shares issued to Old iCore stockholders for purchase consideration		404,786			-
Total		404,786			3,782,191

	Amount
Cash - FGMC trust (net of redemptions)	$	17,002,897
Cash transferred to Forward Purchase Agreement		(12,569,810	)
Gross proceeds		4,433,087
Less: FGMC and Old iCore transaction costs paid		(4,433,087	)
Effect of Business Combination, net of redemptions and transaction costs	$	-

The following table reconciles the elements of the Business Combination to the Company’s consolidated statement of changes in stockholders’ equity (deficit):

All existing FGMC warrants were converted into Preferred Stock warrants with the same terms and conditions:

	Amount
Cash - FGMC trust (net of redemptions)	$	17,002,897
Cash transferred to Forward Purchase Agreement		(12,569,810	)
Gross proceeds		4,433,087
Less: FGMC and Old iCore transaction costs paid		(4,433,087	)
Effect of Business Combination, net of redemptions and transaction costs	$	-

Holder	Number of Warrants		Strike Price
Underwriter		600,000	$	2.00
Sponsor and Investors		10,122,313	$	11.50
Sponsor		1,000,000	$	15.00

All existing FGMC warrants were converted into Convertible Preferred Stock warrants with the same terms and conditions:

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Holder	Number of Warrants		Strike Price
Underwriter		600,000	$	2.00
Sponsor and Investors		10,122,313	$	11.50
Sponsor		1,000,000	$	15.00

~~Basis~~3. ofSUMMARY ~~Presentation~~OF SIGNIFICANT ACCOUNTING POLICIES

~~The~~Basis ~~accompanying financial statements are presented in United States dollars and include the accounts~~ of ~~the~~Presentation Company’s wholly owned subsidiaries, with all intercompany transactions eliminated. They have been prepared on the accrual basis in accordance with accounting principles generally accepted in the United States (GAAP). Significant accounting principles followed by the Company and the methods of applying those principles, which materially affect the determination of financial position, results of operations and cash flows are summarized below.

~~Going~~The ~~Concern~~ accompanying financial statements are presented in United States dollars and ~~Liquidity~~include the accounts of the Company’s wholly owned subsidiaries, with all intercompany transactions eliminated. They have been prepared on the accrual basis in accordance with accounting principles generally accepted in the United States (GAAP). Significant accounting principles followed by the Company and the methods of applying those principles, which materially affect the determination of financial position, results of operations and cash flows are summarized below.

U.Going ~~S. GAAP requires management to assess a company’s ability to continue as a going concern within one year from the financial statement issuance~~ Concern and ~~to provide related note disclosures in certain circumstances.~~ Liquidity

~~The~~U. ~~accompanying~~S. ~~consolidated~~GAAP ~~financial~~requires ~~statements~~management ~~have~~to ~~been~~assess ~~prepared~~a ~~assuming~~company’s ~~that~~ability ~~the~~to ~~Company will~~ continue as a going concern, ~~which~~within ~~contemplates~~one ~~continuity~~year offrom ~~operations,~~the ~~realization~~financial ofstatement ~~assets,~~issuance and ~~liquidation~~to ofprovide ~~liabilities~~related innote ~~the~~disclosures ~~normal~~in ~~course~~certain ~~of business~~circumstances.

~~For~~F-7 ~~the~~Table ~~fiscal year period ended December 31, 2023, the Company generated an operating loss~~ of $10,276,602. In addition, the Company has an accumulated deficit, and net working capital deficit of $115,038,758 and $5,367,985. The Company’s activities were primarily financed through private placements of equity securities and issuance of debt. The Company intends to raise additional capital through the issuance of debt and/or equity securities to fund its operations. The Company is reliant on future fundraising to finance operations in the near future. The financing may not be available on terms satisfactory to the Company, if at all. In light of these matters, there is substantial doubt that the Company will be able to continue as a going concern.Contents

~~Currently,~~The ~~management~~accompanying ~~continues~~consolidated tofinancial ~~develop~~statements ~~its~~have ~~healthcare~~been ~~communications~~prepared ~~system~~assuming ~~and continues to develop alliances with strategic partners to generate revenues~~ that ~~will sustain~~ the Company. ~~Management~~ will also seek to raise additional funds. While management believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. Management’s ability to continue as a going concern, iswhich ~~ultimately~~contemplates ~~dependent~~continuity ~~upon~~of ~~its~~operations, ~~ability~~realization to continually increase the Company’s customer base and realize increased revenues from signed contracts. The consolidated financial statements do not include any adjustments related to the recoverability and classification of ~~recorded~~assets, ~~asset amounts or the amounts~~ and ~~classification~~liquidation of liabilities ~~that~~in ~~might be necessary should~~ the ~~Company~~normal becourse ~~unable~~of ~~to continue as a going concern~~business.

~~Fair~~For ~~Value~~the ~~Measurements~~fiscal year period ended December 31, 2024, the Company generated an operating loss of $15,506,810. In addition, the Company has an accumulated deficit, and net working capital deficit of $148,240,441 and $11,684,622. The Company’s activities were primarily financed through private placements of equity securities and issuance of debt. The Company intends to raise additional capital through the issuance of debt and/or equity securities to fund its operations. The Company is reliant on future fundraising to finance operations in the near future. The financing may not be available on terms satisfactory to the Company, if at all. In light of these matters, there is substantial doubt that the Company will be able to continue as a going concern.

~~Fair~~In ~~value~~2024 isthe ~~defined~~Company asexperienced ~~the~~a ~~price~~continued ~~that~~decline ~~would~~in befinancial ~~received~~stability toand ~~sell~~lack anof ~~asset~~capital orresources ~~paid~~ to ~~transfer~~further adevelop ~~liability~~and ~~in an orderly transaction between~~ market ~~participants~~its attechnology ~~the~~and ~~measurement date (exit price)~~products. ~~ASC~~These ~~820~~factors ~~established~~contributed ~~a fair value hierarchy that prioritizes the inputs used~~ to ~~measure fair value. The hierarchy gives~~ the ~~highest~~decline ~~priority to unadjusted quoted prices~~ in ~~active~~market ~~markets~~capitalization ~~for identical assets or liabilities (level 1 measurement)~~ and ~~the lowest priority~~ to ~~unobservable~~the ~~inputs~~value ~~(level~~of 3its ~~measurement) as follows:~~assets.

~~Level~~Currently, 1management -continues ~~Observable~~to ~~inputs~~develop its healthcare communications system and continues to develop alliances with strategic partners to generate revenues that ~~reflect~~will ~~quoted~~sustain ~~prices~~the ~~are~~Company. ~~available~~Management will also seek to raise additional funds. While management believes in ~~active~~the ~~markets~~viability ~~for~~of ~~identical~~its ~~assets~~strategy orto ~~liabilities~~increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. Management’s ability to continue as ofa going concern is ultimately dependent upon its ability to continually increase the ~~reporting~~Company’s ~~date~~customer base and realize increased revenues from signed contracts. ~~Active~~The ~~markets~~consolidated ~~are~~financial ~~those~~statements indo ~~which~~not ~~transactions~~include ~~for~~any adjustments related to the recoverability and classification of recorded asset amounts or ~~liability~~the ~~occur~~amounts inand ~~sufficient~~classification ~~frequency~~of ~~and~~liabilities ~~volume~~that tomight ~~provide~~be ~~pricing~~necessary ~~information~~should onthe anCompany ~~ongoing~~be ~~basis~~unable to continue as a going concern.

~~F-7~~Fair ~~Table~~Value ~~of Contents~~Measurements

~~Level~~Fair 2value -is ~~Quoted~~defined ~~prices~~as ~~for~~the ~~similar~~price ~~assets~~that would be received to sell an asset or ~~liabilities~~paid to transfer a liability in ~~active~~an ~~markets,~~orderly ~~quoted~~transaction ~~prices~~between ~~for~~market ~~identical~~participants orat ~~similar~~the ~~assets~~measurement ordate ~~liabilities~~(exit inprice). ~~markets~~ASC ~~that~~820 ~~are~~established ~~not~~a ~~active,~~fair value hierarchy that prioritizes the inputs ~~other~~used ~~than~~to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices ~~that~~in ~~are~~active ~~observable~~markets for ~~the~~identical ~~asset~~assets or ~~liability~~liabilities (level 1 measurement) and ~~market~~the ~~corroborated~~lowest priority to unobservable inputs. (level 3 measurement) as follows:

Level 31 - ~~Unobservable~~Observable inputs ~~for~~that ~~which~~reflect ~~there~~quoted isprices ~~little,~~are ifavailable ~~any,~~in ~~market~~active ~~activity~~markets for ~~the~~identical ~~asset~~assets or ~~liability~~liabilities ~~being~~as ~~measured~~of the reporting date. ~~These~~Active ~~inputs~~markets ~~may~~are bethose ~~used~~in ~~with~~which ~~standard~~transactions ~~pricing~~for ~~models~~the asset or ~~other~~liability ~~valuation~~occur orin ~~internally-developed~~sufficient ~~methodologies~~frequency ~~that~~and ~~result~~volume into ~~management’s~~provide ~~best~~pricing ~~estimate~~information ofon ~~fair~~an ~~value~~ongoing basis.

~~The~~F-8 ~~Company~~Table ~~utilizes fair value measurements primarily in conjunction with the valuation~~ of assets acquired and liabilities assumed in a business combination. In addition, certain nonfinancial assets and liabilities are to be measured at fair value on a nonrecurring basis in accordance with applicable GAAP. In general, nonfinancial assets including goodwill, other intangible assets and property and equipment are measured at fair value when there is an indication of impairment and are recorded at fair value only when an impairment is recognized.Contents

AsLevel ~~allowed~~2 by- ~~applicable~~Quoted ~~FASB~~prices ~~guidance, the Company has elected not to apply the fair value option~~ for ~~financial~~similar assets ~~and~~or liabilities toin ~~any~~active ofmarkets, ~~its~~quoted ~~currently~~prices ~~eligible~~for ~~financial~~identical or similar assets or liabilities. ~~The~~in ~~Company’s~~markets ~~financial~~that ~~instruments~~are ~~consist~~not ~~of cash~~active, ~~accounts~~inputs ~~receivable,~~other ~~accounts~~than ~~payable~~quoted ~~and~~prices ~~notes~~that ~~payable.~~are ~~The~~observable ~~Company~~for ~~has determined that~~ the ~~book~~asset ~~value~~or ofliability ~~its outstanding financial instruments as of December 31, 2023~~ and ~~2022,~~market ~~approximated~~corroborated ~~their fair value due to their short-term nature~~inputs.

~~Cash~~Level 3 - Unobservable inputs for which there is little, if any, market activity for the asset or liability being measured. These inputs may be used with standard pricing models or other valuation or internally-developed methodologies that result in management’s best estimate of fair value.

The Company ~~classifies~~utilizes ~~highly~~fair ~~liquid~~value ~~temporary~~measurements ~~investments~~primarily ~~with~~in anconjunction ~~original~~with ~~maturity~~the valuation of ~~three~~assets ~~months~~acquired orand ~~less~~liabilities ~~when~~assumed ~~purchased~~in asa ~~cash~~business ~~equivalents~~combination. ~~The~~In ~~Company~~addition, ~~maintains~~certain ~~cash~~nonfinancial ~~balances~~assets atand ~~various~~liabilities ~~financial~~are ~~institutions.~~to ~~Balances~~be measured at ~~United~~fair ~~States~~value ~~banks~~on ~~are~~a ~~insured~~nonrecurring bybasis ~~the~~in ~~Federal~~accordance ~~Deposit~~with ~~Insurance~~applicable ~~Corporation~~GAAP. upIn togeneral, ~~$250~~nonfinancial assets including goodwill,~~000.~~ ~~The~~other ~~Company~~intangible ~~has~~assets ~~not~~and ~~experienced~~property ~~any~~and ~~losses~~equipment inare ~~such~~measured ~~accounts~~at ~~and~~fair ~~believes~~value itwhen there is ~~not~~an ~~exposed~~indication toof ~~any~~impairment ~~significant~~and ~~risk~~are ~~for~~recorded ~~cash~~at onfair ~~deposit.~~value only when an impairment is recognized.

~~Accounts~~As ~~Receivable~~allowed ~~and~~by ~~Allowance~~applicable FASB guidance, the Company has elected not to apply the fair value option for ~~Doubtful~~financial ~~Accounts~~assets and liabilities to any of its currently eligible financial assets or liabilities. The Company’s financial instruments consist of cash, accounts receivable, accounts payable and notes payable. The Company has determined that the book value of its outstanding financial instruments as of December 31, 2024 and 2023, approximated their fair value due to their short-term nature.

~~Accounts~~Cash receivable are customer obligations due under normal trade terms. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the potential inability of certain customers to make required future payments on amounts due. Management determines the adequacy of this allowance by periodically evaluating the aging and past due nature of individual customer accounts receivable balances and considering the customer’s current financial situation as well as the existing industry economic conditions and other relevant factors that would be useful in assessing the risk of collectability. If the future financial condition of our customers were to deteriorate, resulting in their inability to make specific required payments, additions to the allowance for doubtful accounts may be required. In addition, if the financial condition of our customers improves and collections of amounts outstanding commence or are reasonably assured, then we may reverse previously established allowances for doubtful accounts. The Company has estimated and recorded an allowance for doubtful accounts of $102,061 and $65,000 as of December 31, 2023 and 2022, respectively.

~~Property~~The ~~and~~Company ~~Equipment~~classifies highly liquid temporary investments with an original maturity of three months or less when purchased as cash equivalents. The Company maintains cash balances at various financial institutions. Balances at United States banks are insured by the Federal Deposit Insurance Corporation up to $250,000. ~~net~~The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risk for cash on deposit.

~~Property,~~Accounts ~~equipment,~~Receivable and ~~leasehold~~Allowance improvements are recorded at their historical cost. Depreciation and amortization have been determined using the straight-line method over the estimated useful lives of the assets which are computers and office equipment (3 years) leasehold improvements (5 years), computer software (3 years), vehicles (3 years) and for ~~office~~Doubtful ~~furniture and fixtures (4 to 7 years). The cost of repairs and maintenance is charged to operations in the period incurred.~~ Accounts

~~F-8~~Accounts ~~Table~~receivable are customer obligations due under normal trade terms. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the potential inability of ~~Contents~~certain customers to make required future payments on amounts due. Management determines the adequacy of this allowance by periodically evaluating the aging and past due nature of individual customer accounts receivable balances and considering the customer’s current financial situation as well as the existing industry economic conditions and other relevant factors that would be useful in assessing the risk of collectability. If the future financial condition of our customers were to deteriorate, resulting in their inability to make specific required payments, additions to the allowance for doubtful accounts may be required. In addition, if the financial condition of our customers improves and collections of amounts outstanding commence or are reasonably assured, then we may reverse previously established allowances for doubtful accounts. The Company has estimated and recorded an allowance for doubtful accounts of $144,000 and $102,061 as of December 31, 2024 and 2023, respectively.

~~Software~~Property ~~Development Costs~~ and ~~Acquired~~Equipment, ~~Software~~net

~~The~~Property, ~~Company~~equipment, ~~accounts~~and ~~for~~leasehold ~~software~~improvements ~~development~~are ~~costs,~~recorded ~~including~~at ~~costs~~their tohistorical ~~develop~~cost. ~~software~~Depreciation ~~products~~and oramortization have been determined using the ~~software~~straight-line ~~component~~method ofover ~~products~~the toestimated beuseful ~~sold~~lives toof ~~external~~the ~~users.~~assets Inwhich ~~accordance~~are ~~with~~computers ~~ASC~~and ~~985-730,~~office ~~Computer~~equipment ~~Software~~(3 ~~Research~~years) ~~and~~leasehold ~~Development,~~improvements ~~research~~(5 ~~and~~years), ~~planning~~computer ~~phase~~software ~~costs~~(3 ~~are~~years) ~~expensed~~and asfor ~~incurred~~office furniture and ~~development~~fixtures ~~phase~~(4 ~~costs~~to ~~including~~7 ~~direct~~years). ~~materials~~The ~~and~~cost ~~services,~~of ~~payroll~~repairs and ~~benefits~~maintenance ~~and~~is ~~interest~~charged ~~costs~~to ~~are~~operations ~~capitalized~~in the period incurred.

WeF-9 ~~have~~Table ~~determined that technological feasibility for our products to be marketed to external users was reached before the release~~ of those products. As a result, the development costs and related acquisition costs after the establishment of technological feasibility were capitalized as incurred. Capitalized costs for software to be sold to external users and software acquired in a business combination are amortized based on current and projected future revenue for each product with an annual minimum equal to the straight-line amortization over three years.Contents

~~Long-Lived~~Software ~~Assets~~Development Costs and ~~Goodwill~~Acquired Software

The Company accounts for ~~long-lived~~software ~~assets~~development ~~in accordance with the provisions of ASC 360-10-35~~costs, ~~Property,~~including ~~Plant~~costs ~~and~~to ~~Equipment,~~develop ~~Impairment~~software orproducts ~~Disposal of Long-lived Assets. This accounting standard requires that long-lived assets be reviewed for impairment whenever events~~ or ~~changes in circumstances indicate that~~ the ~~carrying~~software ~~amount~~component ~~may not be recoverable. Recoverability~~ of ~~assets~~products to be ~~held~~sold ~~and used is measured by a comparison of the carrying amount of an asset~~ to ~~future~~external ~~undiscounted net cash flows expected to be generated by the asset~~users. IfIn ~~the~~accordance ~~carrying~~with ~~amount~~ASC of985-730, anComputer ~~asset~~Software ~~exceeds~~Research ~~its~~and ~~estimated future cash flows~~Development, anresearch ~~impairment~~and ~~charge~~planning isphase ~~recognized~~costs byare ~~the~~expensed ~~amount~~as byincurred ~~which~~and ~~the~~development ~~carrying~~phase ~~amount~~costs ofincluding ~~the~~direct ~~asset~~materials ~~exceeds~~and ~~the fair value of the asset. During December 31~~services, ~~2023,~~payroll ~~the Company determined that the carrying value of certain customer relationships exceed their fair value~~ and ~~impairment~~benefits ~~of long-lived assets existed. The Company took an impairment of $105,676~~ and ~~adjusted~~interest ~~the~~costs ~~value~~are ~~of customer relationships to their fair value~~capitalized.

~~The~~We ~~Company~~have ~~accounts~~determined for goodwill and intangible assets in accordance with ASC 350, Intangibles - Goodwill and Other. Goodwill represents the excess of the purchase price of an entity over the estimated fair value of the assets acquired and liabilities assumed. ASC 350 requires that ~~goodwill~~technological ~~and~~feasibility ~~other~~for ~~intangibles~~our ~~with~~products ~~indefinite~~to ~~lives~~ be ~~tested~~marketed ~~for~~to ~~impairment~~external ~~annually~~users orwas onreached anbefore ~~interim basis if events or circumstances indicate that~~ the ~~fair~~release ~~value~~ of anthose ~~asset has decreased below its carrying value~~products. ~~During~~As ~~the~~a ~~fourth quarter of 2020~~result, the ~~Company~~development ~~adopted~~costs ~~ASU No. 2017-04, Intangibles - Goodwill~~ and ~~Other~~related ~~(Topic~~acquisition ~~350):~~costs ~~Simplifying~~after the ~~Test~~establishment ~~for Goodwill Impairment. This guidance simplifies the accounting for goodwill impairment by removing Step 2~~ of ~~the~~technological ~~goodwill~~feasibility ~~impairment~~were ~~test,~~capitalized ~~which~~as ~~requires a hypothetical purchase price allocation~~incurred. ~~Goodwill~~Capitalized ~~impairment~~costs ~~will~~for ~~now~~software to be ~~the~~sold ~~amount by which the carrying value exceeds its fair value, not~~ to ~~exceed~~external ~~the~~users ~~carrying~~and ~~amount~~software ofacquired ~~goodwill.~~in Asa ofbusiness ~~December~~combination ~~31,~~are ~~2023~~amortized ~~the~~based ~~Company~~on ~~determined~~current ~~that the carrying value of certain customer relationships exceed their fair value~~ and ~~impairment~~projected ~~existed~~future inrevenue ~~the~~for ~~amount~~each ofproduct ~~$105,676.~~with ~~The~~an ~~Company~~annual ~~adjusted~~minimum ~~the~~equal ~~value of its customer relationships~~ to ~~their~~the ~~fair~~straight-line ~~value.~~amortization Asover ofthree ~~December 31, 2023 and December 31, 2022, there is no impairment of the Company’s Goodwill~~years.

~~Revenue~~Long-Lived ~~Recognition~~Assets and Goodwill

WeThe ~~have~~Company 6accounts ~~primary~~for ~~sources~~long-lived assets in accordance with the provisions of ~~revenue~~ASC as360-10-35, Property, Plant and Equipment, Impairment or Disposal of Long-lived Assets. This accounting standard requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. As of December 31, 2023, the Company determined that the carrying value of certain customer relationships exceed their fair value and ~~December~~impairment 31of long-lived assets existed. The Company recorded an impairment of $105,676 ~~2022:~~and adjusted the value of customer relationships to their fair value. The Company incurred $6,631,862 of impairment expense in 2024 consisting of $5,723,862 in impairment on the carrying value of its acquired technology purchased in 2024 and $908,000 on the carrying value of its customer lists purchased in 2023.

1The Company accounts for goodwill and intangible assets in accordance with ASC 350, Intangibles - Goodwill and Other. ~~Electronic~~Goodwill ~~Prescription~~represents ~~Software~~the 2excess of the purchase price of an entity over the estimated fair value of the assets acquired and liabilities assumed. ~~Insurance~~ASC ~~Verifications~~350 3requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. ~~ICD-10~~During ~~Medical~~the ~~Coding~~fourth ~~Software~~quarter 4of 2020, the Company adopted ASU No. ~~Encrypted~~2017-04, Intangibles - Goodwill and ~~HIPAA~~Other ~~Compliant~~(Topic ~~Secure~~350): ~~email~~Simplifying 5the Test for Goodwill Impairment. ~~Analytics~~This 6guidance simplifies the accounting for goodwill impairment by removing Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. ~~MSaaS~~Goodwill ~~software~~impairment will now be the amount by which the carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. As of December 31, 2024 and December 31, 2023, there is no impairment of the Company’s Goodwill.

~~F-9~~Revenue ~~Table of Contents~~Recognition

1)We ~~Electronic~~have ~~Prescription~~7 ~~software~~primary ~~services~~sources ~~are~~of ~~provided on an annual subscription basis using the software as a service (‘SaaS’) model with~~ revenue ~~recognized ratably over the contract term. 2) . Insurance verification services are provided on an annual subscription basis using the software~~ as aof ~~service~~December (‘SaaS’) model with revenue recognized ratably over the contract term. 3) ICD-10 Medical Coding services are provided on an annual subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. 4) Encrypted and HIPAA compliant and secure email services are provided on an annual subscription basis using the software as a service (“SaaS”) model with revenues recognized ratably over the contract term. 5) Analytics automatically compiles real-time KPI data on an intuitive dashboard which saves time and helps focus the team during the morning huddle. Additionally31, ~~the~~2024 ~~Practice Metrics page provides custom reporting with rich graphics helping management to view revenue, claims, AR, scheduling~~ and ~~more.~~ 6) ~~MSaaS~~primary ~~software~~sources ~~services~~of ~~are~~revenue ~~provided on an annual subscription basis using the software~~ as aof ~~service~~December ~~(‘SaaS’)~~31, ~~model with revenue recognized ratably over the contract term.~~2023:

~~The~~1. ~~Company~~Electronic ~~accounts~~Prescription ~~for~~Software ~~revenue~~2. ~~from~~Insurance ~~contracts~~Verifications ~~with customers in accordance with ASU No~~3. ~~2017~~ICD-~~09,~~10 ~~Revenue~~Medical ~~from~~Coding ~~Contracts~~Software ~~with~~4. ~~Customers~~Encrypted and aHIPAA ~~series~~Compliant ofSecure ~~related~~email ~~accounting~~5. ~~standard~~Analytics ~~updates (collectively referred to as “Topic 606”)~~6. ~~This~~MSaaS ~~guidance~~software sets forth a five-step revenue recognition model which replaced the prior revenue recognition guidance in its entirety and is intended to eliminate numerous industry-specific pieces of revenue recognition guidance and to require more detailed disclosures7. ~~The~~Patient ~~five~~Billing steps of the revenue recognition model are: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and ~~(5)~~Payment ~~recognize revenue when (or as) the entity satisfies a performance obligation.~~Processing

AtF-10 ~~contract~~Table inception, the Company assesses the goods and services promised in the contract with customers and identifies a performance obligation for each. To determine the performance obligation, the Company considers all products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. The Company measures revenue as the amount of consideration expected to be received in exchange for transferring goods and services. Revenue is recognized net of any taxes collected from customers that are subsequently remitted to governmental authorities.Contents

We1) ~~recognize~~Electronic ~~revenue~~Prescription ~~for~~software ~~our~~services are provided on an annual subscription basis using the software as a service in(‘SaaS’) ~~accordance~~model with ~~accounting~~revenue ~~standard~~recognized ~~ASC~~ratably ~~606~~over the contract term. ~~Our~~2) ~~customers~~Insurance verification services are ~~acquired~~provided ~~through~~on ~~our~~an ~~own~~annual ~~salesforce~~subscription ~~and~~basis ~~through~~using the ~~referrals~~software ~~from~~as ~~our~~a ~~many~~service ~~state~~(‘SaaS’) ~~association~~model ~~marketing~~with ~~partners~~revenue recognized ratably over the contract term. We3) ~~primarily~~ICD-10 ~~generate~~Medical ~~revenue~~Coding ~~from~~services ~~multiple~~are provided on an annual subscription basis using the software as a service (“SaaS”) ~~offering,~~model ~~which~~with ~~typically~~revenues ~~include~~recognized ~~subscriptions~~ratably toover ~~our~~the ~~online~~contract term. 4) Encrypted and HIPAA compliant and secure email services are provided on an annual subscription basis using the software ~~solutions~~as a service (“SaaS”) model with revenues recognized ratably over the contract term. ~~The~~5) ~~Company’s~~Analytics ~~secondary~~automatically ~~source~~compiles ofreal-time ~~revenue~~KPI isdata ~~professional~~on ~~services~~an intuitive dashboard which saves time and ~~other~~helps ~~revenue~~focus ~~related~~the toteam ~~customer~~during ~~onboarding~~the morning huddle. Additionally, ITthe ~~services~~Practice ~~and~~Metrics ~~equipment~~page ~~sales~~provides ~~that~~custom ~~often~~reporting ~~precede~~with arich ~~subscription~~graphics ~~service~~helping ~~offering~~management ~~purchased~~to byview ~~the~~revenue, ~~customer~~claims, AR, scheduling and more. ~~Approximately~~6) ~~90%~~MSaaS ofsoftware ~~our~~services ~~revenue~~are isprovided on an annual subscription ~~based~~basis using the software as a service (‘SaaS’) model with revenue recognized ratably over the ~~remainder~~contract ~~being~~term. ~~professional~~7) ~~services~~Patient Billing and ~~other~~payment ITprocessing ~~related~~services ~~revenue.~~are ~~The~~provided ~~geographic~~on ~~concentration~~an ofannual ~~our~~subscription ~~revenue~~basis isusing ~~100%~~the insoftware ~~North~~as ~~America~~a SaaS model with revenues recognized ratably over the contract term.

~~Management~~The ~~has~~Company ~~determined~~accounts ~~that~~for itrevenue ~~has~~from ~~the~~contracts ~~following~~with ~~performance~~customers ~~obligations~~in ~~related~~accordance towith ~~its~~ASU ~~products~~No. ~~and services: multiple software as a service (SaaS) offering~~2017-09, ~~which~~Revenue ~~typically~~from ~~include~~Contracts ~~subscriptions~~with toCustomers ~~our~~and ~~online~~a ~~software~~series ~~solutions. The Company’s secondary source~~ of ~~revenue~~related isaccounting ~~professional~~standard ~~services~~updates ~~and~~(collectively ~~other~~referred ~~revenue related~~ to ~~customer~~as ~~onboarding,~~“Topic ~~IT services and equipment sales that often precede a subscription service offering purchased by the customer~~606”). ~~Revenue~~This ~~from~~guidance ~~Software~~sets asforth a ~~Service,~~five-step ~~hardware,~~revenue ~~service~~recognition ~~repairs,~~model ~~and~~which ~~support~~replaced &the ~~maintenance~~prior ~~are~~revenue ~~all~~recognition ~~recognized~~guidance ~~at a point~~ in ~~time~~its ~~when~~entirety ~~control~~and ~~of the goods~~ is ~~transferred~~intended to ~~the~~eliminate ~~customer,~~numerous ~~generally~~industry-specific ~~occurring~~pieces ~~upon~~of ~~shipment~~revenue orrecognition ~~delivery~~guidance ~~dependent~~and ~~upon~~to ~~the~~require ~~terms~~more ofdetailed ~~the underlying contract, or services is completed~~disclosures. ~~Our~~The ~~customers~~five dosteps ~~not have the right to take possession~~ of the ~~online~~revenue ~~software~~recognition ~~solution.~~model ~~Revenue~~are: ~~from~~(1) ~~subscriptions,~~identify ~~including~~the ~~additional~~contract(s) ~~fees~~with ~~for~~a ~~items~~customer; ~~such~~(2) asidentify ~~incremental~~the ~~contacts,~~performance isobligations ~~recognized~~in ~~ratably over~~ the ~~subscription~~contract; ~~period~~(3) ~~beginning~~determine on the ~~date~~transaction ~~the~~price; ~~subscription~~(4) isallocate ~~made~~the ~~available~~transaction price to ~~customers.~~the ~~Substantially~~performance ~~all~~obligations ~~subscription~~in ~~contracts~~the ~~are~~contract; ~~one~~and ~~year.~~(5) We recognize revenue ~~from~~when ~~on-boarding~~(or ~~services and equipment~~ as) the ~~services~~entity ~~are~~satisfies ~~provided.~~a ~~Amounts~~performance ~~billed that have not yet met the applicable revenue recognition criteria are recorded as deferred revenue~~obligation.

~~For~~At ~~the~~contract ~~year~~inception, ~~ended~~the ~~December~~Company ~~31,~~assesses ~~2023~~the goods and ~~2022,~~services ~~disaggregated~~promised ~~revenues~~in ~~were~~the ~~recurring~~contract ~~revenues~~with ~~of $7,400,659~~customers and $7identifies a performance obligation for each. To determine the performance obligation,~~206,156,~~ ~~respectively~~the Company considers all products and ~~non-recurring~~services ~~revenues~~promised in the contract regardless of ~~$750,928~~whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. The Company measures revenue as the amount of consideration expected to be received in exchange for transferring goods and ~~$781,746,~~services. ~~respectively~~Revenue is recognized net of any taxes collected from customers that are subsequently remitted to governmental authorities.

~~F-10~~We ~~Table~~recognize revenue for our service in accordance with accounting standard ASC 606. Our customers are acquired through our own salesforce and through the referrals from our many state association marketing partners. We primarily generate revenue from multiple software as a service (SaaS) offering, which typically include subscriptions to our online software solutions. The Company’s secondary source of ~~Contents~~revenue is professional services and other revenue related to customer onboarding, IT services and equipment sales that often precede a subscription service offering purchased by the customer. Approximately 90% of our revenue is subscription based with the remainder being professional services and other IT related revenue. The geographic concentration of our revenue is 100% in North America.

~~For~~Management ~~contracts~~has ~~with~~determined ~~customers~~ that ~~contain~~it ~~multiple~~has the following performance obligations, ~~the~~related ~~Company~~to ~~accounts~~its ~~for~~products ~~the~~and ~~promised~~services: multiple ~~performance~~software ~~obligations~~as ~~separately~~a asservice ~~individual~~(SaaS) ~~performance~~offering, ~~obligations~~which iftypically ~~they~~include ~~are~~subscriptions ~~distinct.~~to Inour ~~determining~~online ~~whether~~software ~~performance~~solutions. ~~obligations~~The ~~meet~~Company’s ~~the~~secondary ~~criteria~~source ~~for~~of ~~being~~revenue ~~distinct,~~is ~~the~~professional ~~Company~~services ~~considers~~and ~~several~~other ~~factors,~~revenue ~~including~~related ~~the~~to ~~degree~~customer ofonboarding, ~~interrelation~~IT services and ~~interdependence~~equipment ~~between~~sales ~~obligations~~that ~~and~~often ~~whether~~precede ora ~~not~~subscription ~~the~~service ~~good~~offering orpurchased ~~service~~by ~~significantly~~the ~~modifies~~customer. orRevenue ~~transforms~~from ~~another~~Software ~~good~~as ora Service, hardware, service inrepairs, ~~the~~and ~~contract.~~support ~~After~~& ~~identifying~~maintenance ~~the~~are ~~separate~~all ~~performance~~recognized ~~obligations,~~at ~~the~~a ~~transaction~~point ~~price~~in istime ~~allocated~~when tocontrol of the ~~separate~~goods ~~performance~~is ~~obligations~~transferred onto athe ~~relative~~customer, ~~standalone~~generally ~~selling~~occurring ~~price~~upon ~~basis.~~shipment ~~The~~or ~~Company~~delivery ~~generally~~dependent ~~determines~~upon the ~~standalone~~terms ~~selling~~of ~~prices~~the ~~based~~underlying oncontract, ~~the~~or ~~prices~~services ~~charged~~is tocompleted. Our customers. ~~Judgment~~do ~~may~~not behave ~~used~~the right to ~~determine~~take possession of the ~~standalone~~online ~~selling~~software ~~prices~~solution. Revenue from subscriptions, including additional fees for items ~~that~~such ~~are~~as ~~not~~incremental ~~sold separately~~contacts, ~~including~~is ~~taking~~recognized ~~into~~ratably ~~consideration~~over ~~either~~the ~~historical~~subscription ~~pricing~~period ~~practices~~beginning oron anthe ~~adjusted~~date ~~market~~the ~~assessment.~~subscription ~~Unsatisfied~~is ~~and~~made ~~partially~~available ~~unsatisfied~~to ~~performance~~customers. ~~obligations~~Substantially asall ofsubscription ~~the~~contracts ~~end~~are ofone ~~the~~year. ~~reporting~~We ~~period~~recognize ~~primarily~~revenue ~~consist~~from ofon-boarding ~~products~~services and equipment as the services ~~for~~are ~~which~~provided. ~~customer~~Amounts ~~purchase~~billed ~~orders~~that have ~~been~~not ~~accepted~~yet ~~and~~met ~~that~~the ~~are~~applicable inrevenue ~~the~~recognition ~~process~~criteria ofare ~~being~~recorded ~~delivered~~as deferred revenue.

~~Transaction~~For ~~price is calculated as~~ the ~~selling~~year ~~price~~ended ~~less~~December ~~any variable consideration~~31, ~~consisting~~2024 ~~of rebates~~ and ~~discounts.~~2023, ~~Discounts~~disaggregated ~~provided~~revenues towere ~~customers~~recurring ~~are~~revenues ~~known at contract inception. Rebates are calculated on the “expected value” method where the Company (1) estimates the probability~~ of ~~each~~$10,193,961and ~~rebate amount which could be earned by the distributor~~$7,400,659, ~~(2)~~respectively ~~multiplies~~and ~~each~~non-recurring ~~estimated~~revenues ~~amount~~of ~~by its assigned probability factor~~$552,505 and ~~(3) calculates a final sum of each of the probability-weighted amounts calculated in step (2). The sum calculated in step (3) is the rebate amount~~$750,928, ~~which along with discounts reduces the amount of revenue recognized~~respectively.

~~The~~F-11 ~~Company~~Table ~~has elected to account for shipping and handling activities that occur after the customer has obtained control~~ of a good as a fulfillment cost rather than as an additional promised service. As a result, the Company accrues the costs of shipping and handling when the related revenue is recognized. Costs incurred for shipping and handling are included in costs of goods sold on the Statement of Operations. Amounts billed to a customer for shipping and handling are reported as revenue on the Statement of Operations.Contents

~~Advertising~~For ~~Costs~~contracts with customers that contain multiple performance obligations, the Company accounts for the promised performance obligations separately as individual performance obligations if they are distinct. In determining whether performance obligations meet the criteria for being distinct, the Company considers several factors, including the degree of interrelation and interdependence between obligations and whether or not the good or service significantly modifies or transforms another good or service in the contract. After identifying the separate performance obligations, the transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. The Company generally determines the standalone selling prices based on the prices charged to customers. Judgment may be used to determine the standalone selling prices for items that are not sold separately, including taking into consideration either historical pricing practices or an adjusted market assessment. Unsatisfied and partially unsatisfied performance obligations as of the end of the reporting period primarily consist of products and services for which customer purchase orders have been accepted and that are in the process of being delivered.

~~Advertising~~Transaction ~~costs~~price ~~are~~is ~~reported~~calculated inas ~~general~~the ~~and~~selling ~~administrative~~price ~~expenses~~less ~~and~~any ~~include~~variable ~~advertising~~consideration, ~~marketing~~consisting of rebates and ~~promotional~~discounts. ~~programs~~Discounts ~~and~~provided to customers are ~~charged~~known asat ~~expenses~~contract ininception. Rebates are calculated on the ~~year~~“expected invalue” method where the Company (1) estimates the probability of each rebate amount which ~~they~~could ~~are~~be ~~incurred.~~earned ~~Advertising~~by ~~costs~~the ~~were~~distributor, ~~$614~~(2) multiplies each estimated amount by its assigned probability factor,~~061~~ and ~~$525,533~~(3) ~~for~~calculates a final sum of each of the ~~years~~probability-weighted ~~ended~~amounts ~~December~~calculated ~~31,~~in ~~2023~~step ~~and~~(2). ~~2022~~The sum calculated in step (3) is the rebate amount, ~~respectively.~~which along with discounts reduces the amount of revenue recognized.

~~Accounting~~The Company has elected to account for ~~Derivative~~shipping ~~Instruments~~and handling activities that occur after the customer has obtained control of a good as a fulfillment cost rather than as an additional promised service. As a result, the Company accrues the costs of shipping and handling when the related revenue is recognized. Costs incurred for shipping and handling are included in costs of goods sold on the Statement of Operations. Amounts billed to a customer for shipping and handling are reported as revenue on the Statement of Operations.

~~The~~Advertising Company accounts for derivative instruments in accordance with ASC 815, which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements.Costs

~~F-11~~Advertising ~~Table~~costs ofare ~~Contents~~reported in general and administrative expenses and include advertising, marketing and promotional programs and are charged as expenses in the year in which they are incurred. Advertising costs were $747,023 and $614,061 for the years ended December 31, 2024 and 2023, respectively.

~~The~~Accounting Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and preferred stock instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for ~~separately~~Derivative from the host contract and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results.Instruments

~~Freestanding~~The ~~warrants~~Company ~~issued~~accounts byfor ~~the~~derivative ~~Company~~instruments in ~~connection~~accordance with ~~the~~ASC ~~issuance~~815, orwhich ~~sale~~requires ofadditional ~~debt~~disclosures ~~and~~about ~~equity~~the ~~instruments~~Company’s ~~are~~objectives ~~considered~~and tostrategies befor using derivative instruments., ~~Pursuant~~how tothe ~~ASC~~derivative ~~815,~~instruments anand ~~evaluation~~related ofhedged ~~specifically~~items ~~identified~~are ~~conditions~~accounted isfor, ~~made~~and tohow ~~determine whether~~ the ~~fair~~derivative ~~value~~instruments ofand ~~warrants~~related ~~issued~~hedging isitems ~~required~~affect tothe befinancial ~~classified as equity or as a derivative liability~~statements.

~~Financial~~F-12 ~~Instruments~~Table ~~with~~of ~~Down Round Features~~Contents

~~With~~The ~~respect to financial instruments, the~~ Company ~~follows~~does ~~the~~not ~~guidance~~use ofderivative ~~FASB~~instruments ~~ASU~~to ~~2017-11,~~hedge ~~“Earnings~~exposures ~~per~~to ~~Share~~cash (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features. Whereby ASU 2017-11 simplifies the accounting for certain financial instruments with down round featuresflow, amarket ~~provision in an equity-linked financial instrument (~~or ~~embedded~~foreign ~~feature)~~currency ~~that~~risk. ~~provides~~Terms ~~a down round adjustment~~ of ~~the~~convertible ~~current~~debt ~~exercise~~and ~~price~~convertible ~~based~~preferred onstock ~~the~~instruments ~~price~~are ofreviewed ~~the future equity offerings. The standard requires companies~~ to ~~disregard~~determine ~~the down round feature when assessing~~ whether ~~the~~or ~~instrument~~not isthey ~~indexed~~contain toembedded ~~its~~derivative ~~own stock, for the purposes of determining liability of equity classification. The Company accounts for~~ instruments ~~with~~that ~~Most~~are ~~Favored~~required ~~Nations~~under ~~(the~~ASC ~~“MFN”)~~815 ~~terms or conditions similar~~ to ~~that of a down round feature. The impact of such terms or conditions will~~ be accounted for ~~when~~separately from the ~~event~~host ~~occurs.~~contract ~~The~~and ~~Diluted~~recorded ~~EPS~~on ~~calculation for~~ the ~~effect~~balance ofsheet ~~the~~at ~~feature~~fair ~~when triggered (i~~value.e. ~~when~~The ~~the~~fair ~~exercise~~value ~~price~~ of ~~the~~derivative ~~related~~liabilities, ~~equity-linked~~if ~~financial~~any, ~~instrument~~ is ~~adjusted~~required ~~downward~~to ~~because~~be ofrevalued ~~the~~at ~~down~~each ~~round~~reporting ~~feature)~~date, ~~and~~with ~~will~~corresponding ~~also~~changes ~~recognize~~in ~~the~~fair ~~effect~~value ofrecorded ~~the~~in ~~trigger~~current ~~within~~period ~~equity~~operating results.

~~Income~~Freestanding ~~Taxes~~warrants issued by the Company in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.

The ~~Company~~allocated ~~follows~~value of the ~~asset~~conversion ~~and~~option ~~liability~~of ~~approach~~debt toand ~~accounting~~warrants ~~for~~are ~~income~~recorded ~~taxes.~~as ~~Under~~a ~~this~~debt ~~method,~~discount ~~deferred tax assets~~ and ~~liabilities~~accreted ~~are~~over ~~measured~~the ~~based~~expected onterm ~~differences~~of ~~between~~ the ~~financial~~convertible ~~reporting~~debt ~~and~~as ~~tax~~interest ~~bases~~expense. ofDerivative ~~assets~~instrument ~~and~~ liabilities ~~measured~~will ~~using enacted tax rates and laws that are expected to~~ be classified in ~~effect~~the ~~when~~balance ~~differences~~sheet ~~are~~as ~~expected~~current toor ~~reverse.~~non-current ~~Valuation~~based ~~allowances~~on ~~are~~whether ~~established~~net ~~when~~cash itsettlement is ~~necessary~~expected towithin ~~reduce~~the ~~deferred~~next ~~income~~12 ~~tax~~months ~~assets~~from to the ~~amount,~~balance ~~if any, expected to be realized in future years~~date.

~~ASC~~Sequencing 740, Accounting for Income taxes (“ASC 740”), requires that deferred tax assets be evaluated for future realization and reduced by a valuation allowance to the extent we believe a portion more likely than not will not be realized. We consider many factors when assessing the likelihood of future realization of our deferred tax assets, including our recent cumulative loss experience and expectations of future taxable income by taxing jurisdictions, the carry forwarding periods available to us for tax reporting purposes and other relevant factors.

~~The~~In ~~Company~~2024, ~~has~~the ~~not~~Company ~~recognized~~adopted a ~~liability~~sequencing ~~for~~policy ~~uncertain~~under ~~tax~~Accounting ~~positions.~~Standards ACodification ~~reconciliation~~(“ASC”) of815-40-35 Derivatives ~~the beginning~~ and ~~ending~~Hedging (“ASC ~~amount~~815”) ofwhereby ~~unrecognized~~in ~~tax~~the ~~benefits~~event orthat ~~penalties~~reclassification ~~has~~of ~~not~~contracts ~~been~~from ~~provided~~equity ~~since~~to ~~there~~assets ~~has~~or ~~been~~liabilities nois ~~unrecognized~~necessary ~~benefit~~pursuant orto ~~penalty.~~ASC If815 ~~there~~due ~~were~~to anthe ~~unrecognized~~Company’s ~~tax~~inability ~~benefit~~to ordemonstrate ~~penalty,~~it ~~the~~has ~~Company~~sufficient ~~would~~authorized ~~recognize~~shares ~~interest~~as ~~accrued~~a ~~related~~result toof ~~unrecognized~~certain ~~tax~~securities ~~benefits~~convertible inor ~~interest~~exchangeable ~~expense~~for ~~and~~a ~~penalties~~potentially inindeterminable ~~operating~~number ~~expenses.~~of ~~The~~shares, ~~Company~~shares ~~files~~will ~~U.S.~~be ~~Federal~~allocated ~~income~~on ~~tax~~the ~~returns~~basis ~~and~~of ~~various~~the ~~returns~~earliest inissuance ~~state~~date ~~jurisdictions.~~of ~~The~~potentially ~~Company's~~dilutive ~~open~~instruments, ~~tax~~with ~~years~~the ~~subject~~earliest togrants ~~examination~~receiving by the ~~Internal~~first ~~Revenue~~allocation ~~Service~~of ~~and~~shares. ~~the~~Pursuant ~~state~~to ~~Departments~~ASC 815, issuances of ~~Revenue~~securities ~~generally~~to ~~remain~~the ~~open~~Company’s ~~for~~employees ~~three~~or ~~years~~directors ~~from~~are ~~the~~not ~~date~~subject ofto ~~filing~~the sequencing policy.

~~Use~~Financial ofInstruments ~~Estimates~~with Down Round Features

~~The~~With ~~preparation~~respect to financial instruments, the Company follows the guidance of FASB ASU 2017-11, “Earnings per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features. Whereby ASU 2017-11 simplifies the accounting for certain financial ~~statements~~instruments with down round features, a provision in ~~conformity~~an ~~with~~equity-linked ~~GAAP~~financial instrument (or embedded feature) that provides a down round adjustment of the current exercise price based on the price of the future equity offerings. The standard requires ~~management~~companies to ~~make~~disregard ~~estimates~~the ~~and~~down ~~assumptions~~round ~~that~~feature ~~affect~~when assessing whether the ~~reported~~instrument ~~amounts~~is ofindexed ~~assets~~to its own stock, ~~liabilities~~for ~~and~~the ~~disclosures~~purposes of ~~contingent~~determining ~~assets~~liability ~~and~~of ~~liabilities~~equity atclassification. The Company accounts for instruments with Most Favored Nations (the ~~date~~“MFN”) terms or conditions similar to that of a down round feature. The impact of such terms or conditions will be accounted for when the ~~financial~~event ~~statements~~occurs. ~~and~~The toDiluted EPS calculation for the ~~reported~~effect ~~amounts~~of the feature when triggered (i.e. when the exercise price of ~~revenue~~the ~~and~~related ~~expenses~~equity-linked ~~during~~financial instrument is adjusted downward because of the ~~reporting~~down ~~periods.~~round ~~Actual~~feature) ~~results~~and ~~could~~will ~~differ~~also ~~from~~recognize ~~those~~the ~~estimates~~effect of the trigger within equity.

~~F-12~~Income ~~Table of Contents~~Taxes

~~Net~~The ~~Loss~~Company ~~Per~~follows ~~Share~~the asset and liability approach to accounting for income taxes. Under this method, deferred tax assets and liabilities are measured based on differences between the financial reporting and tax bases of assets and liabilities measured using enacted tax rates and laws that are expected to be in effect when differences are expected to reverse. Valuation allowances are established when it is necessary to reduce deferred income tax assets to the amount, if any, expected to be realized in future years.

~~Basic~~ASC ~~net~~740, ~~loss~~Accounting ~~per~~for ~~share~~Income istaxes ~~computed~~(“ASC by740”), ~~dividing~~requires ~~net~~that ~~loss~~deferred bytax ~~the~~assets ~~weighted~~be ~~average~~evaluated ~~number of shares of Common Stock outstanding~~ for ~~the~~future ~~period.~~realization ~~Diluted~~and ~~net~~reduced ~~loss~~by ~~per~~a ~~share~~valuation ~~reflects~~allowance to the ~~potential~~extent ~~dilution~~we ofbelieve ~~securities~~a byportion ~~adding~~more ~~other~~likely ~~Common~~than ~~Stock~~not ~~equivalents,~~will ~~including~~not ~~stock~~be ~~options,~~realized. ~~shares~~We ~~issuable~~consider onmany ~~exercise~~factors ofwhen ~~warrants,~~assessing ~~and~~the ~~shares~~likelihood ~~issuable on conversion~~ of ~~promissory~~future ~~notes~~realization ~~in the weighted average number~~ of ~~common~~our ~~shares~~deferred ~~outstanding~~tax ~~for a period~~assets, ifincluding ~~dilutive.~~our ~~Common~~recent ~~stock~~cumulative ~~equivalents~~loss ~~that~~experience ~~are~~and ~~anti-dilutive~~expectations ~~were~~of ~~excluded~~future ~~from~~taxable ~~the~~income ~~computation~~by oftaxing ~~diluted~~jurisdictions, ~~earnings~~the ~~per~~carry ~~share~~forwarding ~~which~~periods ~~consisted~~available ofto ~~all~~us ~~outstanding~~for ~~common~~tax ~~stock~~reporting ~~options~~purposes and ~~warrants~~other relevant factors.

~~Stock-Based~~The ~~Compensation~~Company has not recognized a liability for uncertain tax positions. A reconciliation of the beginning and ending amount of unrecognized tax benefits or penalties has not been provided since there has been no unrecognized benefit or penalty. If there were an unrecognized tax benefit or penalty, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company files U.S. Federal income tax returns and various returns in state jurisdictions. The Company's open tax years subject to examination by the Internal Revenue Service and the state Departments of Revenue generally remain open for three years from the date of filing.

~~The~~Use ~~Company accounts for share-based compensation costs in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires companies to measure the cost~~ of awards of equity instruments, including stock options and restricted stock awards, based on the grant-date fair value of the award and to recognize it as compensation expense over the employee’s requisite service period or the non-employee’s vesting period. An employee’s requisite service period is the period of time over which an employee must provide service in exchange for an award under a share-based payment arrangement and generally is presumed to be the vesting period. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional capital surplus, is recorded as an increase to share capital.Estimates

The ~~Company~~preparation ~~estimates the fair value~~ of ~~each~~financial ~~option~~statements ~~award~~in onconformity ~~the~~with ~~date~~GAAP ofrequires ~~grant~~management ~~using~~to amake ~~Black-Scholes option pricing model. The Company~~ estimates ~~the~~and ~~fair~~assumptions ~~value~~that ofaffect ~~its common stock using~~ the ~~closing~~reported ~~stock~~amounts ~~price~~ of ~~its~~assets, ~~common~~liabilities ~~stock~~and ondisclosures ~~the option grant date. The Company estimates the volatility~~ of ~~its~~contingent ~~common~~assets ~~stock~~and liabilities at the date of ~~grant based on its historical stock prices. The Company uses~~ the ~~risk-free~~financial ~~interest~~statements ~~rate~~and ~~on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal~~ to the ~~expected~~reported ~~life~~amounts of ~~the~~revenue ~~award. The Company has never paid any cash dividends on its common stock~~ and ~~does~~expenses ~~not~~during ~~anticipate paying any cash dividends in~~ the ~~foreseeable~~reporting ~~future~~periods. ~~The~~Actual ~~fair~~results ~~value~~could ofdiffer ~~shares~~from ofthose ~~restricted stock issued are determined by the Company based on the estimated fair value of the Company’s common stock~~estimates.

F-13

Table of Contents

~~Beneficial~~Net ~~Conversion~~Loss ~~Features~~Per ~~and Warrants~~Share

~~The~~Basic ~~Company~~net ~~evaluates~~loss ~~the~~per ~~conversion~~share ~~feature~~is ofcomputed ~~convertible~~by ~~debt~~dividing ~~instruments~~net toloss ~~determine~~by ~~whether~~ the ~~conversion~~weighted ~~feature~~average ~~was~~number ~~beneficial~~of asshares ~~described~~of inCommon ~~ASC~~Stock ~~470-30,~~outstanding ~~Debt~~for ~~with~~the ~~Conversion and Other Options~~period. ~~The~~Diluted ~~Company~~net ~~records~~loss aper ~~beneficial~~share ~~conversion~~reflects ~~feature (“BCF”) related to~~ the ~~issuance~~potential dilution of ~~convertible~~securities ~~debt~~by ~~that~~adding ~~has~~other ~~conversion~~Common ~~features~~Stock atequivalents, ~~fixed~~including orstock ~~adjustable~~options, ~~rates~~shares ~~that~~issuable ~~are~~on ~~in-the-money~~exercise ~~when~~of ~~issued~~warrants, and ~~records~~shares ~~the~~issuable ~~relative~~on ~~fair~~conversion ~~value~~ of ~~any~~promissory ~~warrants~~notes ~~issued~~in ~~with those instruments. The BCF for~~ the ~~convertible~~weighted ~~instruments~~average isnumber ~~recognized~~of ~~and~~common ~~measured~~shares byoutstanding ~~allocating~~for a ~~portion~~period, ofif ~~the~~dilutive. ~~proceeds~~Common tostock ~~the~~equivalents ~~warrants~~that ~~and~~are asanti-dilutive awere ~~reduction~~excluded tofrom the ~~carrying~~computation ~~amount~~ of ~~the~~diluted ~~convertible~~earnings ~~instrument~~per ~~equal~~share ~~to the intrinsic value of the conversion features, both of~~ which ~~are~~consisted ~~credited to additional paid-in capital. The Company calculates the fair value~~ of ~~warrants~~all ~~with~~outstanding ~~the~~common ~~convertible~~stock ~~instruments~~options ~~using~~and ~~the Black-Scholes valuation model~~warrants.

~~Under~~Stock-Based these guidelines, the Company first allocates the value of the proceeds received from a convertible debt transaction between the convertible debt instrument and any other detachable instruments included in the transaction (such as warrants) on a relative fair value basis. A BCF is then measured as the intrinsic value of the conversion option at the commitment date, representing the difference between the effective conversion price and the Company’s stock price on the commitment date multiplied by the number of shares into which the debt instrument is convertible. The allocated value of the BCF and warrants are recorded as a debt discount and accreted over the expected term of the convertible debt as interest expense. If the intrinsic value of the BCF is greater than the proceeds allocated to the convertible debt instrument, the amount of the discount assigned to the BCF is limited to the amount of the proceeds allocated to the convertible debt instrument.Compensation

~~Leases~~ The Company accounts for share-based compensation costs in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires companies to measure the cost of awards of equity instruments, including stock options and restricted stock awards, based on the grant-date fair value of the award and to recognize it as compensation expense over the employee’s requisite service period or the non-employee’s vesting period. An employee’s requisite service period is the period of time over which an employee must provide service in exchange for an award under a share-based payment arrangement and generally is presumed to be the vesting period. Upon exercise of share purchase options, the consideration paid by the option holder, together with the amount previously recognized in additional capital surplus, is recorded as an increase to share capital.

The Company ~~adopted~~estimates ~~ASU~~the ~~No.~~fair ~~2016-02,~~value ~~Leases~~of ~~and~~each aoption ~~series~~award ofon ~~related~~the ~~Accounting~~date ~~Standards~~of ~~Updates~~grant ~~that~~using ~~followed~~a ~~(collectively~~Black-Scholes ~~referred~~option topricing ~~as “Topic 842”)~~model. ~~Topic~~The ~~842~~Company ~~requires~~estimates ~~organizations~~the tofair ~~recognize~~value ~~right-~~of~~-use~~ ~~(“ROU”)~~its ~~lease~~common ~~assets~~stock ~~and~~using ~~lease~~the ~~liabilities~~closing onstock ~~the~~price ~~balance~~of ~~sheet~~its ~~and~~common tostock ~~disclose~~on ~~key~~the ~~information~~option ~~about~~grant ~~leasing arrangements~~date. The ~~classification~~Company ~~criteria~~estimates ~~for~~the ~~distinguishing~~volatility ~~between~~of ~~finance~~its ~~leases~~common ~~and~~stock ~~operating~~at ~~leases~~the ~~are~~date ~~substantially~~of ~~similar~~grant tobased ~~the~~on ~~classification~~its ~~criteria~~historical ~~for~~stock ~~distinguishing~~prices. ~~between~~The ~~capital~~Company ~~leases~~uses ~~and~~the ~~operating~~risk-free ~~leases~~interest inrate on the ~~previous~~implied ~~lease~~yield ~~guidance.~~currently ~~The~~available ~~FASB~~on ~~retained~~U.S. ~~the~~Treasury ~~distinction~~issues ~~between~~with ~~finance~~an ~~leases~~equivalent ~~and~~remaining ~~operating~~term ~~leases,~~approximately ~~leaving~~equal to the ~~effect~~expected life of ~~leases in~~ the ~~statement~~award. ofThe ~~comprehensive~~Company ~~income~~has ~~and~~never ~~the~~paid ~~statement~~any of cash ~~flows~~dividends ~~largely~~on ~~unchanged~~its ~~from~~common ~~previous~~stock ~~U.S.~~and ~~GAAP.~~does ~~The~~not ~~Company~~anticipate ~~utilized~~paying ~~the~~any ~~transition~~cash ~~method~~dividends ~~allowed under ASU 2018-11~~ in ~~which~~the anforeseeable ~~entity~~future. ~~initially~~The ~~applies~~fair ~~the~~value ~~new~~of ~~lease~~shares ~~standard~~of atrestricted ~~the~~stock ~~adoption~~issued ~~date~~are ~~and~~determined ~~recognizes~~by athe ~~cumulative-effect~~Company ~~adjustment~~based toon the ~~opening~~estimated ~~balance~~fair value of ~~retained earnings in~~ the ~~period~~Company’s ofcommon ~~adoption, if any~~stock.

~~The~~F-14 ~~Company~~Table determines, at contract inception, whether or not an arrangement contains a lease and evaluates the contract for classification as an operating or finance lease. For all leases, ROU assets and lease liabilities are recognized based on the present value of lease payments, including annual rent increases, over the lease term at commencement date. If the Company’s lease does not provide an implicit rate in the contract, the Company uses its incremental, secured borrowing rate based on lease term information available as of the adoption date or lease commencement date in determining the present value of lease payments. Any renewal periods are considered in the analysis of each lease to the extent that the Company considers them to be reasonably certain of being exercised.Contents

~~Related Party Transactions~~Leases

The Company ~~accounts~~adopted ~~for~~ASU ~~related~~No. ~~party~~2016-02, ~~transactions~~Leases inand ~~accordance~~a ~~with~~series ~~FASB~~of ~~ASC~~related ~~850,~~Accounting ~~Related~~Standards ~~Party~~Updates ~~Disclosures.~~that Afollowed ~~party~~(collectively isreferred ~~considered~~ to beas ~~related~~“Topic to842”). ~~the~~Topic ~~Company~~842 ifrequires ~~the~~organizations ~~party~~to ~~directly~~recognize orright-of-use ~~indirectly~~(“ROU”) orlease ~~through~~assets ~~one~~and orlease ~~more~~liabilities ~~intermediaries’~~on ~~controls,~~the isbalance ~~controlled~~sheet ~~by,~~and orto isdisclose ~~under~~key ~~common~~information ~~control~~about ~~with~~leasing ~~the Company~~arrangements. ~~Related~~The ~~parties~~classification ~~also~~criteria ~~include~~for ~~principal~~distinguishing ~~owners~~between offinance ~~the~~leases ~~Company,~~and ~~its~~operating ~~management,~~leases ~~members~~are ofsubstantially ~~the~~similar ~~immediate~~to ~~families~~the ofclassification ~~principal~~criteria ~~owners~~for ofdistinguishing ~~the~~between ~~Company~~capital ~~and~~leases ~~its management~~ and ~~other~~operating ~~parties~~leases ~~with~~in ~~which~~ the ~~Company~~previous ~~may~~lease ~~deal~~guidance. ifThe ~~one~~FASB ~~party~~retained ~~controls~~the ordistinction ~~can~~between ~~significantly~~finance ~~influence~~leases ~~the~~and ~~management or~~ operating ~~policies~~leases, ofleaving the ~~other~~effect toof anleases ~~extent~~in ~~that~~the ~~one~~statement of ~~the~~comprehensive ~~transacting~~income ~~parties~~and ~~might~~the bestatement ~~prevented~~of ~~from~~cash ~~fully~~flows ~~pursuing~~largely ~~its~~unchanged ~~own~~from ~~separate~~previous ~~interests~~U.S. AGAAP. ~~party~~The ~~which~~Company ~~can~~utilized ~~significantly influence~~ the ~~management~~transition ormethod ~~operating~~allowed ~~policies~~under ofASU ~~the~~2018-11 ~~transacting~~in ~~parties~~which oran ifentity itinitially ~~has~~applies anthe ~~ownership~~new ~~interest~~lease instandard ~~one~~at of the ~~transacting~~adoption ~~parties~~date and ~~can~~recognizes ~~significantly~~a ~~influence~~cumulative-effect ~~the~~adjustment ~~other~~ to anthe ~~extent~~opening ~~that~~balance ~~one~~of orretained ~~more~~earnings ofin the ~~transacting~~period ~~parties~~of ~~might~~adoption, beif ~~prevented from fully pursuing its own separate interests is also a related party~~any.

~~F-14~~The ~~Table~~Company determines, at contract inception, whether or not an arrangement contains a lease and evaluates the contract for classification as an operating or finance lease. For all leases, ROU assets and lease liabilities are recognized based on the present value of ~~Contents~~lease payments, including annual rent increases, over the lease term at commencement date. If the Company’s lease does not provide an implicit rate in the contract, the Company uses its incremental, secured borrowing rate based on lease term information available as of the adoption date or lease commencement date in determining the present value of lease payments. Any renewal periods are considered in the analysis of each lease to the extent that the Company considers them to be reasonably certain of being exercised.

~~Business~~Related ~~Combinations~~ Party Transactions

The Company ~~applies~~accounts ~~the~~for ~~principles~~related ~~provided~~party transactions in ~~the~~accordance ~~Financial~~with ~~Accounting~~FASB ~~Standards~~ASC ~~Board~~850, ~~(FASB)~~Related ~~Accounting~~Party ~~Standards~~Disclosures. ~~Codification~~A ~~(“ASC”)~~party ~~805,~~is ~~Business~~considered ~~Combinations,~~to be related to ~~determine~~the ~~whether~~Company anif ~~acquisition~~the ~~involves~~party andirectly ~~asset~~or indirectly or athrough ~~business.~~one Inor ~~determining~~more ~~whether~~intermediaries’ ancontrols, ~~acquisition~~is ~~should~~controlled beby, ~~accounted~~or ~~for~~is asunder acommon ~~business~~control ~~combination~~with orthe ~~asset~~Company. ~~acquisition,~~Related ~~The~~parties ~~Company~~also ~~first~~include ~~determines~~principal ~~whether~~owners ~~substantially~~of ~~all~~the Company, its management, members of the ~~fair~~immediate ~~value~~families of principal owners of the ~~gross~~Company ~~assets~~and ~~acquired~~its ismanagement ~~concentrated~~and inother aparties ~~single~~with ~~identifiable~~which ~~asset~~the orCompany amay ~~group~~deal ofif ~~similar~~one ~~identifiable~~party ~~assets.~~controls Ifor ~~this~~can issignificantly influence the ~~case,~~management or operating policies of the ~~single~~other ~~identifiable~~to ~~asset~~an orextent ~~the~~that ~~group~~one of ~~similar~~the ~~assets~~transacting isparties ~~accounted~~might ~~for~~be asprevented anfrom ~~asset~~fully ~~acquisition~~pursuing its own separate interests. IfA ~~this~~party iswhich ~~not~~can ~~the~~significantly ~~case,~~influence ~~The~~the ~~Company~~management ~~then~~or ~~further~~operating ~~evaluate~~policies ~~whether~~of the ~~single~~transacting ~~identifiable~~parties ~~asset~~ or ~~group~~if ofit ~~similar~~has ~~identifiable~~an ~~assets~~ownership ~~and~~interest ~~activities~~in ~~includes,~~one atof athe ~~minimum,~~transacting anparties ~~input~~ and acan ~~substantive~~significantly ~~process~~influence the other to an extent that ~~together~~one ~~significantly~~or ~~contribute~~more toof the ~~ability~~transacting toparties ~~create~~might ~~outputs.~~be Ifprevented ~~so,~~from ~~the~~fully ~~transaction~~pursuing isits ~~accounted~~own ~~for~~separate asinterests is also a ~~business~~related ~~combination~~party.

~~The~~F-15 ~~Company~~Table ~~accounts for business combinations using the acquisition method~~ of accounting which requires that (i) identifiable assets acquired (including identifiable intangible assets) and liabilities assumed generally be measured and recognized at estimated fair value as of the acquisition date and (ii) the excess of the purchase price over the net estimated fair value of identifiable assets acquired and liabilities assumed be recognized as goodwill, which is not amortized for accounting purposes but is subject to testing for impairment at least annually. Contents

~~The~~Business Company measures and recognizes asset acquisitions that are not deemed to be business combinations based on the cost to acquire the assets. Goodwill is not recognized in an asset acquisition with any consideration in excess of net assets acquired allocated to acquired assets on a relative estimated fair value basis. Transaction costs are expensed in a business combination and transaction costs directly attributable to an asset acquisition are considered a component of the cost of the asset acquisition. Combinations

~~Reportable~~The ~~Segments~~Company applies the principles provided in the Financial Accounting Standards Board (FASB) Accounting Standards Codification (“ASC”) 805, Business Combinations, to determine whether an acquisition involves an asset or a business. In determining whether an acquisition should be accounted for as a business combination or asset acquisition, The Company first determines whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this is the case, the single identifiable asset or the group of similar assets is accounted for as an asset acquisition. If this is not the case, The Company then further evaluate whether the single identifiable asset or group of similar identifiable assets and activities includes, at a minimum, an input and a substantive process that together significantly contribute to the ability to create outputs. If so, the transaction is accounted for as a business combination.

~~U.S.~~The ~~GAAP~~Company ~~establishes~~accounts ~~standards~~ for ~~reporting~~business ~~financial~~combinations ~~and~~using ~~descriptive~~the ~~information~~acquisition ~~about~~method ~~a company’s reportable segments. Operating segments are defined as components~~ of anaccounting ~~enterprise about~~ which ~~separate~~requires ~~financial information is available~~ that is(i) ~~evaluated~~identifiable ~~regularly~~assets byacquired ~~the~~(including ~~chief~~identifiable ~~operating~~intangible ~~decision~~assets) ~~maker,~~and orliabilities ~~decision-making~~assumed ~~group,~~generally inbe ~~deciding~~measured ~~how to allocate resources~~ and inrecognized ~~assessing~~at ~~performance.~~estimated ~~The~~fair ~~chief~~value ~~operating~~as ~~decision~~of ~~maker is~~ the ~~Company’s~~acquisition ~~Chief~~date ~~Executive~~and ~~Officer,~~(ii) ~~who currently reviews~~ the ~~financial~~excess ~~performance~~of ~~and~~ the ~~results~~purchase ofprice ~~operations~~over of the ~~Company’s~~net ~~operating~~estimated ~~subsidiaries~~fair onvalue aof ~~consolidated~~identifiable ~~basis~~assets ~~when~~acquired ~~making decisions about allocating resources~~ and ~~assessing~~liabilities ~~performance~~assumed ofbe ~~the~~recognized ~~Company.~~as ~~Accordingly~~goodwill, ~~the~~which ~~Company~~is ~~currently~~not ~~considers~~amortized ~~itself~~for toaccounting bepurposes inbut ais ~~single~~subject ~~reporting~~to ~~segment~~testing for ~~reporting~~impairment ~~purposes~~at ~~focused~~least ~~on the North American market~~annually.

~~F-15~~The ~~Table~~Company measures and recognizes asset acquisitions that are not deemed to be business combinations based on the cost to acquire the assets. Goodwill is not recognized in an asset acquisition with any consideration in excess of ~~Contents~~net assets acquired allocated to acquired assets on a relative estimated fair value basis. Transaction costs are expensed in a business combination and transaction costs directly attributable to an asset acquisition are considered a component of the cost of the asset acquisition.

~~Recently~~Reportable ~~Issued Accounting Pronouncements~~Segments

~~Adopted~~The Company currently operates business as one operating segment which includes two revenue types: recurring and non-recurring. While the Company discloses recurring and non-recurring revenue separately, management does not consider these to be separate segments, as they are sold through the same sales channel and fulfilled by the same teams. Management’s analysis and determination for allocation of resources is not analyzed or broken out by revenue streams, but as one reporting unit. The determination of a single business segment is consistent with the consolidated financial information regularly provided to the Company’s chief operating decision maker (“CODM”). The Company’s CODMs is the Chief Executive Officer, who review and evaluate consolidated net income for purposes of assessing performance, making operating decisions, allocating resources, and planning and forecasting for future periods.

~~On January 1, 2023, the Company adopted ASU 2016~~F-~~13,~~16 ~~“Financial~~Table ~~Instruments – Credit Losses (Topic 326): Measurement~~ of Credit Losses on Financial Instruments,” which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable. The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.Contents

~~Not~~Recently ~~Yet~~Issued ~~Adopted~~Accounting Pronouncements

In October 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-06, “Disclosure Improvements – Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This standard affects a wide variety of Topics in the Codification. The effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective. Early adoption is prohibited. The Company does not expect the adoption of this standard to have a material impact on the Company’s consolidated financial statements and related disclosures.Adopted

InThe ~~November~~Company ~~2023,~~adopted ~~the FASB issued~~ ASU ~~2023~~2016-0713, “~~Segment~~Financial ~~Reporting~~Instruments -– ~~Improving~~Credit ~~Reportable~~Losses ~~Segment Disclosures~~ (Topic ~~280~~326)~~.” The~~: ~~standard~~Measurement isof ~~intended~~Credit toLosses ~~improve~~on ~~reportable~~Financial ~~segment~~Instruments,” ~~disclosure~~which ~~requirements,~~requires ~~primarily~~a ~~through~~methodology ~~enhanced~~that ~~disclosures~~reflects ~~about~~expected ~~significant~~credit ~~expenses. The~~losses ~~standard~~and requires ~~disclosure~~consideration toof ~~include~~a ~~significant~~broader ~~segment~~range ~~expenses~~of ~~that~~reasonable ~~are~~and ~~regularly~~supportable ~~provided~~information to ~~the~~inform ~~CODM,~~credit aloss ~~description~~estimates, ofincluding ~~other~~accounts ~~segment~~receivable. ~~items~~The bystandard ~~reportable~~replaces ~~segment,~~the ~~and~~existing ~~any~~incurred ~~additional~~credit ~~measures~~loss ofmodel awith ~~segment's~~the ~~profit~~Current orExpected ~~loss~~Credit ~~used~~Losses by(“CECL”) ~~the~~model. ~~CODM~~It ~~when~~is ~~deciding~~required ~~how~~ to ~~allocate~~measure ~~resources. The~~credit ~~standard~~losses ~~also~~based ~~requires~~on ~~all~~the ~~annual~~Company’s ~~disclosures~~estimate ~~currently~~of ~~required~~expected bylosses ~~ASC~~rather ~~Topic~~than ~~280~~incurred tolosses, bewhich ~~included~~generally results in ~~interim~~earlier ~~periods. This~~recognition ~~standard~~of isallowances ~~effective~~ for ~~fiscal~~credit ~~years~~losses. ~~beginning~~Under ~~after~~ASC ~~December 15~~326, ~~2023,~~the ~~and~~Company ~~interim~~evaluates ~~periods~~specific ~~within~~criteria, ~~fiscal~~including ~~years~~aging ~~beginning~~and ~~after~~historical ~~December 15~~write-offs, ~~2024,~~the ~~with~~current ~~early~~economic ~~adoption~~condition ~~permitted~~of customers, and ~~requires~~future ~~retrospective~~economic ~~application~~conditions toof ~~all~~countries ~~prior~~utilizing ~~periods~~a ~~presented~~consumption inindex to determine the ~~financial~~appropriate ~~statements~~allowance for credit losses. The Company iscompleted ~~currently~~its ~~evaluating~~assessment of the ~~impact~~new standard and did not adjust the opening balance of ~~this~~retained ~~standard~~earnings onrelating to its ~~consolidated~~trade ~~financial~~receivables. ~~statements~~The ~~and~~Company ~~related~~writes ~~disclosures~~off receivables once it is determined that they are no longer collectible, as local laws allow.

In ~~December~~November 2023, the FASB issued ASU 2023-0907, “~~Improvements~~Segment toReporting ~~Income~~- ~~Tax~~Improving Reportable Segment Disclosures,” a(Topic ~~final~~280).” The standard onis ~~improvements~~intended to ~~income~~improve ~~tax~~reportable ~~disclosures~~segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The standard requires ~~disaggregated~~disclosure ~~information~~to ~~about~~include significant segment expenses that are regularly provided to the CODM, a ~~reporting~~description ~~entity'~~of other segment items by reportable segment, and any additional measures of a segment’s ~~effective~~profit ~~tax~~or ~~rate~~loss ~~reconciliation~~used asby ~~well~~the asCODM ~~information~~when ondeciding ~~income~~how ~~taxes~~to ~~paid~~allocate resources. The standard also requires all annual disclosures currently required by ASC Topic 280 to be included in interim periods. This standard is effective for fiscal years beginning after December 15, ~~2024~~2023, ~~with~~and ~~early~~interim ~~adoption~~periods ~~permitted~~within ~~and~~fiscal ~~should~~years bebeginning ~~applied~~after ~~prospectively. The~~December ~~Company~~15, is2024, ~~currently~~with ~~evaluating~~early ~~the~~adoption ~~impact~~permitted ofand ~~this~~requires ~~standard~~retrospective onapplication ~~its~~to ~~consolidated~~all ~~financial~~prior ~~statements~~periods ~~and~~presented ~~related~~in ~~disclosures~~the financial statements.

~~F-16~~Not ~~Table~~Yet ~~of Contents~~Adopted

4In October 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-06, “Disclosure Improvements – Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ~~STOCKHOLDERS~~standard affects a wide variety of Topics in the Codification. The effective date for each amendment will be the date on which the SEC’s ~~EQUITY~~removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective. Early adoption is prohibited. The Company does not expect the adoption of this standard to have a material impact on the Company’s consolidated financial statements and related disclosures.

~~Common~~In ~~Stock~~December 2023, the FASB issued ASU 2023-09, “Improvements to Income Tax Disclosures,” a final standard on improvements to income tax disclosures, The standard requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The standard is effective for fiscal years beginning after December 15, 2024, with early adoption permitted and should be applied prospectively. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

~~The~~F-17 ~~Company~~Table ~~is authorized to issue up to 100,000,000 shares~~ of ~~Company Common Stock, par value $0.0001 per shares.~~Contents

~~Stock~~4. ~~Issuances~~STOCKHOLDERS’ EQUITY

~~During~~Common the year ended December 31, 2023, the Company issued 3,992,399 shares of common stock of which 1,489,707 shares of common stock were issued for cash of $2,880,985. The Company issued 212,842 shares of common stock related to the conversion of Series A Preferred Stock, 40,000 shares related to the asset acquisition of Preferred Dental Services, 297,888 shares related to inducements for financing agreements, 243,347 shares for stock-based compensation and 1,708,615 shares related to the conversion of debt, warrants and options.

~~During~~The ~~the year ended December 31, 2022, the~~ Company ~~issued~~is ~~13,827,049~~authorized ~~shares~~to ofissue ~~common~~up ~~stock.~~to ~~of which 5~~250,~~722,844 shares of common stock were issued for cash of $450,~~000~~. The Company also issued 227~~,~~368 shares of common stock for the conversion of $22,387 of convertible debt. 700,~~000 shares of ~~common~~Company ~~stock~~Common ~~were issued for the exercise of common stock options for a value of $2~~Stock,~~100.~~ ~~8,426,837~~par ~~shares of common stock were issued related to stock-based compensation for a~~ value of $~~1,817,123~~0.0001 ~~The~~per ~~Company also repurchased and cancelled 1,250,000~~ shares ~~of common stock with a value of $100,000~~.

~~Preferred~~ Stock Issuances

~~The~~During the year ended December 31, 2024 the Company isissued ~~authorized~~1,562,592 toshares ~~issue~~of upcommon tostock 40of which 185,000~~,000~~ shares of common stock were issued for cash of $521,030. The Company issued 763,161 shares of common stock related to the conversion of Series A Convertible Preferred Stock, ~~par~~468,650 ~~value~~shares ~~$0.0001~~of ~~per~~common stock related to the conversion of debt, 15,000 shares. ~~The~~of ~~Preferred~~common ~~Stock~~stock ~~have~~for ~~the~~inducement ~~rights~~for entering into an equity line agreement, ~~preferences~~31,252 ~~powers~~shares of common stock for origination fees on debt, ~~privileges~~1,616 ~~and~~shares ~~restrictions~~of common stock related to the purchase of the assets of Healthcare Cricle of Excellence, ~~qualifications~~69,884 shares of common stock for stock-based compensation and ~~limitations~~28,030 ~~including~~shares ~~but~~of ~~not~~common ~~limited~~stock to: existing holders related to rounding as a result of a reverse stock split.

FDuring the year ended December 31, 2023, the Company issued 199,623 shares of common stock of which 74,486 shares of common stock were issued for cash of $2,880,985. The Company issued 10,643 shares of common stock related to the conversion of Series A Convertible Preferred Stock, 2,000 shares related to the asset acquisition of Preferred Dental Services, 14,895 shares related to inducements for financing agreements, 12,168 shares for stock-17based ~~Table~~compensation and 85,431 shares related to the conversion of ~~Contents~~debt, warrants and options.

•Convertible ~~The conversion price (“Conversion Price”) for the~~ Preferred Stock is initially $10.00 per share; provided that the Conversion Price shall be reset to the lesser of $10.00 or 20% above the simple average of the volume weighted average price on the 20 trading days following 12 months after August 25, 2023; provided further that such Conversion Price shall be no greater than $10.00 and no less than $2.00 and subject to appropriate and customary adjustment. • The holders of Preferred Stock shall not be entitled to vote on any matters submitted to the stockholders of the Company. • From and after the date of the issuance of any shares of Preferred Stock, dividends shall accrue at the rate per annum of 12% of the original issue price for each share of Preferred Stock, prior and in preference to any declaration or payment of any other dividend (subject to appropriate adjustments). • Dividends shall accrue from day to day and shall be cumulative and shall be payable within fifteen (15) business days after the end of the Company’s second quarter, which is June 30, commencing with the quarter ending June 30, 2024 to each holder of Preferred Stock as of such date. • From the Closing of the Business Combination until the second anniversary of the date of the original issuance of the Preferred Stock, the Company may, at its option, pay all or part of the accruing dividends on the Preferred Stock by issuing and delivering additional shares of Preferred Stock to the holders thereof. • The Company shall not declare, pay, or set aside any dividends on shares of any other class or series of capital stock of the Company, unless the holders of the iCoreConnect Preferred Stock then outstanding shall first receive dividends due and owing on each outstanding share of iCoreConnect Preferred Stock. • In the event of any liquidation, dissolution or winding up of the Company, the holders of shares of Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders an amount per share equal to the greater of (i) one times the applicable original issue price, plus any accrued and unpaid dividends, and (ii) such amount as would have been payable had all shares of Preferred Stock been converted into the Company’s Common Stock pursuant to the following paragraph immediately prior to such liquidation, dissolution or winding up, before any payment shall be made to the holders of the Company’s Common Stock. • Each share of Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and non-assessable shares of the Company’s Common Stock as is determined by dividing the original issue price by the Conversion Price in effect at the time of conversion, subject to adjustment. • After 24 months from the Closing of the Business Combination, in the event the closing share price of the Company’s Common Stock shall exceed 140% of the Conversion Price (as defined in the Merger Agreement) then in effect, then (i) each outstanding share of Preferred Stock shall automatically be converted into such number of shares of the Company’s Common Stock as is determined by dividing the original issue price by the Conversion Price in effect at the time of conversion and (ii) such shares may not be reissued by the Company, subject to adjustment. At the time of such conversion, the Company shall declare and pay all of the dividends that are accrued and unpaid as of the time of the conversion by either, at the option of the Company, (i) issuing additional Preferred Stock or (ii) paying cash. • Immediately prior to any such optional conversion the Company shall pay all dividends on the Preferred Stock being converted that are accrued and unpaid as of such time by, either, at the option of the Company: (i) issuing additional Preferred Stock or (ii) paying cash.

~~During~~The ~~the~~Company ~~year~~is ~~ended~~authorized ~~December~~to ~~31,~~issue ~~2023~~up ~~the~~to ~~Company~~40,000,000 ~~issued~~shares ~~46,500~~of Company Series A Convertible Preferred ~~stock for $465~~Stock,~~000~~ inpar ~~cash~~value ~~and~~$0.0001 ~~139,360~~per ~~Series~~shares. AThe Preferred ~~stock~~Stock onhave the ~~cashless~~rights, ~~conversion~~preferences, ~~of 174~~powers,~~200~~ ~~Series~~privileges Aand ~~Preferred~~restrictions, ~~Stock~~qualifications ~~$2.00~~and ~~warrants~~limitations ~~for~~including nobut ~~proceeds.~~not limited to:

~~During~~F-18 ~~the~~Table ~~year ended December 31, 2023, 212,842 shares~~ of ~~Series A Preferred stock were converted into shares of Common Stock on a one for one basis.~~Contents

F• The conversion price (“Conversion Price”) for the Convertible Preferred Stock is initially $10.00 per share; provided that the Conversion Price shall be reset to the lesser of $10.00 or 20% above the simple average of the volume weighted average price on the 20 trading days following 12 months after August 25, 2023; provided further that such Conversion Price shall be no greater than $10.00 and no less than $2.00 and subject to appropriate and customary adjustment. The Conversion Price was set at $2.00 on September 13, 2024 and adjusted to $40.00 subsequent to the reverse stock split completed in December 2024. • The holders of Convertible Preferred Stock shall not be entitled to vote on any matters submitted to the stockholders of the Company. • From and after the date of the issuance of any shares of Convertible Preferred Stock, dividends shall accrue at the rate per annum of 12% of the original issue price for each share of Convertible Preferred Stock, prior and in preference to any declaration or payment of any other dividend (subject to appropriate adjustments). • Dividends shall accrue from day to day and shall be cumulative and shall be payable within fifteen (15) business days after August 23 of each year to each holder of Convertible Preferred Stock as of such date. • From the Closing of the Business Combination until the second anniversary of the date of the original issuance of the Convertible Preferred Stock, the Company may, at its option, pay all or part of the accruing dividends on the Convertible Preferred Stock by issuing and delivering additional shares of Convertible Preferred Stock to the holders thereof. • The Company shall not declare, pay, or set aside any dividends on shares of any other class or series of capital stock of the Company, unless the holders of the iCoreConnect Convertible Preferred Stock then outstanding shall first receive dividends due and owing on each outstanding share of iCoreConnect Convertible Preferred Stock. • In the event of any liquidation, dissolution or winding up of the Company, the holders of shares of Convertible Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Company available for distribution to its stockholders an amount per share equal to the greater of (i) one times the applicable original issue price, plus any accrued and unpaid dividends, and (ii) such amount as would have been payable had all shares of Preferred Stock been converted into the Company’s Common Stock pursuant to the following paragraph immediately prior to such liquidation, dissolution or winding up, before any payment shall be made to the holders of the Company’s Common Stock. • Each share of Convertible Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and non-18assessable ~~Table~~shares of ~~Contents~~the Company’s Common Stock as is determined by dividing the original issue price by the Conversion Price in effect at the time of conversion, subject to adjustment. • After 24 months from the Closing of the Business Combination, in the event the closing share price of the Company’s Common Stock shall exceed 140% of the Conversion Price (as defined in the Merger Agreement) then in effect, then (i) each outstanding share of Convertible Preferred Stock shall automatically be converted into such number of shares of the Company’s Common Stock as is determined by dividing the original issue price by the Conversion Price in effect at the time of conversion and (ii) such shares may not be reissued by the Company, subject to adjustment. At the time of such conversion, the Company shall declare and pay all of the dividends that are accrued and unpaid as of the time of the conversion by either, at the option of the Company, (i) issuing additional Preferred Stock or (ii) paying cash. • Immediately prior to any such optional conversion the Company shall pay all dividends on the Convertible Preferred Stock being converted that are accrued and unpaid as of such time by, either, at the option of the Company: (i) issuing additional Preferred Stock or (ii) paying cash.

~~Common~~During the year ended December 31, 2024 the Company issued nil Series A Convertible Preferred stock for cash, 480,000 Series A Convertible Preferred stock for the assets of FeatherPay, 84,000 Series A Convertible Preferred stock for the assets of Verifi Dental, 57,500 Series A Convertible Preferred stock for the assets of Teamworx, 201,711 Series A Convertible Preferred stock as dividend in kind, 156,369 Series A Preferred stock on the cashless conversion of 252,300 Series A Convertible Preferred Stock ~~Options~~$2.00 warrants for no proceeds.

AsDuring ~~part of~~ the ~~merger,~~year ~~the~~ended ~~Company’s~~December ~~2016~~31, ~~Long~~2024, ~~Term~~3,912,860 ~~Incentive~~shares ~~Plan was cancelled and replaced with the 2023 Stock Plan (“Incentive Plan”) which is administered by the Company’s Board~~ of ~~Directors~~Series ~~Compensation~~A ~~Committee.~~Convertible ~~The~~Preferred ~~Incentive~~stock ~~Plan~~were ~~had~~converted aninto ~~initial~~shares ~~authorized equity pool~~ of ~~1,187,790.~~Common AsStock ofon ~~December~~either: ~~31,~~one ~~2023~~for ~~there~~one ~~are~~or ~~411,462~~five ~~equity~~for ~~grants~~one ~~available under the Incentive Plan~~basis.

~~Certain~~During ~~employees~~the ~~and~~year ~~executives~~ended ~~have~~December ~~been~~31, ~~granted~~2023 ~~options~~the orCompany ~~warrants~~issued ~~that~~46,500 ~~are~~Series ~~compensatory~~A Convertible Preferred stock for $465,000 in ~~nature.~~cash Aand ~~summary~~139,360 ofSeries ~~option~~A ~~activity~~Convertible ~~for~~Preferred stock on the ~~year~~cashless ~~ended~~conversion ~~December~~of 31174,200 ~~2023~~Series ~~and~~A ~~2022~~Preferred ~~are~~Stock ~~presented~~$2.00 ~~below:~~warrants for no proceeds.

2022 Options Outstanding	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years		AggregateIntrinsic Value
Balance Outstanding - January 1, 2022		1,094,005		$	3.58		9.8	$	-
Granted		10,054		$	3.58		9.0		-
Exercised		(23,459	)		-		5.5		-
Forfeited		(335	)	$	4.48		6.2		-
Balance Outstanding - December 31, 2022		1,080,265		$	3.88		8.8	$	-
Exercisable - December 31, 2022		311,049		$	3.58		8.8	$	-

During the year ended December 31, 2023, 212,842 shares of Series A Convertible Preferred stock were converted into 10,643 shares of Common Stock.

2022 Nonvested Options	Number of Options			Weighted Average Grant Date Fair Value		Weighted Average Remaining Years to Vest
Nonvested - January 1, 2022		1,034,856		$	3.58		9.8
Granted		10,054		$	4.48		9.0
Vested		(275,359	)	$	-		8.3
Forfeited/expired		(335	)	$	4.13		9.0
Nonvested - December 31, 2022		769,216		$	3.58		8.8

F-19

Table of Contents

2023 Options Outstanding	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years		Aggregate Intrinsic Value
Balance Outstanding - January 1, 2023		1,080,265		$	3.88		8.8	$	-
Granted		7,446		$	6.04		9.6
Exercised		(310,881	)		3.62		7.6
Forfeited		(502	)	$	2.81		7.8
Balance Outstanding - December 31, 2023		776,328		$	3.74		8.0	$	-
Exercisable - December 31, 2023		381,256		$	3.72		7.9	$	-

Common Stock Options

2023 Nonvested Options	Number of Options			Weighted Average Grant Date Fair Value		Weighted Average Remaining Years to Vest
Nonvested - January 1, 2023		769,216		$	3.58		8.8
Granted		7,446		$	6.04		9.6
Vested		(381,256	)	$	3.72		7.9
Forfeited		(334	)		4.13		9.0
Nonvested - December 31, 2023		395,072		$	3.76		8.0

As part of the merger, the Company’s 2016 Long Term Incentive Plan was cancelled and replaced with the 2023 Stock Plan (“Incentive Plan”) which is administered by the Company’s Board of Directors Compensation Committee. The Incentive Plan has an authorized equity pool of 550,000. As of December 31, 2024 there are 220,689 equity grants available under the Incentive Plan.

AsCertain ~~part~~employees ofand ~~the~~executives ~~merger~~have ~~all~~been ~~vested~~granted options asor ofwarrants ~~August~~that ~~25,~~are ~~2023~~compensatory ~~totaling~~in ~~310,881~~nature. ~~were~~A ~~converted~~summary onof aoption ~~cashless~~activity ~~basis~~for ~~into~~the ~~198~~year ended December 31,~~378~~ ~~shares~~2024 ofand ~~common~~2023 ~~stock.~~are presented below:

As of December 31, 2023, total unrecognized compensation cost related to unvested stock options was approximately $1.5 MM.

2023 Options Outstanding	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years		Aggregate Intrinsic Value

Balance Outstanding - January 1, 2023		54,023		$	77.60		8.8	$	-
Granted		388			120.80		9.6
Exercised		(15,545	)		72.40		7.6
Forfeited		(26	)		56.20		7.8
Balance Outstanding - December 31, 2023		38,840		$	74.80		8.0	$	-

Exercisable - December 31, 2023		19,063		$	74.40		7.9	$	-

F-19 Table of Contents

2023 Nonvested Options	Number of Options			Weighted Average Grant Date Fair Value		Weighted Average Remaining Years to Vest

Nonvested - January 1, 2023		38,484		$	71.60		8.8
Granted		373			120.80		9.6
Vested		(19,063	)		74.40		7.9
Forfeited		(17	)		82.60		9.0
Nonvested - December 31, 2023		19,777		$	75.20		8.0

Restricted Stock Compensation

2024 Options Outstanding	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years		Aggregate Intrinsic Value

Balance Outstanding - January 1, 2024		38,840		$	74.80		8.0	$	-
Granted		273,755			50.53		9.3		-
Exercised		-			-		-		-
Forfeited		(493	)		72.24		8.2		-
Balance Outstanding - December 31, 2024		312,102		$	53.51		9.0	$	-

Exercisable - December 31, 2024		229,405		$	62.96		8.9	$	-

On December 31, 2022, the Company’s Board of Directors approved the grant of 250,000 restricted share of common stock to each of the Directors of the Company, for services rendered during 2021 and 2022, all of which vested on December 31, 2022. Compensation expense related to this grant for the year 2022 was $122,375 based upon fair value of our common stock of $0.089 per share. The Company’s Board of Directors also approved the granting of restricted shares of common stock for employee performance related to 2021 performance with a fair value of $160,645. The Board also approved on January 3, 2023 4,000,000 shares of restricted stock related to the Chief Executive Officer for bonus related to 2022 service with a fair value of $356,000.

2024 Nonvested Options	Number of Options			Weighted Average Grant Date Fair Value		Weighted Average Remaining Years to Vest

Nonvested - January 1, 2024		19,777		$	75.20		8.0
Granted		273,755			50.53		9.3
Vested		(210,342	)		62.96		8.9
Forfeited/expired		(493	)		72.24		8.2
Nonvested - December 31, 2024		82,697		$	27.29		9.3

InAs ~~April~~part ~~2023, the Company’s Board~~ of ~~Directors approved~~ the ~~granting~~merger ofall ~~81,267~~vested ~~restricted~~options ~~shares~~as of ~~common~~August ~~stock~~25, ~~for~~2023 ~~employee~~totaling ~~performance~~15,545 ~~related~~were toconverted ~~2022~~on ~~performance~~a ~~with~~cashless abasis ~~fair~~into ~~value~~9,919 shares of ~~$312,761.~~common stock.

InAs ~~April 2023, the Company’s Board~~ of ~~Directors approved compensation for its Board Members and Committee Members for the year ended~~ December 31, ~~2023. On an annual basis equivalent~~2024, ~~Board~~total ~~Members~~unrecognized ~~are compensated $60,000, with additional~~ compensation ofcost ~~$5,000~~related ~~for being a Committee Member and an additional $5,000 for being a Chair of a Committee and $20,000 for being the Board Chair. Compensation is~~ to beunvested ~~paid quarterly in arrears at the closing~~ stock ~~price~~options ofwas ~~the~~approximately ~~last trading day of the quarter~~$1.4 ~~The Company has recorded an expense of $394,168 for the year ended December 31, 2023~~million.

~~Common~~F-20 ~~Stock~~Table ~~Warrants~~of Contents

~~The~~Restricted ~~Company typically issues warrants to individual investors and institutions to purchase shares of the Company’s Common~~ Stock in connection with public and private placement fundraising activities. Warrants may also be issued to individuals or companies in exchange for services provided for the Company. The warrants are typically exercisable six months after the issue date, expire in five years, and contain a cash exercise provision and registration rights.Compensation

In ~~May~~April 2023, the Company’s ~~entered~~Board ~~into~~of ~~amendments~~Directors approved compensation for its Board Members and Committee Members for the year ended December 31, 2023. On an annual basis equivalent, Board Members are compensated $60,000, with ~~certain~~additional ~~warrant~~compensation ~~holders~~of ~~whose~~$5,000 ~~warrants~~for ~~contained~~being ~~down~~a ~~round~~Committee ~~provisions~~Member and ~~modified~~an ~~these~~additional ~~warrants~~$5,000 tofor ~~remove~~being ~~such~~a ~~provisions~~Chair ~~from~~of ~~inception~~a Committee and $20,000 for being the Board Chair. AsCompensation ~~such~~is to be paid quarterly in arrears at the ~~number~~closing ~~and~~stock ~~exercise~~price of ~~these~~the ~~warrants~~last ~~are~~trading ~~set~~day ~~back~~of tothe ~~their~~quarter. ~~original~~The ~~values~~Company ashas ~~originally~~recorded ~~intended~~an byexpense of $384,889 and $394,168 for the ~~parties~~years ended December 31, 2024 and 2023 respectively.

~~During~~On ~~the~~January ~~year~~3, ~~ended~~2023 ~~December~~the ~~31,~~board ~~2023~~approved 200,000 shares of restricted stock related to the ~~Company~~Chief ~~issued~~Executive ~~45,129~~Officer ~~Common~~for ~~Stock~~bonus ~~Warrants~~related to 2022 service with a fair value of $356,000.

~~During~~In ~~the~~April ~~year ended December 31~~2023, ~~2022,~~ the Company’s ~~issued~~Board ~~536,175~~of ~~Common~~Directors ~~Stock~~approved ~~Warrants. In addition,~~ the ~~Company~~granting ~~purchased~~of 14,~~278~~064 ~~common~~restricted ~~stock~~shares ~~warrants issued to a lender in 2019 as part~~ of acommon ~~Note~~stock ~~Payable~~for ~~that~~employee ~~had~~performance ~~been~~related ~~fully satisfied in 2020. These warrants include anti-dilutive provisions and as such resulted in an additional 28,883 warrants that were~~ to be2022 ~~issued~~performance atwith a ~~strike~~fair ~~price~~value of $~~0.15. The Company purchased these warrants at their restated strike price for $45~~312,~~000~~761.

~~During the year ended December 31, 2022, the Company issued 13,158~~ Common Stock Warrants in connection with issuances of promissory notes, of which 1,424 were issued to related parties. These warrants were designated Common Stock Warrants with an initial term of 5 years and an exercise price of $0.60 and $0.75 and contained no down round provisions. The Company may not effect, and a holder will not be entitled to, convert the Common Stock Warrants, which, upon giving effect to such conversion or exercise, would cause the aggregate number of shares of common stock beneficially owned by the Purchaser (together with its affiliates) to exceed 4.99%. The Company issued convertible debt in December 2022 at a price of $2.39 thereby affecting the down round provision on 659,585 warrants with a trigger price that is lower than $0.30 for any equity instrument issued. As such the Company has recorded a charge of $1,794,704 as a Dividend to Common Stockholders reflecting the increase in value of shares to be received by the warrant holder along with an increase in 366,331 warrants issuable to these holders for a total of 1,014,791 warrants at a new exercise price of $2.39.

OnThe ~~May 18, 2023 the~~ Company ~~determined~~typically ~~that~~issues ~~it not had not properly accounted for certain~~ warrants ~~issued~~to byindividual ~~the~~investors ~~Company~~and ininstitutions ~~2021~~to ~~with~~purchase ~~provisions~~shares ~~(the “down round provisions”) that required the lowering~~ of the ~~exercise~~Company’s ~~price~~Common ofStock ~~the warrant and a proportionate increase~~ in ~~the~~connection ~~number~~with ofpublic ~~shares~~and ~~underlying~~private ~~the~~placement ~~warrants~~fundraising ~~upon~~activities. ~~the~~Warrants ~~issuance~~may ofalso ~~new~~be ~~securities~~issued atto aindividuals ~~price~~or ~~per~~companies ~~shares~~in ~~that~~exchange isfor ~~lower~~services ~~than~~provided ~~the~~for ~~exercise price of~~ the ~~original warrant as per ASU 2017-11~~Company. The ~~Company~~warrants ~~did~~are ~~not~~typically ~~properly~~exercisable ~~account~~six ~~for~~months ~~such~~after ~~down round provisions when~~ the ~~criteria~~issue ~~for~~date, ~~revaluation~~expire ~~was~~in ~~met.~~five ~~The~~years, ~~down~~and ~~round~~contain ~~provisions require the Company to record~~ a ~~non-~~cash ~~charge~~exercise ~~for~~provision ~~the~~and ~~incremental~~registration ~~fair value of the additional shares to be issued upon the occurrence of the triggering event which is $1,794,704 for the year ended December 31,2022~~rights.

~~F-20~~During ~~Table~~the ofyear ~~Contents~~ended December 31, 2024 the Company issued 788,554 Common Stock Warrants.

AsIn ~~part~~May of2023, the ~~Merger,~~Company ~~all~~entered ~~outstanding~~into ~~warrants~~amendments aswith ofcertain ~~August~~warrant ~~25,~~holders ~~2023~~whose ~~totaling~~warrants ~~368,368~~contained ~~were~~down ~~converted~~round onprovisions aand ~~cashless~~modified ~~basis~~these ~~into~~warrants ~~117,301~~to ~~shares~~remove ofsuch ~~common~~provisions ~~stock~~from inception. As ofsuch ~~December 31, 2023,~~ the number and exercise of ~~shares~~these ~~issuable~~warrants ~~upon~~are ~~exercise~~set ofback ~~the~~to ~~Common~~their ~~Stock~~original ~~Warrants~~values ~~was~~as ~~45,129~~originally ~~shares~~intended by the parties.

	Warrant Shares Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Life		Intrinsic Value
Outstanding - December 31, 2021		648,461		$	3.88		4.40	$	-
Granted
Additions including Down Round feature		379,492			2.39		3.40		-
Forfeited/expired		-		$	-		-		-
Outstanding - December 31, 2022		1,027,953		$	3.88		3.45
Granted		45,129			2.09		5.00		-
Exercised		(368,368	)		3.88		2.78		-
Cancelled		(659,585	)	$	3.88		2.78		-
Outstanding - December 31, 2023		45,129		$	2.09		4.80	$	-

During the year ended December 31, 2023, the Company issued 2,257 Common Stock Warrants.

~~Preferred~~F-21 ~~Stock~~Table ~~Warrants~~of Contents

As part of the Merger, all outstanding warrants as of August 25, 2023 totaling 18,419 were converted on a cashless basis into 5,866 shares of common stock. As of December 31, 2024, the ~~Company~~number ~~assumed~~of shares issuable upon exercise of the ~~following~~Common ~~preferred~~Stock ~~stock~~Warrants ~~warrants:~~was 790,811 shares.

$2.00 Preferred Stock Warrants Outstanding	Number ofWarrants			WeightedAverageExercise Price		WeightedAverageRemainingContractualTerm in Years		AggregateIntrinsicValue
	Warrant Shares Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Life		Intrinsic Value
Outstanding – December 31, 2022		-			-		-		-
Outstanding - December 31, 2022		51,398		$	77.66		3.45	$	-
Granted		~~600~~2,~~000~~257			241.0080		105.000		-
Exercised		(174,200	)		2.00		9.8		-
Additions including Down Round feature		(18,419	)		77.60		2.78		-
Expired		-			-		-		-
Forfeited/expired		(32,979	)		77.60		2.78		-
Outstanding – December 31, 2023		425,800		$	2.00		9.7	$	-
Outstanding - December 31, 2023		2,257			41.80		4.80
Granted		572,482			2.98		4.58		-
Exercised		-			-		-		-
Cancelled		-			-		-		-
Outstanding - December 31, 2024		574,739		$	3.13		4.58	$	-

~~During~~Preferred ~~2023~~Stock there was a modification of the $2.00 warrant agreements which were issued in conjunction with the merger and classified as a derivative liability in the amount of $1,987,460. In September 2023 the warrants were modified and as a result are no longer considered a derivative liability and classified as equity.Warrants

$11.50 Preferred Stock Warrants Outstanding	Number ofWarrants		WeightedAverageExercise Price		WeightedAverageRemainingContractualTerm in Years		AggregateIntrinsicValue
Outstanding – December 31, 2022			$					-
Granted		10,122,313		11.50		10		-
Exercised		-		-		-		-
Expired		-		-		-		-
Outstanding – December 31, 2023		10,122,313	$	11.50		9.7	$	-

As part of the Merger, the Company assumed the following preferred stock warrants:

$15.00 Preferred Stock Warrants Outstanding	Number ofWarrants			WeightedAverageExercise Price		WeightedAverageRemainingContractualTerm in Years		AggregateIntrinsicValue
$2.00 Convertible Preferred Stock Warrants Outstanding	Number ofWarrants			WeightedAverageExercise Price		WeightedAverageRemainingContractualTerm in Years		AggregateIntrinsicValue
Outstanding – December 31, 2022		-		$	-		-		-
Granted		1600,000~~,000~~			152.00		10.0		-
Exercised		-(174,200	)		-2.00		-9.8		-
Expired		-			-		-		-
Outstanding – December 31, 2023		1425,~~000,000~~800		$	152.00		9.7	$	-
Granted		-			-		-		-
Exercised		(252,300	)		2.00		8.7		-
Expired		-			-		-		-
Outstanding – December 31, 2024		173,500		$	2.00		8.7	$	-

F-2122 Table of Contents

~~Equity~~During ~~Line~~2023 there was a modification of ~~Credit~~the $2.00 warrant agreements which were issued in conjunction with the merger and classified as a derivative liability in the amount of $1,987,460. In September 2023 the warrants were modified and as a result are no longer considered a derivative liability and classified as equity.

In January 2021 Old iCore and one of its Convertible Debt Holders entered into a Purchase Agreement for up to $5,000,000 shares of the Company’s common stock for 24 months. The purchase price of the stock will be at 75% of the lowest individual daily weighted average price of the past five (5) trading days with the amount to be drawn down as the lesser of $250,000 or 300% of the average shares traded for the ten (10) days prior to the Closing Request Date with a minimum $25,000 put allowance. As part of the agreement, the Company issued 8,378 shares of common stock as a commitment fee. In January 2022 the Company exercised this equity line of credit of an aggregate amount of $350,000 in exchange for 158,273 shares of common stock. The balance available as of December 31, 2022, to draw on the equity line of credit after the draw was $4,650,000. This line expired in January 2023.

$11.50 Convertible Preferred Stock Warrants Outstanding	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2022			$	-				-
Granted		10,122,313		11.50		10		-
Exercised		-		-		-		-
Expired		-		-		-		-
Outstanding – December 31, 2023		10,122,313		11.50		9.7	$	-
Granted		-		-		-		-
Exercised		-		-		-		-
Expired		-		-		-		-
Outstanding – December 31, 2024		10,122,313	$	11.50		8.7	$	-

On September 12, 2023, the Company entered into a purchase agreement with Arena Business Solutions Global SPC II, Ltd (“Arena”), pursuant to which Arena has committed to purchase up to $40 million of the Company’s common stock, at the Company’s direction from time to time, subject to the satisfaction of the conditions. Such sales of Common Stock are subject to certain limitations, and may occur from time to time at the Company’s sole discretion over the approximately 36-month period commencing on the date of the Purchase Agreement subject to registration with the Securities and Exchange Commission. The Company may direct Arena to purchase amounts of its Common Stock under the Purchase Agreement that the Company specifies from time to time in a written notice (an “Advance Notice”) delivered to Arena on any trading day up to the Commitment Amount. The maximum amount that the Company may specify in any one Advance Notice is equal to the following: (A) if the Advance Notice is received by 8:30 A.M. Eastern time, then the maximum amount that the Company may specify is equal to the lesser of (i) an amount equal to 40% of the average Daily Value Traded of the Common Stock of the ten trading days immediately preceding such Advance Notice, or (ii) $20.0 million; and (B) if the Advance Notice is received after 8:30 A.M. Eastern Time but prior to 10:30 A.M. Eastern Time, then the maximum amount that the Company may specify in an Advance Notice is equal to the lesser of: (i) an amount equal to 30% of the average Daily Value Traded of the Common Stock on the ten trading days immediately preceding such Advance Notice, or (ii) $15.0 million. For these purposes, “Daily Value Traded” is the product obtained by multiplying the daily trading volume of the Company’s Common Stock on Nasdaq during regular trading hours, as reported by Bloomberg L.P., by the VWAP (as defined in the Purchase Agreement) for that trading day. Subject to the satisfaction of the conditions under the Purchase Agreement, the Company deliver Advance Notices from time to time, provided that the Pricing Period for all prior advances has been completed. For these purposes, “Pricing Period” means one trading day, as notified by the Company to Arena in the applicable Advance Notice, commencing on the date of the Advance Notice. The purchase price of the shares of Common Stock will be equal to 97% of the simple average of the daily VWAP of the Common Stock during the Pricing Period.

$15.00 Preferred Stock Warrants Outstanding	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2022			$	-				-
Granted		1,000,000		15.00		10		-
Exercised		-		-		-		-
Expired		-		-		-		-
Outstanding – December 31, 2023		1,000,000		15.00		9.7	$	-
Granted		-		-		-		-
Exercised		-		-		-		-
Expired		-		-		-		-
Outstanding – December 31, 2024		1,000,000	$	15.00		8.7	$	-

~~Unless earlier terminated as provided in the Purchase Agreement, the Purchase Agreement will terminate automatically on the earliest to occur of: (i) the first day of the month next following the 36~~F-~~month~~23 ~~anniversary~~Table of the date of the Purchase Agreement; and (ii) the date on which Arena shall have purchased shares of Common Stock under the Purchase Agreement for an aggregate gross purchase price equal to Commitment Amount under the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost or penalty, upon five trading days’ prior written notice to Arena, provided that there are no outstanding Advance Notices the shares of Common Stock under which have not yet been issued. The Company and Arena may also terminate the Purchase Agreement at any time by mutual written consent.Contents

AsEquity ~~consideration~~Line ~~for Arena’s irrevocable commitment to purchase Common Stock upon the terms~~ of and subject to satisfaction of the conditions set forth in the Purchase Agreement, upon execution of the Purchase Agreement, the Company agreed to issue a total of 291,259 shares of Common Stock equaling $600,000 (the “Commitment Fee Shares”) based on a price per share equal to the simple average daily VWAP of the Common Stock during the ten trading days immediately preceding the date on which the SEC declares the Registration Statement effective.Credit

AsIn January 2021 Old iCore and one of ~~December~~its 31Convertible Debt Holders entered into a Purchase Agreement for up to $5,000,000 ~~2023~~shares of the Company’s common stock for 24 months. The purchase price of the stock will be at 75% of the lowest individual daily weighted average price of the past five (5) trading days with the amount to be drawn down as the lesser of $250,000 or 300% of the average shares traded for the ten (10) days prior to the Closing Request Date with a minimum $25,000 put allowance. As part of the agreement, the Company issued 419 shares of common stock as a commitment fee. In January 2022 the Company exercised this equity line of credit of an aggregate amount of $2350,~~940,985~~000 in exchange for 17,~~308,741~~914 shares of ~~Common~~common ~~Stock~~stock. The balance available as of December 31, ~~2023~~2022, to draw on the equity line of credit after the draw was $374,~~059~~650,~~015~~000. ~~and~~This isline ~~subject~~expired toin ~~shareholder~~January ~~approval for the issuance of additional shares~~2023.

On ~~February~~September 1412, ~~2024~~2023, ~~this~~the Company entered into a purchase agreement ~~was~~with ~~terminated~~Arena Business Solutions Global SPC II, Ltd (“Arena”), pursuant to which Arena has committed to purchase up to $40 million of the Company’s common stock, at the Company’s direction from time to time, subject to the satisfaction of the conditions. ~~Refer~~Such sales of Common Stock are subject to ~~Note~~certain 13limitations, and may occur from time to time at the Company’s sole discretion over the approximately 36-month ~~Subsequent~~period ~~Events~~commencing on the date of the Purchase Agreement subject to registration with the Securities and Exchange Commission. The Company may direct Arena to purchase amounts of its Common Stock under the Purchase Agreement that the Company specifies from time to time in a written notice (an “Advance Notice”) delivered to Arena on any trading day up to the Commitment Amount. The maximum amount that the Company may specify in any one Advance Notice is equal to the following: (A) if the Advance Notice is received by 8:30 A.M. Eastern time, then the maximum amount that the Company may specify is equal to the lesser of (i) an amount equal to 40% of the average Daily Value Traded of the Common Stock of the ten trading days immediately preceding such Advance Notice, or (ii) $20.0 million; and (B) if the Advance Notice is received after 8:30 A.M. Eastern Time but prior to 10:30 A.M. Eastern Time, then the maximum amount that the Company may specify in an Advance Notice is equal to the lesser of: (i) an amount equal to 30% of the average Daily Value Traded of the Common Stock on the ten trading days immediately preceding such Advance Notice, or (ii) $15.0 million. For these purposes, “Daily Value Traded” is the product obtained by multiplying the daily trading volume of the Company’s Common Stock on Nasdaq during regular trading hours, as reported by Bloomberg L.P., by the VWAP (as defined in the Purchase Agreement) for ~~additional~~that ~~details~~trading day. Subject to the satisfaction of the conditions under the Purchase Agreement, the Company deliver Advance Notices from time to time, provided that the Pricing Period for all prior advances has been completed. For these purposes, “Pricing Period” means one trading day, as notified by the Company to Arena in the applicable Advance Notice, commencing on the date of the Advance Notice. The purchase price of the shares of Common Stock will be equal to 97% of the simple average of the daily VWAP of the Common Stock during the Pricing Period.

FUnless earlier terminated as provided in the Purchase Agreement, the Purchase Agreement will terminate automatically on the earliest to occur of: (i) the first day of the month next following the 36-22month ~~Table~~anniversary of ~~Contents~~the date of the Purchase Agreement; and (ii) the date on which Arena shall have purchased shares of Common Stock under the Purchase Agreement for an aggregate gross purchase price equal to Commitment Amount under the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost or penalty, upon five trading days’ prior written notice to Arena, provided that there are no outstanding Advance Notices the shares of Common Stock under which have not yet been issued. The Company and Arena may also terminate the Purchase Agreement at any time by mutual written consent.

5.As ~~PROPERTY~~consideration ~~AND~~for ~~EQUIPMENT~~Arena’s irrevocable commitment to purchase Common Stock upon the terms of and subject to satisfaction of the conditions set forth in the Purchase Agreement, ~~NET~~upon execution of the Purchase Agreement, the Company agreed to issue a total of 14,563 shares of Common Stock equaling $600,000 (the “Commitment Fee Shares”) based on a price per share equal to the simple average daily VWAP of the Common Stock during the ten trading days immediately preceding the date on which the SEC declares the Registration Statement effective.

~~Property~~As ~~and~~of ~~equipment~~December 31, ~~net~~2023, ~~consists~~the Company exercised this equity line of credit of an aggregate amount of $2,940,985 in exchange for 65,438 shares of Common Stock. The balance available as of December 31, 2023, to draw on the ~~following:~~equity line of credit after the draw was $37,059,015 and is subject to shareholder approval for the issuance of additional shares.

	December 31,			December 31,
	2023			2022
Furniture and fixtures	$	92,821		$	69,840
Leasehold improvements		42,493			30,298
Equipment		22,240			22,240
Vehicles		-			32,000
Computer software		124,702			-
	$	282,256		$	154,378
Less accumulated depreciation		(79,835	)		(80,184	)
	$	202,421		$	74,194

F-24

Table of Contents

~~Depreciation~~On ~~expense~~February ~~on property and equipment for the years ended December 31~~14, ~~2023 and 2022~~2024, ~~were~~this ~~$17,429~~agreement ~~and~~was ~~$22,521, respectively~~terminated. ~~In 2023 the Company sold its vehicles for a gain of $13,778 and a recovery of depreciation expense of $17,778.~~

6On August 16, 2024, the Company executed a Strata Purchase Agreement with Clearthink Capital Partners, LLC (“Clearthink”) (the “Strata Agreement”). ~~GOODWILL~~Pursuant ~~AND~~to ~~OTHER~~the ~~INTANGIBLE~~Strata ~~ASSETS~~Agreement, ~~NET~~Clearthink has committed to purchase up to $5.0 million (the “Commitment Amount”) of Company common stock, at the Company’s direction from time to time, subject to the satisfaction of the conditions in the Strata Agreement.

~~The~~Such ~~following~~sales ~~table~~of ~~sets~~common ~~forth~~stock, if any, will be subject to certain limitations, and may occur from time to time at the ~~changes~~Company’s insole discretion over the ~~carrying~~approximately ~~amount~~24-month period commencing on the date that a registration statement (the “Registration Statement”) covering the resale by Clearthink of ~~goodwill~~the ~~for~~shares of common stock purchased from the ~~year~~Company ~~ended~~(which ~~December~~the ~~31,~~Company ~~2023~~has agreed to file) is declared effective by the U.S. Securities and ~~2022:~~Exchange Commission (the “SEC”) and remains effective, and the other conditions set forth in the Strata Agreement are satisfied.

	Total
Balance at December 31, 2021	$	1,484,966
2022 activity		-
Balance at December 31, 2022		1,484,966
2023 activity		-
Balance at December 31, 2023	$	1,484,966

On August 16, 2024, the Company executed a Registration Rights Agreement with Clearthink (the “Registration Rights Agreement”). Pursuant to the Registration Rights Agreement, the Company agreed to file a registration statement within 30 days registering the shares of Company common stock issuable pursuant to the Strata Agreement. The registration was filed in September 2024 and deemed effective October 21, 2024.

~~The~~Clearthink ~~following~~has ~~table~~no ~~sets~~right ~~forth~~to require the ~~gross~~Company ~~carrying~~to ~~amounts~~sell ~~and~~any ~~accumulated~~shares ~~amortization~~ of common stock to Clearthink, but Clearthink is obligated to make purchases at the Company’s ~~intangible~~direction ~~assets~~subject asto ofcertain ~~December~~conditions. ~~31,~~There ~~2023~~is ~~and~~no ~~2022:~~upper limit on the price per share that Clearthink could be obligated to pay for the common stock under the Strata Agreement.

	Gross CarryingAmount		Impairment			Accumulated Amortization			Net CarryingAmount
Definite-lived intangible assets at January 1, 2021
Capitalized software	$	3,014,490		-		$	(2,483,429	)	$	531,061
Customer relationships		3,713,434		-			(1,363,054	)		2,350,380
Acquired technology		1,527,186		-			(1,447,758	)		79,428
Total definite-lived intangible assets at December 31, 2022	$	8,255,110	$	-		$	(5,294,241	)	$	2,960,869
Capitalized software		3,741,511		-			(2,838,099	)		903,412
Customer relationships		5,272,578		(105,676	)		(2,186,490	)		2,980,412
Acquired technology		1,527,186		-			(1,527,186	)		-
Total definite-lived intangible assets at December 31, 2023	$	10,541,275	$	(105,676	)	$	(6,551,775	)	$	3,883,824

Actual sales of shares of common stock to Clearthink from time to time will depend on a variety of factors, including, among others, market conditions, the trading price of the Company’s common stock and determinations by the Company as to the appropriate sources of funding for its operations. The net proceeds that the Company may receive under the Strata Agreement cannot be determined at this time, since it will depend on the frequency and prices at which the Company sell shares of its common stock to Clearthink, the Company’s ability to meet the conditions of the Strata Agreement and the other limitations, terms and conditions of the Strata Agreement. The Company expects that any proceeds received by the Company from such sales to Clearthink will be used for working capital and general corporate purposes.

~~F-23~~Under ~~Table~~the applicable rules of ~~Contents~~Nasdaq and the Strata Agreement, the Company will not sell or issue to Clearthink shares of its common stock, other than the Commitment Fee Shares (defined below), in excess of 19.99% of the Company’s shares of common stock outstanding as of the date of the Strata Agreement (the “Exchange Cap”), unless the Company obtains stockholder approval to issue shares of common stock in excess of the Exchange Cap.

~~Amortization~~The ~~expense~~Strata ofAgreement ~~intangible~~also ~~assets~~prohibits ~~was~~the ~~$1,257,534~~Company ~~and~~from ~~$1,269,564,~~directing ~~respectively,~~Clearthink ~~for~~to ~~the~~purchase ~~years~~any ~~ended~~shares ~~December~~of 31common stock if those shares, ~~2023~~when ~~and~~aggregated ~~2022.~~with ~~The~~all other shares of the Company’s ~~amortization~~common isstock ~~based~~then onbeneficially noowned ~~residual~~by ~~value~~Clearthink ~~using~~and its affiliates as a result of purchases under the ~~straight-line~~Strata ~~amortization~~Agreement, ~~method~~would asresult itin ~~best~~Clearthink ~~represents~~and its affiliates having beneficial ownership of more than the ~~benefit~~9.99% of the ~~intangible~~Company’s ~~assets.~~then outstanding common stock.

The ~~following~~Company ~~table~~may ~~sets~~direct ~~forth~~Clearthink to purchase amounts of its common stock under the ~~weighted-average~~Strata ~~amortization~~Agreement ~~period,~~that it specifies from time to time in ~~total~~a ~~and~~written bynotice ~~major~~(a ~~intangible~~“Request ~~asset~~Notice”) ~~class:~~delivered to Clearthink on any trading day up to the Commitment Amount. The maximum amount that the Company may specify in any one Request Notice is equal to the lesser of $1,000,000 or 500% of the average number of shares traded for the 10 trading days prior to the date of the Request Notice.

Asset Class	Weighted-Average Amortization period
Capitalized software		3.2 years
Customer relationships		4.7 years

The purchase price of the shares of common stock will be equal shall equal 80% of the average of the two lowest daily volume-weighted average prices if the Company’s common stock is traded under $0.01 per share and 85% of the average of the two lowest daily volume-weighted average prices if the Company’s common stock is traded between $0.01 to $0.03 and 88% of the average of the two lowest daily volume-weighted average prices if the Company’s common stock is traded between $0.03 - $0.05 and 90% of the average of the two lowest daily volume-weighted average prices if the Company’s common stock is traded over $0.05 during the five trading days preceding the purchase date.

AsUnless ofearlier ~~December~~terminated ~~31,~~as ~~2023~~provided in the Strata Agreement, ~~assuming~~the noStrata ~~additional~~Agreement ~~amortizable~~will ~~intangible~~terminate ~~assets,~~automatically on the ~~expected~~earliest ~~amortization~~to ~~expense~~occur ~~for~~of: (i) the ~~unamortized~~24-month ~~acquired~~anniversary ~~intangible~~of ~~assets~~the ~~for~~date of the ~~next~~Registration ~~five~~Statement ~~years~~becoming effective; and ~~thereafter~~(ii) ~~was~~the asdate ~~follows:~~on which Clearthink shall have purchased shares of common stock under the Strata Agreement for an aggregate gross purchase price equal to Commitment Amount under the Strata Agreement. The Company has the right to terminate the Strata Agreement at any time, at no cost or penalty, upon one trading days prior written notice to Clearthink.

	Estimated
2024	$	1,357,783
2025	$	1,357,783
2026	$	1,087,976
2027	$	80,282

As consideration for Clearthink’s irrevocable commitment to purchase common stock upon the terms of and subject to satisfaction of the conditions set forth in the Strata Agreement, upon execution of the Strata Agreement, the Company agreed to issue a total of 15,000 shares of common stock with a value of $156,030 (the “Commitment Fee Shares”) to Clearthink.

7.On ~~FORWARD~~December ~~PURCHASE~~5, ~~AGREEMENT~~2024, this agreement was terminated.

On ~~August~~December 145, ~~2023~~2024, the Company entered into ~~Prepaid~~an ~~Forward~~Equity Purchase Agreement with Crom Structured Opportunities Fund I, LP (“Crom”) (the “~~FPA~~Equity Purchase Agreement”). ~~with~~Pursuant ~~Old~~to ~~iCore~~the ~~and~~Equity ~~RiverNorth~~Purchase ~~SPAC~~Agreement, ~~Arbitrage~~Crom ~~Fund,~~has ~~L.P.,~~committed ato ~~Delaware~~purchase ~~limited~~up ~~partnership~~to $20.0 million (the “~~Purchaser~~Commitment Amount”) of Company common stock, at the Company’s direction from time to time, subject to the satisfaction of the conditions in the Equity Purchase Agreement. Such sales of common stock, if any, will be subject to certain limitations, and may occur from time to time at the Company’s sole discretion over a 24-month period. As of December 31, 2024, the Equity Purchase Agreement had not be utilized.

InF-25 ~~accordance~~Table ~~with the FPA and subject to the terms and conditions set forth therein, the Purchaser purchased the lesser~~ of (a) 1.5 million shares of FGMC Common Stock and (b) such number of shares of FGMC Common Stock as shall, following the Business Combination, not exceed 9.9% of the total number of shares of FGMC Common Stock to be outstanding (such shares to be purchased, the “Forward Purchase Shares”) from public shareholders for a price no greater than the redemption price per share as is indicated in FGMC’s most recently filed periodic report (the “Prepaid Forward Purchase Price”).Contents

In5. ~~accordance~~PROPERTY ~~with~~AND ~~the terms of the Business Combination~~EQUIPMENT, upon the consummation of the Business Combination, each Forward Purchase Share automatically converted into one share of Preferred Stock (including the shares of the Company’s Common Stock underlying the Preferred Stock, the “Purchased Shares”).NET

~~Upon~~Property ~~the~~and ~~Business Combination closing~~equipment, ~~100,000~~net ~~Purchased~~consists ~~Shares~~of ~~were deemed to be “Commitment Shares” and~~ the ~~remaining Purchased Shares were deemed to be “Prepaid Forward Purchase Shares”.~~following:

Upon the closing of the Business Combination FGMC caused Purchaser to be paid directly out of the funds held in FGMC’s trust account, a cash amount (the “Prepayment Amount”) equal to the number of Purchased Shares multiplied by the amount paid to redeeming stockholders in connection with the Business Combination (the “Redemption Price”). The Redemption Price was $10.69.

	December 31,			December 31,
	2024			2023

Furniture and fixtures	$	90,969		$	92,821
Leasehold improvements		42,493			42,493
Equipment		22,240			22,240
Vehicles		-			-
Computer software		124,701			124,702
		280,403			282,256
Less accumulated depreciation		(106,792	)		(79,835	)
	$	173,611		$	202,421

~~Upon~~Depreciation ~~the~~expense ~~sale~~on ofproperty ~~the~~and ~~Prepaid~~equipment ~~Forward~~for ~~Purchase~~the ~~Shares~~years ~~(or~~ended ~~underlying~~December ~~FGMC~~31, ~~Common~~2024 ~~Stock)~~and by2023, ~~the~~were ~~Purchaser~~$26,957 ~~the~~and ~~Purchaser~~$17,429, ~~will~~respectively. ~~remit~~In 2023 the ~~Reference~~Company ~~Price~~sold ~~(as~~its ~~defined~~vehicles ~~below)~~for ~~per~~a ~~share~~gain toof ~~FGMC.~~$13,778 Onand ~~the~~a ~~earlier~~recovery toof ~~occur~~depreciation expense of: $17,778.

	·	the occurrence of a “Registration Failure” (as defined in the FPA), and
	·	the date that is twelve months after the closing of the Business Combination (the “Maturity Date”), then, for any Common Stock underlying the Prepaid Forward Purchase Shares not sold by the Purchaser, the Purchaser shall, on the 25th trading day after the Maturity Date (the “Payment Date”), pay the Company an amount equal to (i) the number of Prepaid Forward Purchase Shares that the Purchaser held on the Maturity Date, multiplied by (ii) the lowest daily volume weighted average price per share of FGMC Common Stock during the twenty trading days beginning on the day after the Maturity Date less $0.15.

6. GOODWILL AND OTHER INTANGIBLE ASSETS, NET

~~F-24~~The ~~Table~~following table sets forth the changes in the carrying amount of ~~Contents~~goodwill for the year ended December 31, 2024 and 2023:

Between the Maturity Date and the Payment Date, the Purchaser may not sell more than a number of Prepaid Forward Purchase Shares per day equal to the greater of (i) 5% of the Purchased Shares owned by the Purchaser at the Maturity Date and (ii) 10% of the daily trading volume on such date.

	Total
Balance at December 31, 2022	$	1,484,966
2023 activity		-
Balance at December 31, 2023		1,484,966
2024 activity		-
Balance at December 31, 2024	$	1,484,966

The ~~Purchaser~~following ~~has~~table ~~agreed~~sets ~~that~~forth ~~until~~ the ~~Maturity~~gross ~~Date,~~carrying ~~the~~amounts ~~Common Stock underlying the Prepaid Forward Purchase Shares may not be sold for a price less than the Reference Price. The “Reference Price” will initially equal the Redemption Price~~ and ~~will~~accumulated beamortization ~~reduced (but never increased) each month commencing on the first day~~ of the month starting 30 days after the Business Combination closing to the volume weighted average price of the FGMC Common Stock for the preceding 10 trading days, but in no event less than $10.00 per share (the “Floor”) unless in the Company’s ~~sole~~intangible ~~discretion,~~assets ~~the~~as ~~Floor is lowered. Any reduction~~ of ~~the~~December ~~Floor~~31, ~~shall~~2024 beand ~~accomplished through a written notice from the Company to Purchaser.~~2023:

The FPA provides for certain registration rights. In particular, FGMC is required to, within 30 calendar days following written request by Purchaser, file with the SEC a registration statement registering the resale of all shares held by Purchaser and have such registration statement declared effective as soon as practicable after the filing thereof.

	Gross Carrying Amount		Impairment			Accumulated Amortization			Net Carrying Amount
Definite-lived intangible assets at January 1, 2023
Capitalized software	$	3,741,511	$	-		$	(2,838,099	)	$	903,412
Customer relationships		5,272,578		(105,676	)		(2,186,490	)		2,980,412
Acquired technology		1,527,186		-			(1,527,186	)		-
Total definite-lived intangible assets at December 31, 2023	$	10,541,275	$	(105,676	)	$	(6,551,775	)	$	3,883,824
Capitalized software	$	5,144,589	$	-		$	(3,464,974	)	$	1,679,615
Customer relationships		4,183,037		(908,000	)		(3,111,022	)		164,015
Acquired technology		8,675,269		(5,723,862	)		(2,951,407	)		-
Total definite-lived intangible assets at December 31, 2024	$	18,002,895	$	(6,631,862	)	$	(9,527,403	)	$	1,843,630

8.F-26 ~~DEBT~~Table of Contents

		December 31,			December 31,
		2023			2022
(1)	Convertible Note bearing interest at 12% due May, 2023	$	-		$	578,802
(2)	Note bearing interest at 15% due September 1, 2023		-			1,012,500
(2)	Note bearing interest at 15% due September 1, 2023		-			506,250
(3)	Note bearing interest at 18% due October 1, 2026		27,540			32,752
(4)	Secured Promissory Note bearing interest at 17.5% due February 28, 2026		1,988,793			1,960,965
(5)	Promissory Note bearing interest at 14%, due January 15, 2023		-			50,892
(6)	Promissory Note bearing interest at 14%, due September 1, 2023		-			329,227
(7)	Promissory Note bearing interest at 15%, due January 25, 2023		-			509,145
(8)	Promissory Note bearing interest at 15%, due September 1, 2023		-			255,490
(8)	Promissory Note bearing interest at 15%, due September 1, 2023		-			255,547
(9)	Convertible Note bearing interest at 15% due March 2024		-			-
(10)	Convertible Note bearing interest at 15% due June 14, 2024
(11)	Convertible Note bearing interest at 15% due June 14, 2024
(12)	Convertible Note bearing interest at 15% due July 24, 2024		-			-
(13)	Promissory Note bearing interest at 12%, due October 31, 2023		38,609			-
(14)	Convertible Note bearing interest at 12% due May 13, 2024		388,380
(15)	Convertible Note bearing interest at 12%, due October 31, 2024		569,391			-
(15)	Convertible Note bearing interest at 12%, due December 18, 2024		574,961
(16)	Convertible Note bearing interest at 12%, due December 19, 2024		80,722
(17)	Convertible Note bearing interest at 12%, due December 19, 2024		80,509
(14)	Convertible Note bearing interest at 12%, due December 28, 2024		114,781
(2)	Convertible Note bearing interest at 12%, due June 1, 2024		473,743
(18)	Promissory Note bearing interest at 15%, due December 26, 2024		2,000,000
	Total notes payable		6,337,429			5,491,570
	Less: Unamortized debt discounts		-			-
	Less: unamortized financing costs		(196,837	)		(7,444	)
	Total notes payable, net of financing costs		6,140,592			5,484,126
	Less current maturities		(4,720,455	)		(4,034,865	)
	Total Long-Term Debt	$	1,420,137		$	1,449,261

The Company sold as part of the Asset Purchase Agreement for it Managed IT Services, net customer relationships of $1,013,865.

FAmortization expense of intangible assets was $2,975,628 and $1,257,534, respectively, for the years ended December 31, 2024 and 2023. The Company’s amortization is based on no residual value using the straight-25line ~~Table~~amortization method as it best represents the benefit of ~~Contents~~the intangible assets.

1. In April 2021, the Company signed a $500,000 convertible promissory note with a maturity date twelve months after issuance and received in exchange $500,000. An interest charge of 12% per annum shall accrue and be paid on the maturity date. The ~~note~~following istable ~~convertible~~sets ~~into~~forth the Company’s Common Stock at a fixed conversion price of $0.10 per common share based on Old iCore common share value. The Company has right of prepayment. The note holder is limited to receive upon conversion no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. The Company also issued to the Holder 788,000 restricted shares of the Company’s Common Stock and a warrant to purchase 87,132 shares of Company Common Stock with a 5weighted-~~year~~average ~~term.~~amortization ~~The exercise price per share of Common stock under this Warrant is $0.60 per share for the first 43~~period,~~566~~ ~~Warrant Shares and $0.75 for the next 43,566 Warrant Shares. In August 2021 the down round provision~~ in ~~the~~total ~~Warrant Agreement was triggered resulting in an additional 108,915 warrants being issued~~ and ~~the~~by ~~strike~~major ~~price~~intangible ~~repriced~~asset to $0.30 for all 196,047 warrants. In December 2022, the down round provision in the Warrant Agreement was triggered again resulting in an additional 49,012 warrants to be issued and the strike price repriced to $0.24 for all 245,059 warrants. At Maturity this note was renegotiated and term extended to June 2023 for an additional principal consideration of $55,400 under the same interest rate and conditions as the matured note. This note and accrued interest was converted in January 2023 for 202,343 shares of Common Stock. In May 2023 the Company and the warrant holder renegotiated the outstanding warrants back to their original intended values at issuance date of 43,566 exercisable at $0.60 and 43,566 exercisable at $0.75. As part of the Merger, the warrants were converted on a cashless basis into 28,621 shares of Common Stock. 2. In August 2021, the Company signed a $1,000,000 and $500,000 promissory note with a maturity date 24 months after issuance. An interest charge of 15% per annum shall accrue and be paid monthly. The Company also issued to the Holder 33,513 restricted shares of the Company’s Common Stock and 50,269 cash Warrant Shares with a 5-year term. The exercise price per share of Common stock under this Warrant is $0.75 per share. In December 2021 the down round provision in the Warrant Agreement was triggered resulting in an additional 75,403 warrants being issued and the strike price repriced to $0.30 for all 125,672 warrants. In December 2022 the down round provision in the Warrant Agreement was triggered again resulting in an additional 31,418 warrants being issued and the strike price repriced to $0.30 for all 157,090 warrants. In May the Company and the warrant holder renegotiated the outstanding warrants back to their original intended values at issuance date of 50,269 exercisable at $0.75. The promissory note is subordinated to the Company’s senior lenders. As part of the Merger these notes totalling $1,500,000 along with outstanding interest of $nil was converted on August 25, 2023 into 173,339 common shares and the warrants were converted on a cashless basis into 28,621 shares of Common Stock. In August 2023, the Company agreed to a Satisfaction Agreement in conjunction with the conversion of debt in the amount of $1,500,000 to be done at the time of Merger. The Satisfaction Agreement provides that the Company would provide the equity holder cash proceeds on the difference between the proceeds from the sale of stock and the face value of debt up to $1,500,000 subject to certain selling limitations on or before August 2024. The lender sold $1,000,000 worth of stock for a net return of $526,257 and invoked the Satisfaction Agreement in October 2023. In December 2023, the Company and lender agreed to enter into a new Convertible Promissory Note in the amount of $473,743 with a maturity of six months after issuance. An interest rate of 12% per annum shall accrue and be paid on maturity. The Note and accrued interest is convertible at $1.24 per share into the Company’s Common Stock. 3. In November 2021, the Company signed a $40,071 equipment finance agreement with a maturity date 60 months after issuance from a third-party financing company. Payments of principal and interest of $791 are due monthly. 4. On February 28, 2022, the Company signed a $2,000,000 secured promissory note with a maturity date 48 months after issuance and received in exchange $1,970,000 net of fees. An Interest charge of 17.5% per annum shall accrue, with interest only payments being made for the first six months after which both interest and principal will be due. The Company has right of prepayment subject to certain minimum interest payments being made. The Prepayment Fee shall be (i) equal to 6 months’ interest that would have accrued with regard to the prepaid principal, if prepaid prior to the 2nd anniversary of the date of the Initial Advance or Subsequent Advance, as applicable, and (ii) equal to 3 months’ interest that would have accrued with regard to the prepaid principal, if prepaid on or after the 2nd anniversary and prior to the 3rd anniversary of the date of the Initial Advance or Subsequent Advance, as applicable. Additionally, the Company has the following covenant requirements; maintaining a minimum cash balance of $150,000 in its combined bank accounts as well as entering into a Deposit Account Control Agreement; monthly financial reporting requirements and certifications; obtaining other indebtedness without consent; merge, consolidate or transfer assets; pledge assets as collateral; or guarantee without consent of the Lender. In December 2023 the Company and the secured lender entered into a Forbearance Agreement whereby the Company will be required to provide additional reporting weekly and monthly reporting, pay a forbearance fee of $300,000 which would be applied to outstanding interest and fees, along with other customary requests in exchange for a forbearance and the adjustment of the loan to interest only till July 2024.class:

F-26 Table of Contents

Asset Class	Weighted-Average Amortization period
Capitalized software		2.2 years
Customer relationships		3.7 years
Acquired technology		0.0 years

5. In April 2022, the Company signed a $50,000 unsecured promissory note with a maturity date six (6) months after issuance with an interest charge of 14% per annum which shall accrue and be paid on the maturity date. The Company has the right to prepay this note without penalty. At maturity in October 2022, this note was reissued under the same term with a maturity of three (3) months. The promissory note is subordinated to the Company’s senior lender. This note was fully repaid in March 2023. 6. In April 2022, the Company signed a $300,000 unsecured promissory note with a maturity date six (6) months after issuance with an interest charge of 14% per annum which shall accrue and be paid on the maturity date. The Company has the right to prepay this note without penalty. At maturity in October 2022, this note was reissued under the same terms with a maturity of date of six (6) months. In March 2023, the term of this note was extended to September 1, 2023.The promissory note is subordinated to the Company’s senior lenders. As ~~part~~ of ~~the~~December ~~Merger the principal of $300~~31,~~000~~ ~~along with outstanding interest of $55~~2024,~~693~~ ~~was~~assuming converted on August 25, 2023 into 41,104 common shares. 7. In July 2022, the Company signed a $500,000 unsecured promissory note with a maturity date six (6) months after issuance with an interest charge of 15% per annum. The note is callable by the Holder no ~~earlier~~additional ~~than~~amortizable 90intangible ~~days from issue. The Company has the right to prepay this note without penalty. The Company issued to the Holder a warrant to purchase 175~~assets,~~000~~ shares of Company Common Stock with a 5-year term. The exercise price per share of Common stock under this Warrant is $0.25 per share for 87,500 warrants and $0.20 per share for 87,500 warrants. This note was fully repaid in March 2023. 8. In August 2022, the ~~Company~~expected ~~signed~~amortization ~~two~~expense $250,000 unsecured promissory notes with a maturity date six (6) months after issuance with an interest charge of 15% per annum to the same investor in 14 and 9. The notes are callable by the Holder no earlier than 90 days from issue. The Company has the right to prepay this note without penalty. The Company issued to the Holder a warrant to purchase 175,000 shares of Company Common Stock with a 5-year term. The exercise price per share of Common stock under this Warrant is $0.25 per share for ~~87,500 warrants and $0.20 per share for 87,500 warrants. In March 2023,~~ the ~~term~~unamortized ofacquired ~~these~~intangible ~~notes~~assets were extended to September 1, 2023.The promissory notes are subordinated to the Company’s senior lenders. As part of the Merger these notes with principal balance totalling $500,000 along with outstanding interest of $nil was converted on August 25, 2023 into 57,780 common shares. 9. In March 2023, the Company entered into a twelve (12) month Convertible Secured Promissory Note (“Note”). The Note is for ~~$2,500,000 with $500,000 paid to~~ the ~~Holder~~next onfive ~~issuance~~years ~~for net proceeds of $2,000,000. The Note carries~~ and ~~interest~~thereafter ofwas 15% per annum which can be paid in cash or kind and it is convertible either into the Company’s Common Stock after six months from date of issuance at $0.10 per share, or if the business combination between FG Merger Corp. (“FGMC”) and the Company pursuant to the Merger Agreement and Plan of Reorganization by and among FGMC, FG Merger Sub Inc., and the Company dated January 5, 2023, as such agreement may be amended from time to time (the “Business Combination”), occurs then, upon any subsequent conversion of the Note, the holder shall no longer have the right to receive Company common stock upon conversion of the Note, but shall have the right to receive, for each share of Company common stock that would have been issuable upon such conversion immediately prior to the occurrence of the Business Combination, the number of shares of FGMC common stock receivable as a result of such Business Combination by a holder of the number of shares of Company common stock for which the Note is convertible immediately prior to such Business Combination. As a condition of the Note all existing outstanding Notes maturing before September 1, 2023 had their term extended to September 1, 2023. In addition, all vested option holders and all warrant holders were provided with a cashless purchase option at time of the Business Combination. The Note is superior to all notes in terms of security except of our Senior Secured Note Payable. In May 2023 all warrant holders with down round provisions provided a waiver to the potential down round triggering event on any conversion issuance. As part of the Merger this note with principal balance of $2,500,000 along with outstanding interest of $115,535 was converted on August 25, 2023 into 876,522 common shares.follows:

F-27 Table of Contents

	Estimated
2025	$	823,299
2026	$	808,299
2027	$	190,744
2028	$	21,289
2029	$	-

10.		In June 2023, the Company entered into a twelve (12) month note Convertible Promissory Note (“Note”). The Note is for $77,000 and carries an interest rate of 15% per annum. The principal of the Note is convertible into Common Stock of the Company at a twenty percent discount to the closing price of the Company’s Common Stock on September 1, 2023 or if the business combination between FG Merger Corp. (“FGMC”) and the Company pursuant to the Merger Agreement and Plan of Reorganization by and among FGMC, FG Merger Sub Inc., and the Company dated January 5, 2023, as such agreement may be amended from time to time (the “Business Combination”), occurs then, upon any subsequent conversion of the Note, the holder shall no longer have the right to receive Company common stock upon conversion of the Note, but shall have the right to receive, for each share of Company common stock that would have been issuable upon such conversion immediately prior to the occurrence of the Business Combination, the number of shares of FGMC common stock receivable as a result of such Business Combination by a holder of the number of shares of Company common stock for which the Note is convertible immediately prior to such Business Combination at a twenty percent discount to such exchange ratio. The promissory note is subordinated to the Company’s senior lenders. As part of the Merger the principal of $77,000 along with outstanding interest of $2,074 was converted on August 25, 2023 into 9,138 common shares.
11.		In June 2023, the Company entered into a twelve (12) month note Convertible Promissory Note (“Note”). The Note is for $6,000 and carries an interest rate of 15% per annum. The principal of the Note is convertible into Common Stock of the Company at a twenty percent discount to the closing price of the Company’s Common Stock on September 1, 2023 or if the business combination between FG Merger Corp. (“FGMC”) and the Company pursuant to the Merger Agreement and Plan of Reorganization by and among FGMC, FG Merger Sub Inc., and the Company dated January 5, 2023, as such agreement may be amended from time to time (the “Business Combination”), occurs then, upon any subsequent conversion of the Note, the holder shall no longer have the right to receive Company common stock upon conversion of the Note, but shall have the right to receive, for each share of Company common stock that would have been issuable upon such conversion immediately prior to the occurrence of the Business Combination, the number of shares of FGMC common stock receivable as a result of such Business Combination by a holder of the number of shares of Company common stock for which the Note is convertible immediately prior to such Business Combination at a twenty percent discount to such exchange ratio. The promissory note is subordinated to the Company’s senior lenders. As part of the Merger the principal of $6,000 along with outstanding interest of $162 was converted on August 25, 2023 into 712 common shares.
12.		In July 2023, the Company entered into a twelve (12) month note Convertible Promissory Note (“Note”). The Note is for $40,000 and carries an interest rate of 15% per annum. The principal of the Note is convertible into Common Stock of the Company at a twenty percent discount to the closing price of the Company’s Common Stock on September 1, 2023 or if the business combination between FG Merger Corp. (“FGMC”) and the Company pursuant to the Merger Agreement and Plan of Reorganization by and among FGMC, FG Merger Sub Inc., and the Company dated January 5, 2023, as such agreement may be amended from time to time (the “Business Combination”), occurs then, upon any subsequent conversion of the Note, the holder shall no longer have the right to receive Company common stock upon conversion of the Note, but shall have the right to receive, for each share of Company common stock that would have been issuable upon such conversion immediately prior to the occurrence of the Business Combination, the number of shares of FGMC common stock receivable as a result of such Business Combination by a holder of the number of shares of Company common stock for which the Note is convertible immediately prior to such Business Combination at a twenty percent discount to such exchange ratio. The promissory note is subordinated to the Company’s senior lenders. As part of the Merger the principal of $40,000 along with outstanding interest of $412 was converted on August 25, 2023 into 4,670 common shares.
13.	In September 2023 the Company entered into a sixty-day Promissory Note (“Note”) in the amount of $1,200,000 related to its purchase of the assets of Preferred Dental Development LLC. The Note carries an interest of 12% per annum and is subordinated to the Company’s senior lenders. The principal balance of the note was fully repaid in December 31, 2023 with only the interest portion of $38,609 outstanding as of December 31, 2023. The promissory note is subordinated to the Company’s senior lenders

7. FORWARD PURCHASE AGREEMENT

~~F-28~~On ~~Table~~August of14, ~~Contents~~2023, the Company entered into Prepaid Forward Purchase Agreement (the “FPA”) with Old iCore and RiverNorth SPAC Arbitrage Fund, L.P., a Delaware limited partnership (the “Purchaser”).

~~14.~~ In ~~October~~accordance ~~2023,~~with the ~~Company~~FPA ~~entered into a promissory note for $350,000. The maturity of the Promissory Note is May 13, 2024~~ and ~~carries~~subject an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate of $1.85 per share. In conjunction with the Promissory Note, the Company also issued a five-year warrant to ~~purchase 24,500 shares of Company common stock with an exercise price of $2.04. The value of~~ the ~~warrants~~terms ~~of 13,498 as determined by a Black-Scholes calculation is separated from the value of the note~~ and ~~expensed~~conditions ~~equally~~set ~~over~~forth ~~the term of the note as a financing fee. On December 28~~therein, ~~2023,~~ the ~~Company~~Purchaser ~~entered~~purchased ~~into a securities purchase agreement with~~ the ~~existing~~lesser ~~investor, pursuant to which the Company issued the investor a convertible note in principal amount~~ of ~~$100,000. The maturity of the convertible note is December 28, 2024 and carries an interest rate of 12% per annum and is initially convertible into Company common stock at~~ (a) ~~conversion rate equal to 120% of the closing price of the Company’s common stock on the date of issuance which was $~~1.315 ormillion $1.57 for the share price of conversion. In December 2023, the Company entered into an amendment with holder of an Amendment to Convertible Promissory Notes issued in October 2023 whereby the holder of the Note agreed that the Note would not be convertible into shares of ~~Company~~FGMC Common Stock ~~unless~~ and ~~until the Company’s shareholders approve such conversion per NASDAQ Listing Rule 5635~~(db). ~~The~~such ~~Company~~number ~~and the Note holder also entered into amendments to the warrants to purchase common stock issued in connection with the issuance~~ of ~~the~~shares ~~Note, pursuant to which the holder~~ of ~~the~~FGMC ~~Warrants~~Common ~~agreed~~Stock ~~that~~as the Warrants would not become exercisable unless and until the Company’s shareholders approve the exercise of the Warrants pursuant to NASDAQ Listing Rule 5635(d). The promissory notes are subordinated to the Company’s senior lender. 15. In October 2023shall, ~~the~~following ~~Company entered into a securities purchase agreement with an investor, pursuant to which~~ the ~~Company~~Business ~~issued the investor a Convertible Promissory Note in principal amount of $500~~Combination,~~000.~~ ~~The~~not ~~maturity~~exceed of the Convertible Promissory Note is October 31, 2024 and carries an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate equal to 120% of the closing price of the Company’s common stock on the date of issuance which was $19.58 or $1.90. In December 2023, the Company entered into a securities purchase agreement with the existing investor, pursuant to which the Company issued the investor a convertible note in principal amount of $500,000. The maturity of the convertible note is December 18, 2024 and carries an interest rate of 129% ~~per annum and is initially convertible into Company common stock at a conversion rate equal to 120%~~ of the ~~closing~~total ~~price~~number of ~~the~~shares ~~Company’s common stock on the date~~ of ~~issuance~~FGMC ~~which~~Common ~~was~~Stock ~~$2.31 or $2.77 for the share price of conversion. The promissory notes are subordinated~~ to ~~the~~be ~~Company’s~~outstanding ~~senior~~(such ~~lender.~~shares ~~16. In December 2023, the Company entered into a securities purchase agreement pursuant~~ to ~~which~~be ~~the Company issued a convertible note in principal amount of $70~~purchased,~~000.~~ ~~The maturity of~~ the ~~convertible~~“Forward ~~note~~Purchase isShares”) ~~December~~from ~~19,~~public ~~2024~~shareholders ~~and~~for ~~carries an interest rate of 12% per annum and is initially convertible into Company common stock at~~ a ~~conversion rate equal to 120% of the closing~~ price ofno ~~the~~greater ~~Company’s~~than ~~common stock on~~ the ~~date~~redemption ~~of issuance which was $1.69 or $2.03 for the share~~ price of conversion. The promissory notes are subordinated to the Company’s senior lender. 17. In December 2023, the Company entered into a securities purchase agreement pursuant to which the Company issued a convertible note in principal amount of $70,000. The maturity of the convertible note is December 19, 2024 and carries an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate equal to 120% of the closing price of the Company’s common stock on the date of issuance which was $1.69 or $2.03 for the share ~~price~~as of conversion. The promissory notes are subordinated to the Company’s senior lender. 18. In December 2023, the Company issued a subordinated note to a service provider in principal amount of $2,000,000 in exchange for conversion of an account payable in the amount of $2,000,000. The maturity of the subordinated note is ~~December~~indicated ~~26, 2024 and carries an interest rate of 15% per annum and is to be paid~~ in interest only installments for three months followed with a ballon payment in month four and then a combination of principal and interest payments for the remaining term. The note is secured by the assets of the Company and is junior to the security interest of the CompanyFGMC’s ~~senior~~most ~~lender.~~recently Asfiled ~~part~~periodic ofreport (the ~~note~~“Prepaid ~~payable~~Forward ~~the~~Purchase ~~Company agreed to purchase investor relation consulting services totaling $200,000 payable in quarterly installments beginning in January 2024~~Price”).

9.In ~~INCOME~~accordance ~~TAXES~~with the terms of the Business Combination, upon the consummation of the Business Combination, each Forward Purchase Share automatically converted into one share of Preferred Stock (including the shares of the Company’s Common Stock underlying the Preferred Stock, the “Purchased Shares”).

~~The~~Upon ~~Company~~the ~~has~~Business ~~incurred~~Combination ~~net losses since inception. As of December 31~~closing, ~~2023~~100, ~~the Company had cumulative federal net operating loss carryforwards of approximately $27,559,~~000 ~~which~~Purchased ~~are~~Shares ~~available~~were deemed to be ~~carried~~“Commitment ~~forward~~Shares” ~~indefinitely~~ and ~~federal net operating loss carryforwards of approximately $62,985,000 which at~~ the ~~latter~~remaining ~~date~~Purchased ~~may~~Shares bewere ~~carried~~deemed forward for tax years ending through December 31, 2038. As of December 31, 2023, the Company had cumulative state net operating loss carryforward of approximately $5,900,000 which will begin expiring in 2031 if not utilized prior to ~~then. Utilization of NOL carryforwards may~~ be ~~limited~~“Prepaid ~~under~~Forward ~~various~~Purchase ~~sections of the Internal Revenue Code depending on the nature of the Company’s operations~~Shares”. ~~The Company’s income tax returns are subject to examination by the Internal Revenue Service and applicable state taxing authorities, generally for a period of three years from the date of filing.~~

~~F-29~~Upon ~~Table~~the closing of ~~Contents~~the Business Combination FGMC caused Purchaser to be paid directly out of the funds held in FGMC’s trust account, a cash amount (the “Prepayment Amount”) equal to the number of Purchased Shares multiplied by the amount paid to redeeming stockholders in connection with the Business Combination (the “Redemption Price”). The Redemption Price was $10.69.

~~Deferred~~Upon ~~taxes~~the ~~comprise~~sale of the ~~following~~Prepaid asForward ofPurchase ~~December~~Shares 31(or underlying FGMC Common Stock) by the Purchaser, ~~2023~~the ~~and~~Purchaser ~~2022~~will remit the Reference Price (as defined below) per share to FGMC. On the earlier to occur of:

		2023			2022
	·	the occurrence of a “Registration Failure” (as defined in the FPA), and
Net Operating Losses		$	19,676,000		$	14,849,000
	·	the date that is twelve months after the closing of the Business Combination (the “Maturity Date”), then, for any Common Stock underlying the Prepaid Forward Purchase Shares not sold by the Purchaser, the Purchaser shall, on the 25th trading day after the Maturity Date (the “Payment Date”), pay the Company an amount equal to (i) the number of Prepaid Forward Purchase Shares that the Purchaser held on the Maturity Date, multiplied by (ii) the lowest daily volume weighted average price per share of FGMC Common Stock during the twenty trading days beginning on the day after the Maturity Date less $0.15.
Intangible assets			926,000			74,000
Stock-based compensation-nonqualified			433,000			418,000
Property and equipment			(12,000	)		(140,000	)
Allowance for bad debts			25,000			-
Forward purchase agreement			562,000			-
Organizational costs			224,000			195,000
ROU lease liability			289,000			-
Net Deferred Tax Asset			22,123,000			15,396,000
ROU lease asset			(273,000	)		-
Total Deferred Tax Liability			(273,000	)		-
Valuation Allowance		$	(21,850,000	)	$	(15,396,000	)
Reconciliation of the effective income tax rate to the federal statutory rate:
Federal Income Tax Rate			21	%		21	%
Permanent Differences			(3	)%		(2	)
State Taxes, net			0	%		3
Cumulative adjustments			23	%
Change in valuation allowance including the effect of the rate change			(41	)%		(22	)%
Effective income tax rate			0	%		0	%

~~10.~~F-27 ~~CONCENTRATION~~Table OFof ~~CREDIT RISK~~Contents

~~Financial~~Between ~~instruments that potentially subject~~ the ~~Company~~Maturity toDate ~~concentrations of credit risk consist of cash~~ and ~~trade~~the ~~accounts~~Payment ~~receivables. The Company places its cash with high-credit-quality financial institutions. At times~~Date, ~~such~~the ~~cash~~Purchaser may benot insell ~~excess~~more ofthan ~~the~~a ~~Federal~~number ~~Deposit~~of ~~Insurance~~Prepaid ~~Corporation~~Forward ~~(“FDIC”)~~Purchase ~~insurance~~Shares ~~coverage limit of $250,000~~ per ~~depositor.~~day Asequal ato ~~result,~~the ~~there~~greater ~~could be a concentration~~ of ~~credit~~(i) ~~risk~~5% ~~related to amounts on deposit in excess~~ of ~~FDIC~~the ~~insurance~~Purchased ~~coverage.~~Shares ~~The~~owned ~~Company~~by ~~has not experienced any losses due to these excess deposits and believes~~ the ~~risk~~Purchaser isat ~~not significant. With respect to trade receivables, management routinely assesses~~ the ~~financial~~Maturity ~~strength~~Date ~~of its customers~~ and, as(ii) a10% ~~consequence,~~of ~~believes that~~ the ~~receivable~~daily ~~credit~~trading ~~risk~~volume ~~exposure~~on issuch ~~limited~~date.

The ~~Company~~Purchaser has ~~historically~~agreed ~~provided~~that ~~financial~~until ~~terms~~the toMaturity ~~customers~~Date, inthe ~~accordance~~Common ~~with~~Stock ~~what~~underlying ~~management~~the ~~views~~Prepaid asForward ~~industry~~Purchase ~~norms.~~Shares ~~Access~~may tonot ~~the~~be ~~Company’s~~sold ~~software~~for ~~products~~a ~~usually~~price ~~requires~~less ~~immediate~~than ~~payment~~the ~~but~~Reference ~~can~~Price. ~~extend~~The ~~several~~“Reference ~~months~~Price” ~~under~~will ~~certain~~initially ~~circumstances.~~equal ~~Management~~the ~~periodically~~Redemption Price and ~~regularly~~will ~~reviews~~be ~~customer~~reduced ~~account~~(but ~~activity~~never inincreased) ~~order~~each tomonth ~~assess~~commencing on the ~~adequacy~~first day of ~~allowances~~the ~~for~~month ~~doubtful~~starting ~~accounts,~~30 ~~considering~~days ~~such~~after ~~factors~~the asBusiness ~~economic~~Combination ~~conditions~~closing ~~and~~to ~~each~~the ~~customer’s~~volume ~~payment~~weighted ~~history~~average ~~and~~price ~~creditworthiness.~~of If the ~~financial~~FGMC ~~condition~~Common ofStock ~~our~~for ~~customers~~the ~~were~~preceding to10 ~~deteriorate~~trading days, orbut ifin ~~they~~no ~~were~~event ~~otherwise~~less ~~unable~~than to$10.00 ~~make~~per ~~payments~~share in(the ~~accordance~~“Floor”) ~~with~~unless ~~management~~in the Company’s ~~expectations~~sole discretion, wethe ~~might~~Floor ~~have~~is tolowered. ~~increase~~Any ~~our~~reduction ~~allowance~~of ~~for~~the ~~doubtful~~Floor ~~accounts,~~shall ~~modify~~be ~~their~~accomplished ~~financial~~through ~~terms~~a ~~and/or~~written ~~pursue~~notice ~~alternative~~from ~~collection~~the ~~methods~~Company to Purchaser.

The ~~Company~~FPA ~~has~~provides nofor ~~significant~~certain ~~customers~~registration ~~(greater~~rights. ~~than~~In ~~10%~~particular, ofFGMC ~~total~~is ~~revenue)~~required into, ~~its~~within ~~2023~~30 ~~and~~calendar ~~2022~~days ~~revenue.~~following ~~The~~written ~~Company~~request ~~has~~by ~~accounts~~Purchaser, ~~receivable~~file ~~concentration~~ with ~~one~~the ~~customer~~SEC ina ~~2023~~registration ~~representing~~statement ~~25%~~registering ~~and~~the ~~two~~resale ~~customers with concentrations~~ of ~~12%~~all ~~and~~shares ~~11%~~held ~~respectively~~by ofPurchaser ~~total accounts receivables outstanding as of December 31, 2023~~ and ~~one~~have ~~customers~~such ~~that~~registration ~~represent~~statement ~~31%~~declared ofeffective ~~accounts~~as ~~receivable~~soon ~~outstanding~~ as ofpracticable ~~December~~after ~~31,~~the ~~2022~~filing thereof.

~~F-30~~In ~~Table~~August of2024, ~~Contents~~the parties entered into an amendment which extend the conversion date to the maturity date. In addition, the parties confirmed their agreement that the Prepaid Forward Purchase Shares would not be eligible for dividends or any downside protection while such shares remained as Preferred Stock.

~~11.~~In ~~COMMITMENTS~~November ~~AND~~2024, ~~CONTINGENCIES~~the Company elected to convert the FPA Series A Preferred Shares into Common Stock on its agreed upon one for one basis resulting in 53,771 Common Stock being issued and 1,075,403 Series A Shares being cancelled.

The FPA was extinguished in March of 2025 (Arefer to Note 18). ~~LEASE~~The ~~COMMITMENTS~~Company received $7,000 for the cancellation of the agreement.

~~On September 22, 2021, the Company signed a six year and one month lease agreement for approximately 7,650 square feet for its new headquarters commencing on January 1, 2022, located in Ocoee, Florida~~8. The lease provides for a five-year renewal term at the option of the Company. In April 2023, the Company entered into a lease agreement with its existing landlord of its Florida location for a lease of an additional 2,295 square feet of space beginning at the earlier of June 1, 2023 or completion of build out for a five year term. DEBT

The Company signed a three-year lease agreement for approximately 2,100 square feet of office space located in Concord, NC on July 16, 2020. In August 2023, the Company extended its lease for another year on similar terms and conditions as its current lease.

		December 31,			December 31,
		2024			2023
(1)	Convertible Note bearing interest at 12%, due July 31, 2024	$	-		$	473,743
(1)	Convertible Promissory Note bearing interest at 12%, due August 1, 2025		479,149			-
(1)	Convertible Promissory Note bearing interest at 12%, due August 1, 2025		425,907			-
(2)	Note bearing interest at 18% due October 1, 2026		18,202			27,540
(3)	Secured Promissory Note bearing interest at 17.5% due February 28, 2026		1,786,437			1,988,793
(4)	Promissory Note bearing interest at 12%, due October 31, 2023		-			38,609
(5)	Convertible Note bearing interest at 12% due October 31, 2024		-			388,380
(5)	Convertible Note bearing interest at 12%, due December 28, 2024		-			114,781
(6)	Convertible Note bearing interest at 12%, due October 31, 2024		-			569,391
(6)	Convertible Note bearing interest at 12%, due December 18, 2024		-			574,961
(6)	Convertible Promissory Note bearing interest at 12%, due August 1, 2027		221,041			-
(6)	Convertible Promissory Note bearing interest at 12%, due August 1, 2027		1,136,272			-
(7)	Convertible Note bearing interest at 12%, due March 19, 2025		-			80,722
(7)	Convertible Promissory Note bearing interest at 12%, due March 19, 2025		78,709			-
(8)	Convertible Note bearing interest at 12%, due March 19, 2025		-			80,509
(8)	Convertible Promissory Note bearing interest at 12%, due March 19, 2025		78,709			-
(9)	Promissory Note bearing interest at 15%, due December 26, 2024		2,199,692			2,000,000
(10)	Convertible Promissory Note bearing interest at 12%, due August 1, 2027		55,623			-
(11)	Convertible Promissory Note bearing interest at 12%, due August 1, 2027		5,562			-
(12)	Convertible Note bearing interest at 16%, due February 26, 2025		731,967			-
(12)	Convertible Note bearing interest at 12%, due July 30, 2025		2,922			-
(12)	Convertible Note bearing interest at 16%, due December 3, 2025		277,110			-
(12)	Convertible Note bearing interest at 16%, due December 3, 2025		277,110			-
(13)	Promissory Note bearing interest at 12%, due February 14, 2025		55,614			-
(13)	Promissory Note bearing interest at 12%, due July 15, 2025		133,306			-
(14)	Convertible Promissory Note bearing interest at 12%, due August 1, 2027		820,295			-
(15)	Convertible Promissory Note bearing interest at 12%, due September 30, 2025		113,942			-
(15)	Convertible Promissory Note bearing interest at 12%, due November, 2025		111,881			-
	Total notes payable		9,009,450			6,337,429
	Less: Unamortized debt discounts		(94,037	)		-
	Less: unamortized financing costs		(1,722,238	)		(196,837	)
	Total notes payable, net of financing costs		7,193,175			6,140,592
	Less current maturities		(5,352,256	)		(4,720,455	)
	Total Long-Term Debt	$	1,840,919		$	1,420,137

~~With~~F-28 ~~the~~Table ~~acquisition~~ of Advantech, the Company signed a two-year lease on May 12, 2021, for an office in Scottsdale, AZ. In May 2023, the Company extended its lease for an additional 24 months for this location beginning July 1, 2023 under similar terms and conditions as its current lease.Contents

As1. On February 9, 2024, the Company issued a convertible note and entered into a securities purchase agreement with an investor with an effective date of December 3129, 2023, ~~undiscounted~~pursuant ~~future~~to ~~lease~~which ~~obligations~~the Company in principal amount of $473,743 in exchange for the ~~office~~conversion ~~space~~of a payable in the amount of $473,743. The maturity of the convertible note is June 1, 2024 and carries an interest rate of 12% per annum and is convertible into Company common stock at a conversion rate equal to 100% of the closing price of the Company’s common stock on December 29, 2023. At maturity this note was reissued under the existing terms with a maturity date of July 31, 2024 in addition the Company issued 3,735 restricted common stock at maturity. The value of the Common Stock was deemed to be $37,338 and was expensed on issuance. On maturity this note was extended under the same terms to July 31, 2024. On August 13, 2024, with an effective date of August 1, 2024 the Company entered into securities purchase agreement with the note holders whose debt had matured as of July 31, 2024 totaling $507,060 inclusive of all unamortized OID, accrued interest and outstanding principal. The parties entered into a new convertible promissory note with a maturity date of August 1, 2025. The note is convertible at $10.60 with a mandatory conversion if the Company’s stock price is $13.80 or above subject to there being at least 75,000 daily share trading volume over five consecutive days. The note carries an interest rate of 12% per annum with all interest and principal due at maturity. The note is subordinated to the Company’s senior lenders. On June 1, 2024, the Company issued a convertible note and entered into a securities purchase agreement with another related investor, pursuant to which the Company in principal amount of $397,622 in exchange for the conversion of a payable in the amount of $397,622. The maturity of convertible note is July 31, 2024 and carries an interest rate of 12% per annum and is convertible into Company common stock at a conversion rate equal to 100% of the closing price of the Company’s common stock on June 1, 2024. On August 13, 2024, with an effective date of August 1, 2024 the Company entered into securities purchase agreement with the note holders whose debt had matured as of July 31, 2024 totaling $405,636 inclusive of all unamortized OID, accrued interest and outstanding principal. The parties entered into a new convertible promissory note with a maturity date of August 1, 2025. The note is convertible at $10.60 with a mandatory conversion if the Company’s stock price is $13.80 or above subject to there being at least 75,000 daily share trading volume over five consecutive days. The note carries an interest rate of 12% per annum with all interest and principal due at maturity. The note is subordinated to the Company’s senior lenders. 2. In November 2021, the Company signed a $40,071 equipment finance agreement with a maturity date 60 months after issuance from a third-party financing company. Payments of principal and interest of $791 are due monthly. 3. On February 28, 2022, the Company signed a $2,000,000 secured promissory note with a maturity date 48 months after issuance and received in exchange $1,970,000 net of fees. An Interest charge of 17.5% per annum shall accrue, with interest only payments being made for the first six months after which both interest and principal will be due. The Company has right of prepayment subject to certain minimum interest payments being made. The Prepayment Fee shall be (i) equal to 6 months’ interest that would have accrued with regard to the prepaid principal, if prepaid prior to the 2nd anniversary of the date of the Initial Advance or Subsequent Advance, as ~~follows:~~applicable, and (ii) equal to 3 months’ interest that would have accrued with regard to the prepaid principal, if prepaid on or after the 2nd anniversary and prior to the 3rd anniversary of the date of the Initial Advance or Subsequent Advance, as applicable. Additionally, the Company has the following covenant requirements; maintaining a minimum cash balance of $150,000 in its combined bank accounts as well as entering into a Deposit Account Control Agreement; monthly financial reporting requirements and certifications; obtaining other indebtedness without consent; merge, consolidate or transfer assets; pledge assets as collateral; or guarantee without consent of the Lender. On February 12, 2024, the Company entered into a Forbearance Agreement with an effective date of December 31, 2023 whereby the Company agreed to make $300,000 payment to cure certain defaults under the original Loan Agreement. In addition, the Company agreed to increase the default rate of interest in the Loan Agreement, report certain financial and cash metrics on a weekly basis, budgetary updates as well as pay down of balance of 10% of all financing raised over $500,000, in exchange for interest only payments until July 2024 and waiver of all covenants. The Company has obtained an additional waiver until December 31, 2024.

Lease Commitments
as of December 31, 2023
Less than 1 year		1-3 years		3-5 years		Total
$	369,849	$	1,059,423	$	89,038	$	1,518,310

F-29

Table of Contents

~~Lease~~4. ~~costs~~In September 2023 the Company entered into a sixty-day Promissory Note (“Note”) in the amount of $1,200,000 related to its purchase of the assets of Preferred Dental Development LLC. The Note carries an interest of 12% per annum and is subordinated to the Company’s senior lenders. The principal balance of the note was fully repaid in December 31, 2023 with only the interest portion of $38,609 outstanding as of December 31, 2023. The note was fully repaid in January 2024. The promissory note was subordinated to the Company’s senior lenders. 5. In October 2023, the Company entered into a promissory note for $350,000. The maturity of the Promissory Note is May 13, 2024 and carries an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate of $37.00 per share. In conjunction with the Promissory Note, the Company also issued a five-year ~~ended~~warrant ~~December~~to purchase 1,225 shares of Company common stock with an exercise price of $40.80. The value of the warrants was $13,498 as determined by a Black-Scholes calculation is separated from the value of the note and expensed equally over the term of the note as a financing fee. At maturity this note was extended under existing terms till July 31, 2024 in addition the Company will issue 2,577 restricted common stock at maturity. The value of the Common Stock was deemed to be $21,640 and was expensed on issuance. On August 13, 2024, with an effective date of August 1, 2024, the Company entered into an extension of the term of the note to October 31, 2024 under the same terms and conditions. In November 2024 the holder exercised their option to convert their note and converted $396,258 representing all principal and interest into 37,208 shares of common stock. The promissory note was subordinated to the Company’s senior lenders. On December 28, 2023, ~~were~~the Company entered into a securities purchase agreement with the existing investor, pursuant to which the Company issued the investor a convertible note in principal amount of $~~347~~100,~~910~~000. The maturity of the convertible note is December 28, 2024 and ~~cash~~carries ~~paid~~an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate equal to 120% of the closing price of the Company’s common stock on the date of issuance which was $26.20 or $31.40 for ~~amounts~~the ~~included~~share price of conversion. In December 2023, the Company entered into an amendment with holder of an Amendment to Convertible Promissory Notes issued in October 2023 whereby the ~~measurement~~holder of ~~lease~~the ~~liabilities~~Note agreed that the Note would not be convertible into shares of Company Common Stock unless and until the Company’s shareholders approve such conversion per NASDAQ Listing Rule 5635(d). The Company and the Note holder also entered into amendments to the warrants to purchase common stock issued in connection with the issuance of the Note, pursuant to which the holder of the Warrants agreed that the Warrants would not become exercisable unless and until the Company’s shareholders approve the exercise of the Warrants pursuant to NASDAQ Listing Rule 5635(d), such approval was obtained on May 31, 2024. On August 13, 2024, with an effective date of August 1, 2024 the Company entered into an exchange agreement and new convertible promissory note with the holder totaling $118,425 inclusive of any and all unamortized OID, accrued interest and outstanding principal. Pursuant to the exchange agreements the Company issued a new note that extended the term of the original debt to August 1, 2027 and provide for a new conversion price of $16.00 with a mandatory conversion if the ~~year~~Company’s ~~ended~~stock ~~December~~price is at $20.80 or above subject to there being at least 75,000 daily share trading volume over five consecutive days. The new note carries an interest rate of 12% per annum with all interest and principal due at maturity. In November 2024 the holder exercised their option to convert their note and converted $122,669 representing all principal and interest into 7,667 shares of common stock. The promissory note is subordinated to the Company’s senior lenders. 6. In October 2023, the Company entered into a securities purchase agreement with an investor, pursuant to which the Company issued the investor a Convertible Promissory Note in principal amount of $500,000. The maturity of the Convertible Promissory Note is October 31, 2024 and carries an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate equal to 120% of the closing price of the Company’s common stock on the date of issuance which was $31.60 or $38.00. In December 2023, ~~were~~the Company entered into a securities purchase agreement with the existing investor, pursuant to which the Company issued the investor a convertible note in principal amount of $40500,~~412~~000. AsThe maturity of the convertible note is December 18, 2024 and carries an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate equal to 120% of the closing price of the Company’s common stock on the date of issuance which was $46.20 or $55.40 for the share price of conversion. On August 13, 2024, with an effective date of August 1, 2024 the Company entered into exchange agreements and convertible promissory notes with the note holder whose debt matured after July 31, 2024 totaling $1,082,192 inclusive of all unamortized OID, accrued interest and outstanding principal. Pursuant to the exchange agreements the Company issued a new note that extended the term of the original debt to August 1, 2027 and provide for a new conversion price of $16.00 with a mandatory conversion if the Company’s stock price is at $20.80 or above subject to there being at least 75,000 daily share trading volume over five consecutive days. The new note carries an interest rate of 12% per annum with all interest and principal due at maturity. On April 2, 2024 the Company entered into a promissory note in the principal amount of $200,000 with the existing investor. The maturity of the promissory note is June 30, 2024 and carries an interest rate of 16% per annum with interest and principal due at maturity. On August 13, 2024, with an effective date of August 1, 2024 the Company entered into an exchange agreement and new convertible promissory note with the holder totaling $210,521 inclusive of any and all unamortized OID, accrued interest and outstanding principal. Pursuant to the exchange agreements the Company issued a new note that extended the term of the original debt to August 1, 2027 and provide for a new conversion price of $16.00 with a mandatory conversion if the Company’s stock price is at $20.80 or above subject to there being at least 75,000 daily share trading volume over five consecutive days. The new note carries an interest rate of 12% per annum with all interest and principal due at maturity. The promissory notes are subordinate to the Company’s senior lenders. 7. In December 2023, the ~~following~~Company ~~represents~~entered into a securities purchase agreement pursuant to which the ~~difference~~Company ~~between~~issued a convertible note in principal amount of $70,000. The maturity of the ~~remaining~~convertible ~~undiscounted~~note ~~lease~~is ~~commitments~~December ~~under~~19, ~~non-cancelable~~2024 ~~leases~~and carries an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate equal to 120% of the ~~lease~~closing ~~liabilities:~~price of the Company’s common stock on the date of issuance which was $33.80 or $40.56 for the share price of conversion. At maturity, the note was extended on the same terms until March 19, 2025. The promissory note is subordinated to the Company’s senior lender. 8. In December 2023, the Company entered into a securities purchase agreement pursuant to which the Company issued a convertible note in principal amount of $70,000. The maturity of the convertible note is December 19, 2024 and carries an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate equal to 120% of the closing price of the Company’s common stock on the date of issuance which was $33.80 or $40.56 for the share price of conversion. At maturity, the note was extended on the same terms until March 19, 2025. The promissory note is subordinated to the Company’s senior lender.

Undiscounted minimum lease commitments	$	1,518,310
Less: Imputed Interest		(330,476	)
Lease liabilities	$	1,187,834

F-30

Table of Contents

F-9. In December 2023, the Company issued a subordinated note to a service provider in principal amount of $2,000,000 in exchange for conversion of an account payable in the amount of $2,000,000. The maturity of the subordinated note is December 26, 2024 and carries an interest rate of 15% per annum and is to be paid in interest only installments for three months followed with a ballon payment in month four and then a combination of principal and interest payments for the remaining term. The note is secured by the assets of the Company and is junior to the security interest of the Company’s senior lender. As part of the note payable the Company agreed to purchase investor relation consulting services totaling $200,000 payable in quarterly installments beginning in January 2024. The Company was not incompliance with certain provisions of the loan as of December 31, ~~Table~~2024 and has disputed the amounts owed. 10. On February 1, 2024, the Company entered into a securities purchase agreement with an investor, pursuant to which the Company issued the investor a convertible note in principal amount of ~~Contents~~$50,000 in exchange for $50,000. The maturity of the convertible note is February 1, 2025 and carries an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate equal to 120% of the closing price of the Company’s common stock on the date of issuance. The convertible note is being sold and issued without registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated under the Securities Act as sales to an accredited investor, and in reliance on similar exemptions under applicable state laws. . On August 13, 2024, with an effective date of August 1, 2024 the Company entered into an exchange agreement and new convertible promissory note with the holder totaling $52,975 inclusive of any and all unamortized OID, accrued interest and outstanding principal. Pursuant to the exchange agreements the Company issued a new note that extended the term of the original debt to August 1, 2027 and provide for a new conversion price of $16.00 with a mandatory conversion if the Company’s stock price is at $20.80 or above subject to there being at least 75,000 daily share trading volume over five consecutive days. The new note carries an interest rate of 12% per annum with all interest and principal due at maturity. The promissory note is subordinated to the Company’s senior lender. 11. On February 1, 2024, the Company entered into a securities purchase agreement with an investor, pursuant to which the Company issued the investor a convertible note in principal amount of $5,000 in exchange for $5,000. The maturity of the convertible note is February 1, 2025 and carries an interest rate of 12% per annum and is initially convertible into Company common stock at a conversion rate equal to 120% of the closing price of the Company’s common stock on the date of issuance. The convertible note is being sold and issued without registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated under the Securities Act as sales to an accredited investor, and in reliance on similar exemptions under applicable state laws. . On August 13, 2024, with an effective date of August 1, 2024 the Company entered into an exchange agreement and new convertible promissory note with the holder totaling $5,298 inclusive of any and all unamortized OID, accrued interest and outstanding principal. Pursuant to the exchange agreements the Company issued a new note that extended the term of the original debt to August 1, 2027 and provide for a new conversion price of $16.00 with a mandatory conversion if the Company’s stock price is at $20.80 or above subject to there being at least 75,000 daily share trading volume over five consecutive days. The new note carries an interest rate of 12% per annum with all interest and principal due at maturity. The promissory note is subordinated to the Company’s senior lender.

~~(B)~~F-31 ~~EMPLOYMENT~~Table ~~AGREEMENTS~~of ~~WITH NAMED EXECUTIVE OFFICERS~~Contents

~~Chief~~12. ~~Executive~~On ~~Officer~~February 26, 2024, The Company executed a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (the “Investors”). Pursuant to the terms and conditions of the Purchase Agreement, the Investors agreed to purchase from the Company unsecured convertible notes in the aggregate principal amount of up to $2,375,000. The Purchase Agreement contemplates funding of the investment across two tranches. At the first closing (the “Initial Closing”) an aggregate principal amount of $1,375,000 will be issued upon the satisfaction of certain customary closing conditions in exchange for aggregate gross proceeds of $1,250,000, representing an original issue discount of 10%. On such date (the “Initial Closing Date”), the Company will also issue the Investors 4,259 shares of Company common stock (the “Commitment Shares”). Subject to satisfying the conditions discussed below, the Company has the right under the Purchase Agreement, but not the obligation, to require that the Investors purchase additional Notes at one additional closing. Upon notice, the Company may require that the Investors purchase an additional aggregate principal amount of $1,100,000 of Notes, in exchange for aggregate gross proceeds of $1,000,000, if, among other items, (i) the Registration Statement (as described below) is effective; and (ii) the Shareholder Approval (as described below) has been obtained. The Notes will mature 12 months from their respective issuance date (the “Maturity Date”), unless earlier converted. Commencing on the six-month anniversary of the issue date, the Company will be required to make monthly amortization payments pursuant to the Note of approximately 1/6th of the principal amount of the Note per month (the “Amortization Payments”). The Notes will be the Company’s unsecured obligations and equal in right of payment with all of our other indebtedness and other indebtedness of any of our subsidiaries. The Notes were issued with an original issue discount of 10.0% per annum, and will not accrue additional interest during the term; provided that the interest rate of the Notes will automatically increase to 16% per annum (the “Default Rate”) upon the occurrence and continuance of an event of default. Each holder of Notes may convert all, or any part, of the outstanding Notes, at any time at such holder’s option, into shares of the Company’s common stock at an initial “Conversion Price” of $36.96 per share, which is subject to proportional adjustment upon the occurrence of any stock split, stock dividend, stock combination and/or similar transactions. With limited exceptions, if the Company at any time while a Note is outstanding, issues any common stock or securities entitling any person or entity to acquire shares of common stock (upon conversion, exercise or otherwise), at an effective price per share less than the Conversion Price then the Conversion Price shall be reduced to the same price as the new investment. A holder shall not have the right to convert any portion of a Note to the extent that, after giving effect to such conversion, the holder (together with certain related parties) would beneficially own in excess of 4.99%, or the “Maximum Percentage”, of shares of the Company’s common stock outstanding immediately after giving effect to such conversion. If the Company fails to make any Amortization Payments when due, then each holder may alternatively elect to convert all or any portion of such holder’s Notes at a conversion price equal to the lesser of (i) the Conversion Price, and (ii) 90% of the lowest VWAP of the common stock during the five (5) consecutive trading days immediately prior to such conversion. On April 26, 2024, the Company and the Investors entered into an amendment to the Purchase Agreements (the “Amendment”) and related transaction documents, pursuant to which the terms of the Financing were amended. The amended terms include, but are not limited to, an increase in the total amount of the Notes issuable under the Financing to an aggregate principal amount of up to $8,250,000. Pursuant to the Amendment, the Company has the right to provide the Note holders a notice that permits the holders to voluntarily convert the Notes at any time at the Market Price (defined below) on the date of conversion (such notice “Voluntary Conversion Notice”) with no floor price. On July 31, 2024, a second closing occurred (the “Second Closing”), pursuant to which an aggregate principal amount of $384,406 of Notes (the “July Notes”) was issued in exchange for aggregate gross proceeds of $349,460, representing an original issue discount of 10%. On such date (the “Second Closing Date”), the Company also issued the Investors 2,537 shares of Company common stock (the “Second Commitment Shares”). The Notes will mature 12 months from their respective issuance date (the “Maturity Date”), unless earlier converted. Commencing on the six-month anniversary of the issue date, the Company will be required to make monthly amortization payments pursuant to the Note of approximately 1/6th of the principal amount of the Note per month (the “Amortization Payments”). The Notes will be the Company’s unsecured obligations and equal in right of payment with all of our other indebtedness and other indebtedness of any of our subsidiaries. The Notes were issued with an original issue discount of 10.0% per annum, and will not accrue additional interest during the term; provided that the interest rate of the Notes will automatically increase to 16% per annum (the “Default Rate”) upon the occurrence and continuance of an event of default (See “— Events of Default” below). Each holder of Notes may convert all, or any part, of the outstanding Notes, at any time at such holder’s option, into shares of the Company’s common stock at an initial “Conversion Price” of $15.40 per share, which is subject to proportional adjustment upon the occurrence of any stock split, stock dividend, stock combination and/or similar transactions. Notwithstanding the foregoing, on July 31, 2024, the Company provided the holders of all of the Notes a Voluntary Conversion Notice and accordingly, the Notes may be converted by the holders at any time at the Market Price (defined below) with no floor price. With limited exceptions, if the Company at any time while a Note is outstanding, issues any common stock or securities entitling any person or entity to acquire shares of common stock (upon conversion, exercise or otherwise), at an effective price per share less than the Conversion Price then the Conversion Price shall be reduced to the same price as the new investment. A holder shall not have the right to convert any portion of a Note to the extent that, after giving effect to such conversion, the holder (together with certain related parties) would beneficially own in excess of 4.99%, or the “Maximum Percentage”, of shares of the Company’s common stock outstanding immediately after giving effect to such conversion. If the Company fails to make any Amortization Payments when due, then each holder may alternatively elect to convert all or any portion of such holder’s Notes at a conversion price equal to the lesser of (i) the Conversion Price, and (ii) 90% of the lowest VWAP of the common stock during the five (5) consecutive trading days immediately prior to such conversion (the “Market Price”). The Notes contain standard and customary events of defaults (each, an “Event of Default”), including but not limited: (i) failure to pay to the holder any amounts when due; iii) the failure to timely file or make effective the Registration Statement (as described below) pursuant to the Registration Rights Agreement, (iii) the failure to obtain Shareholder Approval (as described below), and (iv) bankruptcy or insolvency of the Company. The Notes prohibit the Company from entering specified fundamental transactions (including, without limitation, mergers, business combinations and similar transactions) unless the Company (or the Company’s successor) assumes in writing all of the obligations under the Notes and the other transaction documents in the Financing. In addition, if such event occurs then the holder of the Note shall have the right to (i) be repaid the full amount owed under the Note and (ii) receive upon conversion of all or any portion of the Note such stock, securities or assets which the holder would have been entitled to receive in such transaction had the Note been converted immediately prior to such transaction (without regard to any limitations on conversion set forth herein).

We entered into an employment agreement, effective September 1, 2023, with Robert McDermott, pursuant to which he agreed to serve as our Chief Executive Officer for an initial term of three years, which will be automatically renewed for additional oneF-~~year~~32 ~~terms~~Table ~~unless either party chooses not to renew the agreement. Mr. McDermott’s agreement provided for an initial annual base salary~~ of $500,000. Mr. McDermott is eligible to receive an annual bonus of up to 100% of his base salary, provided final determination on the amount of the annual bonus, if any, will be made by the Compensation Committee of the Board of Directors, based on criteria established by the Compensation Committee. Pursuant to his agreement, for each fiscal year during the term, Mr. McDermott will be entitled to an annual equity grant of up to $2,500,000; provided that the final determination on the amount of the annual grant, if any, will be made by the Compensation Committee of the Board of Directors, based on criteria established by the Compensation Committee.Contents

IfOn ~~Mr.~~July ~~McDermott’s~~31, ~~employment~~2024, isthe ~~terminated~~parties atentered ~~our~~into ~~election~~a ~~without~~registration rights agreement (the “~~cause~~Registration Rights Agreement”), orwhich bygrants Mrthe Investors certain customary registration rights in connection with the Financing with respect to the shares of common stock underlying the July Notes. ~~McDermott~~In ~~for~~accordance ~~“good~~with ~~reason~~the terms and conditions of the Registration Rights Agreement,” ~~Mr.~~the ~~McDermott~~Company shall beprepare ~~entitled~~and tofile ~~receive~~with ~~severance~~the ~~payments~~SEC ~~equal~~a registration statement on Form S-1 (the “Registration Statement”) registering the resale of the common stock underlying all of the Notes within 90 days and to 18have ~~months~~such registration statement effective by within 120 days after the execution of Mrthe Registration Rights Agreement. ~~McDermott’s~~In ~~base~~compliance ~~salary;~~with ~~provided~~Nasdaq ~~that~~Listing ~~such~~Rule ~~amounts~~5635(d), the Company shall benot ~~increased~~issue toany 24shares ~~months~~of common stock underlying the July Notes if the issuance of ~~Mr.~~such ~~McDermott~~shares of common stock would exceed the aggregate number of shares of common stock which the Company may issue upon conversion of the July Notes without breaching the Company’s ~~base~~obligations ~~salary~~under ifthe Mrrules or regulations of the Nasdaq Stock Market. ~~McDermott’s~~Pursuant ~~agreement~~to isthe ~~terminated~~Purchase ~~without~~Agreement, ~~“cause”~~the orCompany byagreed Mrto hold a special stockholder seeking stockholder approval of the issuance of all of the common stock underlying the July Notes in compliance with the rules and regulations of the Nasdaq Stock Market. ~~McDermott~~The Company obtained shareholder approval for ~~“good~~such ~~reason”~~transaction ~~within~~on ~~three~~September ~~months~~16, ~~prior~~2024. On July 31, 2024, the Company and the Investors entered into a waiver agreement pursuant to orwhich ~~twelve~~the ~~months~~Investors ~~after~~agreed to waive certain events of default under the Notes related to the Company’s failure to file its Form 10-K on a ~~“change~~timely basis and delays in registering the resale of ~~control~~the common stock underlying the Notes issued in February 2024. In consideration for the waiver, the Company issued the investors warrants to purchase an aggregate of 84,028 shares (the “Warrants”). In ~~addition~~compliance with Nasdaq Listing Rule 5635(d), the Company is not able to issue any shares of common stock upon exercise of the Warrants if ~~Mr.~~the ~~McDermott~~issuance of such shares of common stock would exceed the aggregate number of shares of common stock which the Company may without breaching the Company’s ~~agreement~~obligations under the rules or regulations of the Nasdaq Stock Market. The Company obtained shareholder approval for such transaction on September 16, 2024. Each Warrant has an initial exercise price per share equal to $18.00. The Warrants are immediately exercisable and will expire on the five-year anniversary of the original issuance date. The exercise price and number of shares of common stock issuable upon exercise is ~~terminated~~subject ~~without~~to ~~“cause”~~appropriate adjustment in the event of stock dividends, stock splits, reorganizations or bysimilar Mrevents affecting our shares of common stock and the exercise price. ~~McDermott~~Subject to certain exemptions outlined in the Warrant, for ~~“good~~the ~~reason”~~life ~~within~~of ~~three~~the ~~months~~Warrant, ~~prior~~if tothe Company sells or ~~twelve~~issues ~~months~~any ~~after~~common stock or convertible security, at an effective price per share less than the exercise price of the Warrant then in effect (a “~~change~~Dilutive Issuance”), the exercise price of ~~control,”~~the ~~any~~Warrant will be reduced to the price per share in the Dilutive Issuance and the number of shares issuable upon exercise of the ~~unvested~~Warrant ~~equity~~shall ~~awards~~be proportionally adjusted so that the aggregate exercise price of the Warrant shall ~~also~~remain ~~immediately~~unchanged; ~~vest~~provided that the exercise price of the Warrants may not be lowered below $2.70 ~~During~~per share. A holder (together with its affiliates) may not exercise any ~~period~~portion of the Warrants to the extent that ~~Mr.~~the ~~McDermott~~holder iswould ~~entitled~~own tomore ~~severance~~than ~~payments~~4.99% (or, at the ~~Company~~election ~~will~~of ~~continue~~the toholder, ~~pay~~9.99%) of the ~~same~~outstanding ~~portion~~shares of Mrcommon stock immediately after exercise. ~~McDermott’s~~If ~~medical~~at the time a holder exercises its Warrants, a registration statement registering the resale of the shares of common stock underlying the Warrants under the Securities Act is not then effective or available and ~~dental~~an ~~insurance~~exemption ~~premiums~~from registration under ~~COBRA~~the asSecurities ~~during~~Act ~~active~~is ~~employment~~not ~~until~~available for the ~~earlier~~issuance of ~~(1)~~such ~~six~~shares, ~~months~~then ~~from~~in lieu of making the ~~termination~~cash payment otherwise contemplated to be made to us upon such exercise in payment of ~~employment~~the aggregate exercise price, orthe holder may elect instead to receive upon such exercise (2either in whole or in part) the ~~date~~net Mrnumber of shares of common stock determined according to a formula set forth in the Warrants. ~~McDermott~~The isregistration ~~eligible~~statement for ~~medical~~the ~~and/or~~resale ~~dental~~of ~~insurance~~the ~~benefits~~common ~~from~~stock ~~another~~underlying ~~employer.~~the Mrwarrants went effective on October 23, 2024. ~~McDermott~~The ~~agreed~~warrants ~~not~~were toinitially ~~compete~~valued ~~with~~using usBlack ~~until~~Scholes 12and ~~months~~then ~~after~~fair ~~the~~valued ~~termination~~at ofeach ~~his~~reporting ~~employment~~period using the Black Scholes model.

~~Chief~~F-33 ~~Financial~~Table ~~Officer~~of Contents

WeOn ~~entered~~December ~~into~~6, 2024, a third closing occurred (the “Third Closing”), pursuant to which an ~~employment~~aggregate ~~agreement~~principal amount of $550,000 ~~effective~~of ~~September~~Notes 1(the “December Notes”) was issued in exchange for aggregate gross proceeds of $500,000, ~~2023~~representing an original issue discount of 10%. On such date (the “Third Closing Date”), ~~with~~the ~~Archit~~Company ~~Shah~~also issue the Investors 14,672 ~~pursuant~~shares of Company common stock (the “Third Commitment Shares”). The Notes will mature 12 months from their respective issuance date (the “Maturity Date”), unless earlier converted. Commencing on the six-month anniversary of the issue date, the Company will be required to ~~which~~make hemonthly ~~agreed~~amortization payments pursuant to ~~serve~~the asNote of approximately 1/6th of the principal amount of the Note per month (the “Amortization Payments”). The Notes will be the Company’s unsecured obligations and equal in right of payment with all of our ~~Chief~~other ~~Financial~~indebtedness ~~Officer~~and ~~for~~other indebtedness of any of our subsidiaries. The Notes were issued with an ~~initial~~original ~~term~~issue discount of ~~three~~10.0% ~~years~~per annum, ~~which~~and will benot ~~automatically~~accrue ~~renewed~~additional ~~for~~interest ~~additional~~during ~~one-year~~the ~~terms~~term; ~~unless~~provided ~~either~~that ~~party~~the ~~chooses~~interest ~~not~~rate of the Notes will automatically increase to ~~renew~~16% per annum (the ~~agreement.~~“Default MrRate”) upon the occurrence and continuance of an event of default (See “— Events of Default” below). ~~Shah~~Each holder of Notes may convert all, or any part, of the outstanding Notes, at any time at such holder’s ~~agreement~~option, ~~provided~~into ~~for~~shares of the Company’s common stock at an initial ~~annual~~“Conversion ~~base~~Price” ~~salary~~ of $~~314,000~~4. ~~Mr.~~176 ~~Shah~~per share, which is ~~eligible~~subject to ~~receive~~proportional anadjustment ~~annual~~upon ~~bonus~~the occurrence of upany tostock ~~50%~~split, ofstock ~~his~~dividend, ~~base~~stock ~~salary,~~combination ~~provided final~~and/or ~~determination~~similar transactions. Notwithstanding the foregoing, on December 5, 2024, the ~~amount~~Company provided the holders of all of the ~~annual~~Notes ~~bonus~~a Voluntary Conversion Notice and accordingly, the Notes may be converted by the holders at any time at the Market Price (defined below). With limited exceptions, if the Company at any time while a Note is outstanding, ~~will~~issues any common stock or securities entitling any person or entity to acquire shares of common stock (upon conversion, exercise or otherwise), at an effective price per share less than the Conversion Price then the Conversion Price shall be ~~made~~reduced byto the ~~Compensation~~same ~~Committee~~price ofas the ~~Board~~new investment. A holder shall not have the right to convert any portion of ~~Directors~~a Note to the extent that, ~~based~~after ongiving ~~criteria~~effect ~~established~~to bysuch conversion, the ~~Compensation~~holder ~~Committee~~(together with certain related parties) would beneficially own in excess of 4.99%, ~~Pursuant~~or tothe ~~his~~“Maximum ~~agreement~~Percentage”, Mrof shares of the Company’s common stock outstanding immediately after giving effect to such conversion. ~~Shah~~If ~~for~~the Company fails to make any Amortization Payments when due, then each ~~fiscal~~holder ~~year~~may ~~during~~alternatively elect to convert all or any portion of such holder’s Notes at a conversion price equal to the ~~term~~lesser of (i) the Conversion Price, ~~Mr.~~and ~~Shah~~(ii) ~~will~~90% beof ~~entitled~~the lowest VWAP of the common stock during the five (5) consecutive trading days immediately prior to ansuch ~~annual~~conversion ~~equity~~(the ~~grant~~“Market Price”). The Notes contain standard and customary events of updefaults to(each, ~~$693~~an “Event of Default”),~~000~~ including but not limited: (i) failure to pay to the holder any amounts when due; ~~provided~~iii) ~~that~~the failure to timely file or make effective the ~~final~~Registration ~~determination~~Statement on(as described below) pursuant to the ~~amount~~Registration Rights Agreement, (iii) the failure to obtain Shareholder Approval (as described below), and (iv) bankruptcy or insolvency of the ~~annual~~Company. ~~grant~~The Notes prohibit the Company from entering specified fundamental transactions (including, ifwithout ~~any~~limitation, ~~will~~mergers, business combinations and similar transactions) unless the Company (or the Company’s successor) assumes in writing all of the obligations under the Notes and the other transaction documents in the Financing. In addition, if such event occurs then the holder of the Note shall have the right to (i) be ~~made~~repaid bythe full amount owed under the ~~Compensation~~Note ~~Committee~~and (ii) receive upon conversion of all or any portion of the ~~Board~~Note such stock, securities or assets which the holder would have been entitled to receive in such transaction had the Note been converted immediately prior to such transaction (without regard to any limitations on conversion set forth herein). During the year the holders converted a total of ~~Directors~~$1,188,925 ~~based~~in principal and interest into 342,682 shares of common stock. The Company obtained waivers from its lenders with respect to defaults on ~~criteria~~covenants ~~established~~related byto financial restatement of its Form 10Q for the ~~Compensation~~three ~~Committee~~and nine months ended September 30, 2024 as outlined in Note 17.

IfF-34 ~~Mr.~~Table ~~Shah’s employment is terminated at our election without “cause”, or by Mr. Shah for “good reason,” Mr. Shah shall be entitled to receive severance payments equal to six months~~ of Mr. Shah’s base salary; provided that such amounts shall be increased to 12 months of Mr. Shah’s base salary if Mr. Shah’s agreement is terminated without “cause” or by Mr. Shah for “good reason” within three months prior to or twelve months after of a “change of control.” In addition, if Mr. Shah’s agreement is terminated without “cause” or by Mr. Shah for “good reason” within three months prior to or twelve months after of a “change of control,” any of the unvested equity awards shall also immediately vest. During any period that Mr. Shah is entitled to severance payments, the Company will continue to pay the same portion of Mr. Shah’s medical and dental insurance premiums under COBRA as during active employment until the earlier of (1) six months from the termination of employment, or (2) the date Mr. Shah is eligible for medical and/or dental insurance benefits from another employer. Mr. Shah agreed not to compete with us until 12 months after the termination of his employment.Contents

F-32 Table of Contents

13.

On May 14, 2024, The Company executed a securities purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”). Pursuant to the terms and conditions of the Purchase Agreement, the Investors agreed to purchase from the Company unsecured convertible note in the aggregate principal amount of $178,250. The Note will mature 11 months from the respective issuance date (the “Maturity Date”), unless earlier converted. Commencing on the one-month anniversary of the issue date, the Company will be required to make monthly amortization payments pursuant to the Note of approximately 1/10th of the principal amount of the Note per month (the “Amortization Payments”). The Note will be the Company’s unsecured obligations and equal in right of payment with all of our other indebtedness and other indebtedness of any of our subsidiaries. The Notes were issued with an original issue discount of 10.0% per annum, and will accrue 12% interest during the term; provided that the interest rate of the Notes will automatically increase to 22% per annum (the “Default Rate”) upon the occurrence and continuance of an event of default. The Note may convert all, or any part, of the outstanding Notes, at any time at such holder’s option, into shares of the Company’s common stock at an initial “Conversion Price” of $10.00 per share, which is subject to proportional adjustment upon the occurrence of any stock split, stock dividend, stock combination and/or similar transactions in the event of default only. A holder shall not have the right to convert any portion of a Note to the extent that, after giving effect to such conversion, the holder (together with certain related parties) would beneficially own in excess of 4.99%, or the “Maximum Percentage”, of shares of the Company’s common stock outstanding immediately after giving effect to such conversion. The promissory note is subordinated to the Company’s senior lenders.

On September 4, 2024 the Company issued a second securities purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”). Pursuant to the terms and conditions of the Purchase Agreement, the Investors agreed to purchase from the Company unsecured convertible note in the aggregate principal amount of $127,200. The Note will mature 12 months from the respective issuance date (the “Maturity Date”), unless earlier converted. Commencing on the sixth-month anniversary of the issue date, the Company will be required to make monthly amortization payments pursuant to the Note of approximately 1/6th of the principal amount of the Note per month (the “Amortization Payments”). The Note will be the Company’s unsecured obligations and equal in right of payment with all of our other indebtedness and other indebtedness of any of our subsidiaries. The Notes were issued with an original issue discount of 10.0% per annum, and will accrue 12% interest during the term; provided that the interest rate of the Notes will automatically increase to 22% per annum (the “Default Rate”) upon the occurrence and continuance of an event of default. The Note may convert all, or any part, of the outstanding Notes, at any time at such holder’s option, into shares of the Company’s common stock at an initial “Conversion Price” of $10.00 per share, which is subject to proportional adjustment upon the occurrence of any stock split, stock dividend, stock combination and/or similar transactions in the event of default only. A holder shall not have the right to convert any portion of a Note to the extent that, after giving effect to such conversion, the holder (together with certain related parties) would beneficially own in excess of 4.99%, or the “Maximum Percentage”, of shares of the Company’s common stock outstanding immediately after giving effect to such conversion. The promissory note is subordinated to the Company’s senior lenders.

The Company obtained waiver from its lender with respect to defaults on covenants related to financial restatement of its Form 10Q for the three and nine months ended September 30, 2024 as outlined in Note 17 and the untimely filing of its Form 10-K for the year ended December 31, 2024 and its Form 10-Q for the three months ended March 31, 2025.

14.

On May 22, 2024, iCoreConnect, Inc. (the “Company”) issued an unsecured note in the aggregate principal amount of $500,000 (the “Note”) to a single lender. The Note matures on November 15, 2025 (the “Maturity Date”), unless earlier repaid. On the Maturity Date, all principal and interest will be due along with an origination amount of $65,000. Commencing November 15, 2024, interest will accrue on the outstanding principal and the origination amount at the rate of 15% per annum; provided that the interest rate will automatically increase by 1.5% per month, compounded monthly upon the occurrence of an event of default. If the Company completes a transaction or series of related transactions pursuant to which a material portion of the Company’s outstanding debt is paid, refinanced, recapitalized, compromised, or otherwise satisfied, then all amounts under the Note will become immediately due and payable. If the Company does not repay the Note, including the origination amount, prior to November 15, 2024, the Company shall be required to issue the lender 11,250 shares of Company common stock (the “Rollover Shares”). The Note contains standard and customary events of defaults, including but not limited: (i) failure to pay to the holder any amounts when due; (ii) the failure to pay when due any other debts of the Company, and (iii) bankruptcy or insolvency of the Company. The promissory note is subordinated to the Company’s senior lenders.

On August 13, 2024, with an effective date of August 1, 2024 the Company entered into an exchange agreement and new convertible promissory note with the holder totaling $781,253 inclusive of any and all unamortized OID, accrued interest and outstanding principal. Pursuant to the exchange agreements the Company issued a new note that extended the term of the original debt to August 1, 2027 and provide for a new conversion price of $16.00 with a mandatory conversion if the Company’s stock price is at $20.80 or above subject to there being at least 75,000 daily share trading volume over five consecutive days. The new note carries an interest rate of 12% per annum with all interest and principal due at maturity. The promissory notes are subordinated to the Company’s senior lenders.

~~Chief~~F-35 ~~Operating~~Table ~~Officer~~of Contents

We15. ~~entered~~On ~~into~~September an13, ~~employment~~2024 ~~agreement,~~the ~~effective~~Company ~~September~~executed 1,a ~~2023,~~securities purchase agreement (the “Purchase Agreement”) with ~~David~~an ~~Fidanza~~institutional ~~pursuant~~investor (the “Investor”). Pursuant to ~~which~~the heterms and conditions of the Purchase Agreement, the Investor agreed to ~~serve~~purchase asfrom ~~our~~the ~~Chief~~Company ~~Operating~~unsecured ~~Officer~~convertible ~~for~~notes anin ~~initial~~the ~~term~~aggregate ofprincipal ~~three~~amount ~~years~~of $220,000. ~~which~~At closing an aggregate principal amount of $110,000 will be ~~automatically~~issued ~~renewed~~upon the satisfaction of certain customary closing conditions in exchange for ~~additional~~aggregate ~~one-year~~gross ~~terms~~proceeds ~~unless~~of ~~either~~$100,000, ~~party~~representing ~~chooses~~an ~~not~~original toissue ~~renew~~discount ~~the~~of ~~agreement~~10%. MrThe Note will mature 12 months from its respective issuance date (the “Maturity Date”), unless earlier converted with all principal and interest due at maturity. ~~Fidanza~~The holder of Note may convert all, or any part, of the outstanding Note, at any time at such holder’s ~~agreement~~option, ~~provided~~into ~~for~~shares of the Company’s common stock at an initial ~~annual~~“Conversion ~~base~~Price” ~~salary~~ of $~~296,000~~10.60 ~~Mr.~~per ~~Fidanza~~share, which is ~~eligible~~subject to ~~receive~~proportional anadjustment ~~annual~~upon ~~bonus~~the occurrence of upany stock split, stock dividend, stock combination and/or similar transactions. With limited exceptions, if the Company at any time while a Note is outstanding, issues any common stock or securities entitling any person or entity to ~~50%~~acquire shares of ~~his~~common ~~base~~stock ~~salary~~(upon conversion, ~~provided final~~exercise ~~determination~~or onotherwise), at an effective price per share less than the ~~amount~~Conversion ofPrice then the ~~annual~~Conversion ~~bonus,~~Price ifshall be reduced to the same price as the new investment. A holder shall not have the right to convert any portion of a Note to the extent that, ~~will~~after begiving ~~made~~effect byto such conversion, the ~~Compensation~~holder ~~Committee~~(together with certain related parties) would beneficially own in excess of 4.99%, or the ~~Board~~“Maximum Percentage”, of ~~Directors,~~shares ~~based~~of onthe ~~criteria~~Company’s ~~established~~common bystock outstanding immediately after giving effect to such conversion. The promissory note is subordinated to the ~~Compensation~~Company’s ~~Committee~~senior lenders. ~~Pursuant~~On November 9, 2024, pursuant to ~~his~~the ~~agreement~~terms and conditions of the Purchase Agreement, ~~Mr.~~the ~~Fidanza~~Investor ~~for~~issued ~~each~~its ~~fiscal~~second ~~year~~unsecured ~~during~~convertible notes in the ~~term~~aggregate principal amount of $110,000 Mrfor aggregate gross proceeds of $100,000, representing an original issue discount of 10%. ~~Fidanza~~The Note will bemature ~~entitled~~12 tomonths anfrom ~~annual~~its ~~equity~~respective ~~grant~~issuance date (the “Maturity Date”), unless earlier converted with all principal and interest due at maturity. The holder of upNote tomay ~~$666~~convert all,~~000;~~ ~~provided~~or ~~that~~any part, of the ~~final~~outstanding ~~determination~~Note, onat any time at such holder’s option, into shares of the ~~amount~~Company’s common stock at an initial “Conversion Price” of $10.60 per share, which is subject to proportional adjustment upon the ~~annual~~occurrence ~~grant~~of any stock split, stock dividend, stock combination and/or similar transactions. With limited exceptions, if the Company at any time while a Note is outstanding, ~~will~~issues any common stock or securities entitling any person or entity to acquire shares of common stock (upon conversion, exercise or otherwise), at an effective price per share less than the Conversion Price then the Conversion Price shall be ~~made~~reduced byto the ~~Compensation~~same ~~Committee~~price as the new investment. A holder shall not have the right to convert any portion of a Note to the ~~Board~~extent that, after giving effect to such conversion, the holder (together with certain related parties) would beneficially own in excess of ~~Directors~~4.99%, ~~based~~or the “Maximum Percentage”, of shares of the Company’s common stock outstanding immediately after giving effect to such conversion. The promissory note is subordinated to the Company’s senior lenders. The Company obtained waivers from its lenders with respect to defaults on ~~criteria~~covenants ~~established~~related byto financial restatement of its Form 10Q for the ~~Compensation~~three ~~Committee~~and nine months ended September 30, 2024 as outlined in Note 17.

~~If Mr~~9. ~~Fidanza’s~~DEIVATIVE employment is terminated at our election without “cause”, or by Mr. Fidanza for “good reason,” Mr. Fidanza shall be entitled to receive severance payments equal to six months of Mr. Fidanza’s base salary; provided that such amounts shall be increased to 12 months of Mr. Fidanza’s base salary if Mr. Fidanza’s agreement is terminated without “cause” or by Mr. Fidanza for “good reason” within three months prior to or twelve months after of a “change of control.” In addition, if Mr. Fidanza’s agreement is terminated without “cause” or by Mr. Fidanza for “good reason” within three months prior to or twelve months after of a “change of control,” any of the unvested equity awards shall also immediately vest. During any period that Mr. Fidanza is entitled to severance payments, the Company will continue to pay the same portion of Mr. Fidanza’s medical and dental insurance premiums under COBRA as during active employment until the earlier of (1) six months from the termination of employment, or (2) the date Mr. Fidanza is eligible for medical and/or dental insurance benefits from another employer. Mr. Fidanza agreed not to compete with us until 12 months after the termination of his employment.LIABILITIES

~~Chief~~On ~~Technology~~July ~~Officer~~31, 2024 the Company entered into a waivers related to certain conditions as part of two notes issued in February 2024 and the Company issued warrants as consideration for these waivers.

WeThe ~~entered~~warrants ~~into~~associated ~~an employment agreement, effective September 1, 2023,~~ with ~~Murali~~the ~~Chakravarthi~~waiver ~~pursuant~~are tosubject ~~which each officer agreed~~ to ~~serve as our Chief Technology Officer for an initial term of three years, which will be automatically renewed for additional one~~anti-~~year~~dilution ~~terms~~adjustments ~~unless~~outlined ~~either~~in ~~party chooses not to renew~~ the ~~agreement~~warrants. ~~Mr.~~In ~~Chakravarthi’s~~accordance ~~agreement~~with ~~provided~~FASB ~~for~~ASC ~~an initial annual base salary of $300~~815,~~000.~~ ~~Mr. Chakravarthi is eligible to receive an annual bonus of up to 50% of his base salary, provided final determination on~~ the ~~amount~~warrants ofalong ~~the~~all ~~annual~~future ~~bonus,~~warrants ifand ~~any,~~all ~~will~~convertible befeatures ~~made by the Compensation Committee~~ of ~~the~~convertible ~~Board~~debt ofissued ~~Directors,~~from ~~based~~February on2024 ~~criteria~~were ~~established~~classified byas ~~the Compensation Committee~~liabilities. ~~Pursuant~~In ~~to his agreement~~addition, ~~Mr. Chakravarthi for each fiscal year during~~ the ~~term,~~warrants ~~Mr.~~and ~~Chakravarthi~~convertible ~~will~~features must be ~~entitled~~valued toevery anreporting ~~annual~~period ~~equity~~and ~~grant~~adjust ~~of up~~ to ~~$675000;~~market ~~provided~~with ~~that~~ the ~~final~~increase ~~determination~~or ondecrease ~~the~~being ~~amount~~adjusted ofthrough ~~the~~earnings. ~~annual~~As ~~grant,~~of ifDecember ~~any~~31, ~~will~~204 beand ~~made~~December by31, 2023 the ~~Compensation~~fair ~~Committee~~value of ~~the~~these ~~Board~~liabilities ofwas ~~Directors~~$1,726,251 ~~based~~and onnil ~~criteria established by the Compensation Committee~~respectively.

~~If Mr~~10. ~~Chakravarthi’s~~FAIR ~~employment~~VALUE isOF ~~terminated~~FINANCIAL at our election without “cause”, or by Mr. Chakravarthi for “good reason,” Mr. Chakravarthi shall be entitled to receive severance payments equal to six months of Mr. Chakravarthi’s base salary; provided that such amounts shall be increased to 12 months of Mr. Chakravarthi’s base salary if Mr. Chakravarthi’s agreement is terminated without “cause” or by Mr. Chakravarthi for “good reason” within three months prior to or twelve months after of a “change of control.” In addition, if Mr. Chakravarthi’s agreement is terminated without “cause” or by Mr. Chakravarthi for “good reason” within three months prior to or twelve months after of a “change of control,” any of the unvested equity awards shall also immediately vest. During any period that Mr. Chakravarthi is entitled to severance payments, the Company will continue to pay the same portion of Mr. Chakravarthi’s medical and dental insurance premiums under COBRA as during active employment until the earlier of (1) six months from the termination of employment, or (2) the date Mr. Chakravarthi is eligible for medical and/or dental insurance benefits from another employer. Mr. Chakravarthi agreed not to compete with us until 12 months after the termination of his employment.INSTRUMENTS

~~F-33~~Derivative ~~Table of Contents~~Liabilities

~~(C)~~For ~~LITIGATION~~purposes of determining whether certain instruments are derivatives for accounting treatment, the Company follows the accounting standard that provides guidance for determining whether an equity-linked financial instrument, or embedded feature, is indexed to an entity’s own stock. The standard applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity’s own common stock.

~~The~~Liabilities ~~Company~~measured ~~from~~at ~~time~~fair tovalue ~~time,~~on ~~may be~~ a ~~party~~recurring tobasis ~~various~~are ~~litigation,~~summarized ~~claims~~as and disputes, arising in the ordinary course of business. While the ultimate impact of such actions cannot be predicted with certainty, we believe the outcome of these matters, except for that noted below, will not have a material adverse effect on our financial condition or results of operations.follows:

On August 18, 2021, iCoreConnect received a Notice of Disposition of Collateral under section 9-611 of the Uniform Commercial Code (“UCC”) (Arizona Revised Statutes 47-611) purporting to set a foreclosure sale, under the UCC, of its assets that were previously pledged as security to Sonoran Pacific Resources, LLP, an Arizona limited liability partnership (“SPR”) and Jerry Smith (“Smith”) (collectively, the “lender”). On November 1, 2022, iCoreConnect entered into a settlement agreement and release (the “Settlement Agreement”) with SPR and Smith in connection with the above litigation. In order to resolve all matters subject to the dispute, the Settlement Agreement provided that on, or before, the 60th day following the effective date of the Settlement Agreement, which was November 1, 2022 (such 60th day, the “Payment Date”), iCoreConnect shall redeem, and/or or iCoreConnect’s designees shall acquire, a total of 9,000,000 shares of iCoreConnect Common Stock from SPR and certain shareholders or affiliates of SPR at a purchase price of $0.08 per share. The Settlement Agreement further provided that in addition to the purchase of the foregoing 9,000,000 shares, iCoreConnect or its designee will have the option, but not the obligation, to acquire or redeem any or all of the remaining 5,401,887 shares held by certain shareholders or affiliates of SPR on, or before, the Payment Date, at the cost of $0.08 per share. In connection with the dispute, iCoreConnect had previously posted a cash bond of $200,000 with the court. Pursuant to the Settlement Agreement, $100,000 was released to SPR upon execution of the Settlement Agreement, which amount will be credited toward the payment of the 9,000,000 shares described above. The foregoing share purchase obligation was satisfied on December 30, 2022. Upon the payment for the shares, the remaining $100,000 of the bond was released to SPR in consideration for the release of all claims and liens and the dismissal of the litigation. Upon iCoreConnect’s compliance with the above share repurchase obligations, J.D. Smith, the son of Jerry Smith, resigned as a director and chairman of Board of Directors. The Settlement Agreement provides that upon the performance of each of the parties of their obligations thereunder, SPR and Smith, on the one hand, and iCoreConnect, on the other hand, each agrees to a complete release of the other party or parties. The Settlement Agreement was fully completed on December 30, 2022 and a full release received from the courts.

		Level 1		Level 2	Level 3		Total
Derivative liability related to fair value of beneficial conversion features	$	-	$	-	$	455,170	$	455,170
Derivative liability related to fair value of Warrants		-		-		1,271,081		1,271,081
		-		-

Filing Compare · iCoreConnect Inc.